#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Aberrant structural-functional coupling in adult cannabis users
#Text=Cellular studies indicate that endocannabinoid type-1 retrograde signaling plays a major role in synaptic plasticity.
1-1	0-8	Aberrant	_	
1-2	9-30	structural-functional	_	
1-3	31-39	coupling	_	
1-4	40-42	in	_	
1-5	43-48	adult	_	
1-6	49-57	cannabis	_	
1-7	58-63	users	_	
1-8	64-72	Cellular	_	
1-9	73-80	studies	_	
1-10	81-89	indicate	_	
1-11	90-94	that	_	
1-12	95-110	endocannabinoid	_	
1-13	111-115	type	_	
1-14	115-116	-	_	
1-15	116-117	1	_	
1-16	118-128	retrograde	_	
1-17	129-138	signaling	_	
1-18	139-144	plays	_	
1-19	145-146	a	_	
1-20	147-152	major	_	
1-21	153-157	role	_	
1-22	158-160	in	_	
1-23	161-169	synaptic	_	
1-24	170-180	plasticity	_	
1-25	180-181	.	_	

#Text=Disruption of these processes by delta-9-tetrahydrocannabinol (THC) could produce alterations either in structural and functional brain connectivity or in their association in cannabis (CB) users.
2-1	182-192	Disruption	_	
2-2	193-195	of	_	
2-3	196-201	these	_	
2-4	202-211	processes	_	
2-5	212-214	by	_	
2-6	215-220	delta	_	
2-7	220-221	-	_	
2-8	221-222	9	_	
2-9	222-223	-	_	
2-10	223-243	tetrahydrocannabinol	_	
2-11	244-245	(	_	
2-12	245-248	THC	_	
2-13	248-249	)	_	
2-14	250-255	could	_	
2-15	256-263	produce	_	
2-16	264-275	alterations	_	
2-17	276-282	either	_	
2-18	283-285	in	_	
2-19	286-296	structural	_	
2-20	297-300	and	_	
2-21	301-311	functional	_	
2-22	312-317	brain	_	
2-23	318-330	connectivity	_	
2-24	331-333	or	_	
2-25	334-336	in	_	
2-26	337-342	their	_	
2-27	343-354	association	_	
2-28	355-357	in	_	
2-29	358-366	cannabis	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[1]	
2-30	367-368	(	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[1]	
2-31	368-370	CB	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[1]	
2-32	370-371	)	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[1]	
2-33	372-377	users	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[1]	
2-34	377-378	.	_	

#Text=Graph theoretic structural and functional networks were generated with diffusion tensor imaging and resting-state functional imaging in 37 current CB users and 31 healthy non-users.
3-1	379-384	Graph	_	
3-2	385-394	theoretic	_	
3-3	395-405	structural	_	
3-4	406-409	and	_	
3-5	410-420	functional	_	
3-6	421-429	networks	_	
3-7	430-434	were	_	
3-8	435-444	generated	_	
3-9	445-449	with	_	
3-10	450-459	diffusion	_	
3-11	460-466	tensor	_	
3-12	467-474	imaging	_	
3-13	475-478	and	_	
3-14	479-492	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[2]	
3-15	493-503	functional	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[2]	
3-16	504-511	imaging	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[2]	
3-17	512-514	in	_	
3-18	515-517	37	_	
3-19	518-525	current	_	
3-20	526-528	CB	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[3]	
3-21	529-534	users	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[3]	
3-22	535-538	and	_	
3-23	539-541	31	_	
3-24	542-549	healthy	_	
3-25	550-559	non-users	_	
3-26	559-560	.	_	

#Text=The primary outcome measures were coupling between structural and functional connectivity, global network characteristics, association between the coupling and network properties, and measures of rich-club organization.
4-1	561-564	The	_	
4-2	565-572	primary	_	
4-3	573-580	outcome	_	
4-4	581-589	measures	_	
4-5	590-594	were	_	
4-6	595-603	coupling	_	
4-7	604-611	between	_	
4-8	612-622	structural	_	
4-9	623-626	and	_	
4-10	627-637	functional	_	
4-11	638-650	connectivity	_	
4-12	650-651	,	_	
4-13	652-658	global	_	
4-14	659-666	network	_	
4-15	667-682	characteristics	_	
4-16	682-683	,	_	
4-17	684-695	association	_	
4-18	696-703	between	_	
4-19	704-707	the	_	
4-20	708-716	coupling	_	
4-21	717-720	and	_	
4-22	721-728	network	_	
4-23	729-739	properties	_	
4-24	739-740	,	_	
4-25	741-744	and	_	
4-26	745-753	measures	_	
4-27	754-756	of	_	
4-28	757-766	rich-club	_	
4-29	767-779	organization	_	
4-30	779-780	.	_	

#Text=Structural-functional coupling was globally preserved showing a positive association in current CB users.
5-1	781-802	Structural-functional	_	
5-2	803-811	coupling	_	
5-3	812-815	was	_	
5-4	816-824	globally	_	
5-5	825-834	preserved	_	
5-6	835-842	showing	_	
5-7	843-844	a	_	
5-8	845-853	positive	_	
5-9	854-865	association	_	
5-10	866-868	in	_	
5-11	869-876	current	_	
5-12	877-879	CB	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[4]	
5-13	880-885	users	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[4]	
5-14	885-886	.	_	

#Text=However, the users had disrupted associations between structural-functional coupling and network topological characteristics, most perturbed for shorter connections implying region-specific disruption by CB use.
6-1	887-894	However	_	
6-2	894-895	,	_	
6-3	896-899	the	_	
6-4	900-905	users	_	
6-5	906-909	had	_	
6-6	910-919	disrupted	_	
6-7	920-932	associations	_	
6-8	933-940	between	_	
6-9	941-962	structural-functional	_	
6-10	963-971	coupling	_	
6-11	972-975	and	_	
6-12	976-983	network	_	
6-13	984-995	topological	_	
6-14	996-1011	characteristics	_	
6-15	1011-1012	,	_	
6-16	1013-1017	most	_	
6-17	1018-1027	perturbed	_	
6-18	1028-1031	for	_	
6-19	1032-1039	shorter	_	
6-20	1040-1051	connections	_	
6-21	1052-1060	implying	_	
6-22	1061-1076	region-specific	_	
6-23	1077-1087	disruption	_	
6-24	1088-1090	by	_	
6-25	1091-1093	CB	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[5]	
6-26	1094-1097	use	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[5]	
6-27	1097-1098	.	_	

#Text=Rich-club analysis revealed impaired structural-functional coupling in the hippocampus and caudate of users.
7-1	1099-1108	Rich-club	_	
7-2	1109-1117	analysis	_	
7-3	1118-1126	revealed	_	
7-4	1127-1135	impaired	_	
7-5	1136-1157	structural-functional	_	
7-6	1158-1166	coupling	_	
7-7	1167-1169	in	_	
7-8	1170-1173	the	_	
7-9	1174-1185	hippocampus	_	
7-10	1186-1189	and	_	
7-11	1190-1197	caudate	_	
7-12	1198-1200	of	_	
7-13	1201-1206	users	_	
7-14	1206-1207	.	_	

#Text=This study provides evidence of the abnormal structural-functional association in CB users.
8-1	1208-1212	This	_	
8-2	1213-1218	study	_	
8-3	1219-1227	provides	_	
8-4	1228-1236	evidence	_	
8-5	1237-1239	of	_	
8-6	1240-1243	the	_	
8-7	1244-1252	abnormal	_	
8-8	1253-1274	structural-functional	_	
8-9	1275-1286	association	_	
8-10	1287-1289	in	_	
8-11	1290-1292	CB	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[6]	
8-12	1293-1298	users	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[6]	
8-13	1298-1299	.	_	

#Text=The effect was predominant in shorter connections of the brain network, suggesting that the impact of CB use or predispositional factors may be most apparent in local interconnections.
9-1	1300-1303	The	_	
9-2	1304-1310	effect	_	
9-3	1311-1314	was	_	
9-4	1315-1326	predominant	_	
9-5	1327-1329	in	_	
9-6	1330-1337	shorter	_	
9-7	1338-1349	connections	_	
9-8	1350-1352	of	_	
9-9	1353-1356	the	_	
9-10	1357-1362	brain	_	
9-11	1363-1370	network	_	
9-12	1370-1371	,	_	
9-13	1372-1382	suggesting	_	
9-14	1383-1387	that	_	
9-15	1388-1391	the	_	
9-16	1392-1398	impact	_	
9-17	1399-1401	of	_	
9-18	1402-1404	CB	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[7]	
9-19	1405-1408	use	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[7]	
9-20	1409-1411	or	_	
9-21	1412-1428	predispositional	_	
9-22	1429-1436	factors	_	
9-23	1437-1440	may	_	
9-24	1441-1443	be	_	
9-25	1444-1448	most	_	
9-26	1449-1457	apparent	_	
9-27	1458-1460	in	_	
9-28	1461-1466	local	_	
9-29	1467-1483	interconnections	_	
9-30	1483-1484	.	_	

#Text=Notably, the hippocampus and caudate specifically showed aberrant structural and functional coupling.
10-1	1485-1492	Notably	_	
10-2	1492-1493	,	_	
10-3	1494-1497	the	_	
10-4	1498-1509	hippocampus	_	
10-5	1510-1513	and	_	
10-6	1514-1521	caudate	_	
10-7	1522-1534	specifically	_	
10-8	1535-1541	showed	_	
10-9	1542-1550	aberrant	_	
10-10	1551-1561	structural	_	
10-11	1562-1565	and	_	
10-12	1566-1576	functional	_	
10-13	1577-1585	coupling	_	
10-14	1585-1586	.	_	

#Text=These structures have high CB1 receptor density and may also be associated with changes in learning and habit formation that occur with chronic cannabis use.
11-1	1587-1592	These	_	
11-2	1593-1603	structures	_	
11-3	1604-1608	have	_	
11-4	1609-1613	high	_	
11-5	1614-1617	CB1	_	
11-6	1618-1626	receptor	_	
11-7	1627-1634	density	_	
11-8	1635-1638	and	_	
11-9	1639-1642	may	_	
11-10	1643-1647	also	_	
11-11	1648-1650	be	_	
11-12	1651-1661	associated	_	
11-13	1662-1666	with	_	
11-14	1667-1674	changes	_	
11-15	1675-1677	in	_	
11-16	1678-1686	learning	_	
11-17	1687-1690	and	_	
11-18	1691-1696	habit	_	
11-19	1697-1706	formation	_	
11-20	1707-1711	that	_	
11-21	1712-1717	occur	_	
11-22	1718-1722	with	_	
11-23	1723-1730	chronic	_	
11-24	1731-1739	cannabis	_	
11-25	1740-1743	use	_	
11-26	1743-1744	.	_	

#Text=INTRODUCTION
#Text=Rates of cannabis (CB) use have rapidly escalated in the United States over the past decade.
12-1	1745-1757	INTRODUCTION	_	
12-2	1758-1763	Rates	_	
12-3	1764-1766	of	_	
12-4	1767-1775	cannabis	_	
12-5	1776-1777	(	_	
12-6	1777-1779	CB	_	
12-7	1779-1780	)	_	
12-8	1781-1784	use	_	
12-9	1785-1789	have	_	
12-10	1790-1797	rapidly	_	
12-11	1798-1807	escalated	_	
12-12	1808-1810	in	_	
12-13	1811-1814	the	_	
12-14	1815-1821	United	_	
12-15	1822-1828	States	_	
12-16	1829-1833	over	_	
12-17	1834-1837	the	_	
12-18	1838-1842	past	_	
12-19	1843-1849	decade	_	
12-20	1849-1850	.	_	

#Text=A recent national survey indicated that 22.2 million persons were current users of marijuana, corresponding to 8.3% of the population 12 years of age or older.
13-1	1851-1852	A	_	
13-2	1853-1859	recent	_	
13-3	1860-1868	national	_	
13-4	1869-1875	survey	_	
13-5	1876-1885	indicated	_	
13-6	1886-1890	that	_	
13-7	1891-1895	22.2	_	
13-8	1896-1903	million	_	
13-9	1904-1911	persons	_	
13-10	1912-1916	were	_	
13-11	1917-1924	current	_	
13-12	1925-1930	users	_	
13-13	1931-1933	of	_	
13-14	1934-1943	marijuana	_	
13-15	1943-1944	,	_	
13-16	1945-1958	corresponding	_	
13-17	1959-1961	to	_	
13-18	1962-1966	8.3%	_	
13-19	1967-1969	of	_	
13-20	1970-1973	the	_	
13-21	1974-1984	population	_	
13-22	1985-1987	12	_	
13-23	1988-1993	years	_	
13-24	1994-1996	of	_	
13-25	1997-2000	age	_	
13-26	2001-2003	or	_	
13-27	2004-2009	older	_	
13-28	2009-2010	.	_	

#Text=The primary psychoactive component of CB is Δ9–tetrahydrocannabinol (THC) known as a low-efficacy agonist for the endocannabinoid type 1 (CB1) receptors.
14-1	2011-2014	The	_	
14-2	2015-2022	primary	_	
14-3	2023-2035	psychoactive	_	
14-4	2036-2045	component	_	
14-5	2046-2048	of	_	
14-6	2049-2051	CB	_	
14-7	2052-2054	is	_	
14-8	2055-2057	Δ9	_	
14-9	2057-2058	–	_	
14-10	2058-2078	tetrahydrocannabinol	_	
14-11	2079-2080	(	_	
14-12	2080-2083	THC	_	
14-13	2083-2084	)	_	
14-14	2085-2090	known	_	
14-15	2091-2093	as	_	
14-16	2094-2095	a	_	
14-17	2096-2108	low-efficacy	_	
14-18	2109-2116	agonist	_	
14-19	2117-2120	for	_	
14-20	2121-2124	the	_	
14-21	2125-2140	endocannabinoid	_	
14-22	2141-2145	type	_	
14-23	2146-2147	1	_	
14-24	2148-2149	(	_	
14-25	2149-2152	CB1	_	
14-26	2152-2153	)	_	
14-27	2154-2163	receptors	_	
14-28	2163-2164	.	_	

#Text=CB1 receptors are widely distributed in the brain, particularly in the cerebellum, basal ganglia, neocortical regions and hippocampus.
15-1	2165-2168	CB1	_	
15-2	2169-2178	receptors	_	
15-3	2179-2182	are	_	
15-4	2183-2189	widely	_	
15-5	2190-2201	distributed	_	
15-6	2202-2204	in	_	
15-7	2205-2208	the	_	
15-8	2209-2214	brain	_	
15-9	2214-2215	,	_	
15-10	2216-2228	particularly	_	
15-11	2229-2231	in	_	
15-12	2232-2235	the	_	
15-13	2236-2246	cerebellum	_	
15-14	2246-2247	,	_	
15-15	2248-2253	basal	_	
15-16	2254-2261	ganglia	_	
15-17	2261-2262	,	_	
15-18	2263-2274	neocortical	_	
15-19	2275-2282	regions	_	
15-20	2283-2286	and	_	
15-21	2287-2298	hippocampus	_	
15-22	2298-2299	.	_	

#Text=Since the endocannabinoid system mediates various forms of synaptic plasticity, THC likely interferes with these processes.
16-1	2300-2305	Since	_	
16-2	2306-2309	the	_	
16-3	2310-2325	endocannabinoid	_	
16-4	2326-2332	system	_	
16-5	2333-2341	mediates	_	
16-6	2342-2349	various	_	
16-7	2350-2355	forms	_	
16-8	2356-2358	of	_	
16-9	2359-2367	synaptic	_	
16-10	2368-2378	plasticity	_	
16-11	2378-2379	,	_	
16-12	2380-2383	THC	_	
16-13	2384-2390	likely	_	
16-14	2391-2401	interferes	_	
16-15	2402-2406	with	_	
16-16	2407-2412	these	_	
16-17	2413-2422	processes	_	
16-18	2422-2423	.	_	

#Text=In hippocampal culture of rat neurons, for example, THC can inhibit induction of new synapse formation.
17-1	2424-2426	In	_	
17-2	2427-2438	hippocampal	_	
17-3	2439-2446	culture	_	
17-4	2447-2449	of	_	
17-5	2450-2453	rat	_	
17-6	2454-2461	neurons	_	
17-7	2461-2462	,	_	
17-8	2463-2466	for	_	
17-9	2467-2474	example	_	
17-10	2474-2475	,	_	
17-11	2476-2479	THC	_	
17-12	2480-2483	can	_	
17-13	2484-2491	inhibit	_	
17-14	2492-2501	induction	_	
17-15	2502-2504	of	_	
17-16	2505-2508	new	_	
17-17	2509-2516	synapse	_	
17-18	2517-2526	formation	_	
17-19	2526-2527	.	_	

#Text=THC exposure in adolescent rats results in disruption of endocannabinoid signaling, normal maturation of the glutamatergic system and synaptic pruning.
18-1	2528-2531	THC	_	
18-2	2532-2540	exposure	_	
18-3	2541-2543	in	_	
18-4	2544-2554	adolescent	_	
18-5	2555-2559	rats	_	
18-6	2560-2567	results	_	
18-7	2568-2570	in	_	
18-8	2571-2581	disruption	_	
18-9	2582-2584	of	_	
18-10	2585-2600	endocannabinoid	_	
18-11	2601-2610	signaling	_	
18-12	2610-2611	,	_	
18-13	2612-2618	normal	_	
18-14	2619-2629	maturation	_	
18-15	2630-2632	of	_	
18-16	2633-2636	the	_	
18-17	2637-2650	glutamatergic	_	
18-18	2651-2657	system	_	
18-19	2658-2661	and	_	
18-20	2662-2670	synaptic	_	
18-21	2671-2678	pruning	_	
18-22	2678-2679	.	_	

#Text=THC treatment in adolescent rats also results in lower dendritic length and numbers in the hippocampus coupled with impaired radial maze performance.
19-1	2680-2683	THC	_	
19-2	2684-2693	treatment	_	
19-3	2694-2696	in	_	
19-4	2697-2707	adolescent	_	
19-5	2708-2712	rats	_	
19-6	2713-2717	also	_	
19-7	2718-2725	results	_	
19-8	2726-2728	in	_	
19-9	2729-2734	lower	_	
19-10	2735-2744	dendritic	_	
19-11	2745-2751	length	_	
19-12	2752-2755	and	_	
19-13	2756-2763	numbers	_	
19-14	2764-2766	in	_	
19-15	2767-2770	the	_	
19-16	2771-2782	hippocampus	_	
19-17	2783-2790	coupled	_	
19-18	2791-2795	with	_	
19-19	2796-2804	impaired	_	
19-20	2805-2811	radial	_	
19-21	2812-2816	maze	_	
19-22	2817-2828	performance	_	
19-23	2828-2829	.	_	

#Text=These findings are consistent with a pivotal role for the endocannabinoid system in the development of neural connectivity and function.
20-1	2830-2835	These	_	
20-2	2836-2844	findings	_	
20-3	2845-2848	are	_	
20-4	2849-2859	consistent	_	
20-5	2860-2864	with	_	
20-6	2865-2866	a	_	
20-7	2867-2874	pivotal	_	
20-8	2875-2879	role	_	
20-9	2880-2883	for	_	
20-10	2884-2887	the	_	
20-11	2888-2903	endocannabinoid	_	
20-12	2904-2910	system	_	
20-13	2911-2913	in	_	
20-14	2914-2917	the	_	
20-15	2918-2929	development	_	
20-16	2930-2932	of	_	
20-17	2933-2939	neural	_	
20-18	2940-2952	connectivity	_	
20-19	2953-2956	and	_	
20-20	2957-2965	function	_	
20-21	2965-2966	.	_	

#Text=Consequently, there is a pressing need to clarify how cannabinoids affect brain connectivity in humans and whether these changes account for specific harms or possible benefits of CB use.
21-1	2967-2979	Consequently	_	
21-2	2979-2980	,	_	
21-3	2981-2986	there	_	
21-4	2987-2989	is	_	
21-5	2990-2991	a	_	
21-6	2992-3000	pressing	_	
21-7	3001-3005	need	_	
21-8	3006-3008	to	_	
21-9	3009-3016	clarify	_	
21-10	3017-3020	how	_	
21-11	3021-3033	cannabinoids	_	
21-12	3034-3040	affect	_	
21-13	3041-3046	brain	_	
21-14	3047-3059	connectivity	_	
21-15	3060-3062	in	_	
21-16	3063-3069	humans	_	
21-17	3070-3073	and	_	
21-18	3074-3081	whether	_	
21-19	3082-3087	these	_	
21-20	3088-3095	changes	_	
21-21	3096-3103	account	_	
21-22	3104-3107	for	_	
21-23	3108-3116	specific	_	
21-24	3117-3122	harms	_	
21-25	3123-3125	or	_	
21-26	3126-3134	possible	_	
21-27	3135-3143	benefits	_	
21-28	3144-3146	of	_	
21-29	3147-3149	CB	_	
21-30	3150-3153	use	_	
21-31	3153-3154	.	_	

#Text=Functional neuroimaging studies, which examine correlations in activity between brain regions, suggest that acute THC administration alters resting-state functional connectivity (FC).
22-1	3155-3165	Functional	_	
22-2	3166-3178	neuroimaging	_	
22-3	3179-3186	studies	_	
22-4	3186-3187	,	_	
22-5	3188-3193	which	_	
22-6	3194-3201	examine	_	
22-7	3202-3214	correlations	_	
22-8	3215-3217	in	_	
22-9	3218-3226	activity	_	
22-10	3227-3234	between	_	
22-11	3235-3240	brain	_	
22-12	3241-3248	regions	_	
22-13	3248-3249	,	_	
22-14	3250-3257	suggest	_	
22-15	3258-3262	that	_	
22-16	3263-3268	acute	_	
22-17	3269-3272	THC	_	
22-18	3273-3287	administration	_	
22-19	3288-3294	alters	_	
22-20	3295-3308	resting-state	_	
22-21	3309-3319	functional	_	
22-22	3320-3332	connectivity	_	
22-23	3333-3334	(	_	
22-24	3334-3336	FC	_	
22-25	3336-3337	)	_	
22-26	3337-3338	.	_	

#Text=Chronic CB users exhibited altered functional recruitment of the prefrontal cortex, inhibitory control networks (mean age = 23.7 years) and regions spanning the cerebellum to the prefrontal cortex (mean age = 19.3 year).
23-1	3339-3346	Chronic	_	
23-2	3347-3349	CB	_	
23-3	3350-3355	users	_	
23-4	3356-3365	exhibited	_	
23-5	3366-3373	altered	_	
23-6	3374-3384	functional	_	
23-7	3385-3396	recruitment	_	
23-8	3397-3399	of	_	
23-9	3400-3403	the	_	
23-10	3404-3414	prefrontal	_	
23-11	3415-3421	cortex	_	
23-12	3421-3422	,	_	
23-13	3423-3433	inhibitory	_	
23-14	3434-3441	control	_	
23-15	3442-3450	networks	_	
23-16	3451-3452	(	_	
23-17	3452-3456	mean	_	
23-18	3457-3460	age	_	
23-19	3461-3462	=	_	
23-20	3463-3467	23.7	_	
23-21	3468-3473	years	_	
23-22	3473-3474	)	_	
23-23	3475-3478	and	_	
23-24	3479-3486	regions	_	
23-25	3487-3495	spanning	_	
23-26	3496-3499	the	_	
23-27	3500-3510	cerebellum	_	
23-28	3511-3513	to	_	
23-29	3514-3517	the	_	
23-30	3518-3528	prefrontal	_	
23-31	3529-3535	cortex	_	
23-32	3536-3537	(	_	
23-33	3537-3541	mean	_	
23-34	3542-3545	age	_	
23-35	3546-3547	=	_	
23-36	3548-3552	19.3	_	
23-37	3553-3557	year	_	
23-38	3557-3558	)	_	
23-39	3558-3559	.	_	

#Text=Diffusion tensor imaging (DTI) provides a way to map network organization using white matter (WM) tractography to examine structural connectivity (SC) between gray matter regions.
24-1	3560-3569	Diffusion	_	
24-2	3570-3576	tensor	_	
24-3	3577-3584	imaging	_	
24-4	3585-3586	(	_	
24-5	3586-3589	DTI	_	
24-6	3589-3590	)	_	
24-7	3591-3599	provides	_	
24-8	3600-3601	a	_	
24-9	3602-3605	way	_	
24-10	3606-3608	to	_	
24-11	3609-3612	map	_	
24-12	3613-3620	network	_	
24-13	3621-3633	organization	_	
24-14	3634-3639	using	_	
24-15	3640-3645	white	_	
24-16	3646-3652	matter	_	
24-17	3653-3654	(	_	
24-18	3654-3656	WM	_	
24-19	3656-3657	)	_	
24-20	3658-3670	tractography	_	
24-21	3671-3673	to	_	
24-22	3674-3681	examine	_	
24-23	3682-3692	structural	_	
24-24	3693-3705	connectivity	_	
24-25	3706-3707	(	_	
24-26	3707-3709	SC	_	
24-27	3709-3710	)	_	
24-28	3711-3718	between	_	
24-29	3719-3723	gray	_	
24-30	3724-3730	matter	_	
24-31	3731-3738	regions	_	
24-32	3738-3739	.	_	

#Text=The integration of SC with FC allows the characterization of functional dynamics of the brain in terms of spatial topology.
25-1	3740-3743	The	_	
25-2	3744-3755	integration	_	
25-3	3756-3758	of	_	
25-4	3759-3761	SC	_	
25-5	3762-3766	with	_	
25-6	3767-3769	FC	_	
25-7	3770-3776	allows	_	
25-8	3777-3780	the	_	
25-9	3781-3797	characterization	_	
25-10	3798-3800	of	_	
25-11	3801-3811	functional	_	
25-12	3812-3820	dynamics	_	
25-13	3821-3823	of	_	
25-14	3824-3827	the	_	
25-15	3828-3833	brain	_	
25-16	3834-3836	in	_	
25-17	3837-3842	terms	_	
25-18	3843-3845	of	_	
25-19	3846-3853	spatial	_	
25-20	3854-3862	topology	_	
25-21	3862-3863	.	_	

#Text=This approach, termed structural-functional (SC-FC) coupling, is defined by the association between FC and SC allowing more sensitive detection of subtle brain alterations than any single imaging modality.
26-1	3864-3868	This	_	
26-2	3869-3877	approach	_	
26-3	3877-3878	,	_	
26-4	3879-3885	termed	_	
26-5	3886-3907	structural-functional	_	
26-6	3908-3909	(	_	
26-7	3909-3914	SC-FC	_	
26-8	3914-3915	)	_	
26-9	3916-3924	coupling	_	
26-10	3924-3925	,	_	
26-11	3926-3928	is	_	
26-12	3929-3936	defined	_	
26-13	3937-3939	by	_	
26-14	3940-3943	the	_	
26-15	3944-3955	association	_	
26-16	3956-3963	between	_	
26-17	3964-3966	FC	_	
26-18	3967-3970	and	_	
26-19	3971-3973	SC	_	
26-20	3974-3982	allowing	_	
26-21	3983-3987	more	_	
26-22	3988-3997	sensitive	_	
26-23	3998-4007	detection	_	
26-24	4008-4010	of	_	
26-25	4011-4017	subtle	_	
26-26	4018-4023	brain	_	
26-27	4024-4035	alterations	_	
26-28	4036-4040	than	_	
26-29	4041-4044	any	_	
26-30	4045-4051	single	_	
26-31	4052-4059	imaging	_	
26-32	4060-4068	modality	_	
26-33	4068-4069	.	_	

#Text=Importantly, the structural network constrains the functional network to regions with direct connections.
27-1	4070-4081	Importantly	_	
27-2	4081-4082	,	_	
27-3	4083-4086	the	_	
27-4	4087-4097	structural	_	
27-5	4098-4105	network	_	
27-6	4106-4116	constrains	_	
27-7	4117-4120	the	_	
27-8	4121-4131	functional	_	
27-9	4132-4139	network	_	
27-10	4140-4142	to	_	
27-11	4143-4150	regions	_	
27-12	4151-4155	with	_	
27-13	4156-4162	direct	_	
27-14	4163-4174	connections	_	
27-15	4174-4175	.	_	

#Text=It therefore would be well suited to test how observed cellular alterations in synaptic connectivity and signaling impact the functional organization of the brain in human CB users.
28-1	4176-4178	It	_	
28-2	4179-4188	therefore	_	
28-3	4189-4194	would	_	
28-4	4195-4197	be	_	
28-5	4198-4202	well	_	
28-6	4203-4209	suited	_	
28-7	4210-4212	to	_	
28-8	4213-4217	test	_	
28-9	4218-4221	how	_	
28-10	4222-4230	observed	_	
28-11	4231-4239	cellular	_	
28-12	4240-4251	alterations	_	
28-13	4252-4254	in	_	
28-14	4255-4263	synaptic	_	
28-15	4264-4276	connectivity	_	
28-16	4277-4280	and	_	
28-17	4281-4290	signaling	_	
28-18	4291-4297	impact	_	
28-19	4298-4301	the	_	
28-20	4302-4312	functional	_	
28-21	4313-4325	organization	_	
28-22	4326-4328	of	_	
28-23	4329-4332	the	_	
28-24	4333-4338	brain	_	
28-25	4339-4341	in	_	
28-26	4342-4347	human	_	
28-27	4348-4350	CB	_	
28-28	4351-4356	users	_	
28-29	4356-4357	.	_	

#Text=While SC-FC coupling has not yet been assessed in CB users, this approach has shown alterations in other neuropsychiatric disorders.
29-1	4358-4363	While	_	
29-2	4364-4369	SC-FC	_	
29-3	4370-4378	coupling	_	
29-4	4379-4382	has	_	
29-5	4383-4386	not	_	
29-6	4387-4390	yet	_	
29-7	4391-4395	been	_	
29-8	4396-4404	assessed	_	
29-9	4405-4407	in	_	
29-10	4408-4410	CB	_	
29-11	4411-4416	users	_	
29-12	4416-4417	,	_	
29-13	4418-4422	this	_	
29-14	4423-4431	approach	_	
29-15	4432-4435	has	_	
29-16	4436-4441	shown	_	
29-17	4442-4453	alterations	_	
29-18	4454-4456	in	_	
29-19	4457-4462	other	_	
29-20	4463-4479	neuropsychiatric	_	
29-21	4480-4489	disorders	_	
29-22	4489-4490	.	_	

#Text=For example, SC-FC coupling disturbances have recently been reported in schizophrenia, a neuropsychiatric disorder for which CB use is a risk factor.
30-1	4491-4494	For	_	
30-2	4495-4502	example	_	
30-3	4502-4503	,	_	
30-4	4504-4509	SC-FC	_	
30-5	4510-4518	coupling	_	
30-6	4519-4531	disturbances	_	
30-7	4532-4536	have	_	
30-8	4537-4545	recently	_	
30-9	4546-4550	been	_	
30-10	4551-4559	reported	_	
30-11	4560-4562	in	_	
30-12	4563-4576	schizophrenia	_	
30-13	4576-4577	,	_	
30-14	4578-4579	a	_	
30-15	4580-4596	neuropsychiatric	_	
30-16	4597-4605	disorder	_	
30-17	4606-4609	for	_	
30-18	4610-4615	which	_	
30-19	4616-4618	CB	_	
30-20	4619-4622	use	_	
30-21	4623-4625	is	_	
30-22	4626-4627	a	_	
30-23	4628-4632	risk	_	
30-24	4633-4639	factor	_	
30-25	4639-4640	.	_	

#Text=In this study, we tested whether the association of the structure-function network was affected in current CB users.
31-1	4641-4643	In	_	
31-2	4644-4648	this	_	
31-3	4649-4654	study	_	
31-4	4654-4655	,	_	
31-5	4656-4658	we	_	
31-6	4659-4665	tested	_	
31-7	4666-4673	whether	_	
31-8	4674-4677	the	_	
31-9	4678-4689	association	_	
31-10	4690-4692	of	_	
31-11	4693-4696	the	_	
31-12	4697-4715	structure-function	_	
31-13	4716-4723	network	_	
31-14	4724-4727	was	_	
31-15	4728-4736	affected	_	
31-16	4737-4739	in	_	
31-17	4740-4747	current	_	
31-18	4748-4750	CB	_	
31-19	4751-4756	users	_	
31-20	4756-4757	.	_	

#Text=We anticipated that the association (i.e., coupling) between SC and FC of CB users would be “globally” preserved, i.e., the intact positive coupling in the whole brain connectivity, which is also known to be dependent on the connection distance.
32-1	4758-4760	We	_	
32-2	4761-4772	anticipated	_	
32-3	4773-4777	that	_	
32-4	4778-4781	the	_	
32-5	4782-4793	association	_	
32-6	4794-4795	(	_	
32-7	4795-4798	i.e	_	
32-8	4798-4799	.	_	
32-9	4799-4800	,	_	
32-10	4801-4809	coupling	_	
32-11	4809-4810	)	_	
32-12	4811-4818	between	_	
32-13	4819-4821	SC	_	
32-14	4822-4825	and	_	
32-15	4826-4828	FC	_	
32-16	4829-4831	of	_	
32-17	4832-4834	CB	_	
32-18	4835-4840	users	_	
32-19	4841-4846	would	_	
32-20	4847-4849	be	_	
32-21	4850-4851	“	_	
32-22	4851-4859	globally	_	
32-23	4859-4860	”	_	
32-24	4861-4870	preserved	_	
32-25	4870-4871	,	_	
32-26	4872-4875	i.e	_	
32-27	4875-4876	.	_	
32-28	4876-4877	,	_	
32-29	4878-4881	the	_	
32-30	4882-4888	intact	_	
32-31	4889-4897	positive	_	
32-32	4898-4906	coupling	_	
32-33	4907-4909	in	_	
32-34	4910-4913	the	_	
32-35	4914-4919	whole	_	
32-36	4920-4925	brain	_	
32-37	4926-4938	connectivity	_	
32-38	4938-4939	,	_	
32-39	4940-4945	which	_	
32-40	4946-4948	is	_	
32-41	4949-4953	also	_	
32-42	4954-4959	known	_	
32-43	4960-4962	to	_	
32-44	4963-4965	be	_	
32-45	4966-4975	dependent	_	
32-46	4976-4978	on	_	
32-47	4979-4982	the	_	
32-48	4983-4993	connection	_	
32-49	4994-5002	distance	_	
32-50	5002-5003	.	_	

#Text=Structural neuroimaging abnormalities in adult CB users have been most consistent for regions high in CB receptors.
33-1	5004-5014	Structural	_	
33-2	5015-5027	neuroimaging	_	
33-3	5028-5041	abnormalities	_	
33-4	5042-5044	in	_	
33-5	5045-5050	adult	_	
33-6	5051-5053	CB	_	
33-7	5054-5059	users	_	
33-8	5060-5064	have	_	
33-9	5065-5069	been	_	
33-10	5070-5074	most	_	
33-11	5075-5085	consistent	_	
33-12	5086-5089	for	_	
33-13	5090-5097	regions	_	
33-14	5098-5102	high	_	
33-15	5103-5105	in	_	
33-16	5106-5108	CB	_	
33-17	5109-5118	receptors	_	
33-18	5118-5119	.	_	

#Text=Thus, we expected that alterations of SC-FC coupling would be found in these “local” regions rich in CB1 receptors, associated with regionally-specific topological changes of connectivity.
34-1	5120-5124	Thus	_	
34-2	5124-5125	,	_	
34-3	5126-5128	we	_	
34-4	5129-5137	expected	_	
34-5	5138-5142	that	_	
34-6	5143-5154	alterations	_	
34-7	5155-5157	of	_	
34-8	5158-5163	SC-FC	_	
34-9	5164-5172	coupling	_	
34-10	5173-5178	would	_	
34-11	5179-5181	be	_	
34-12	5182-5187	found	_	
34-13	5188-5190	in	_	
34-14	5191-5196	these	_	
34-15	5197-5198	“	_	
34-16	5198-5203	local	_	
34-17	5203-5204	”	_	
34-18	5205-5212	regions	_	
34-19	5213-5217	rich	_	
34-20	5218-5220	in	_	
34-21	5221-5224	CB1	_	
34-22	5225-5234	receptors	_	
34-23	5234-5235	,	_	
34-24	5236-5246	associated	_	
34-25	5247-5251	with	_	
34-26	5252-5271	regionally-specific	_	
34-27	5272-5283	topological	_	
34-28	5284-5291	changes	_	
34-29	5292-5294	of	_	
34-30	5295-5307	connectivity	_	
34-31	5307-5308	.	_	

#Text=In addition, the importance of “Rich Club” (RC) connections with regard to SC-FC coupling has been previously demonstrated.
35-1	5309-5311	In	_	
35-2	5312-5320	addition	_	
35-3	5320-5321	,	_	
35-4	5322-5325	the	_	
35-5	5326-5336	importance	_	
35-6	5337-5339	of	_	
35-7	5340-5341	“	_	
35-8	5341-5345	Rich	_	
35-9	5346-5350	Club	_	
35-10	5350-5351	”	_	
35-11	5352-5353	(	_	
35-12	5353-5355	RC	_	
35-13	5355-5356	)	_	
35-14	5357-5368	connections	_	
35-15	5369-5373	with	_	
35-16	5374-5380	regard	_	
35-17	5381-5383	to	_	
35-18	5384-5389	SC-FC	_	
35-19	5390-5398	coupling	_	
35-20	5399-5402	has	_	
35-21	5403-5407	been	_	
35-22	5408-5418	previously	_	
35-23	5419-5431	demonstrated	_	
35-24	5431-5432	.	_	

#Text=Rich-club nodes of a network have been defined as the nodes that are not only much more connected but also highly linked among themselves.
36-1	5433-5442	Rich-club	_	
36-2	5443-5448	nodes	_	
36-3	5449-5451	of	_	
36-4	5452-5453	a	_	
36-5	5454-5461	network	_	
36-6	5462-5466	have	_	
36-7	5467-5471	been	_	
36-8	5472-5479	defined	_	
36-9	5480-5482	as	_	
36-10	5483-5486	the	_	
36-11	5487-5492	nodes	_	
36-12	5493-5497	that	_	
36-13	5498-5501	are	_	
36-14	5502-5505	not	_	
36-15	5506-5510	only	_	
36-16	5511-5515	much	_	
36-17	5516-5520	more	_	
36-18	5521-5530	connected	_	
36-19	5531-5534	but	_	
36-20	5535-5539	also	_	
36-21	5540-5546	highly	_	
36-22	5547-5553	linked	_	
36-23	5554-5559	among	_	
36-24	5560-5570	themselves	_	
36-25	5570-5571	.	_	

#Text=Since the regions of higher CB1 receptor density overlap with central hub regions in the brain network identified by RC, we also hypothesized that RC regions with higher CB1 receptor density would exhibit alterations of SC-FC coupling in CB users.
37-1	5572-5577	Since	_	
37-2	5578-5581	the	_	
37-3	5582-5589	regions	_	
37-4	5590-5592	of	_	
37-5	5593-5599	higher	_	
37-6	5600-5603	CB1	_	
37-7	5604-5612	receptor	_	
37-8	5613-5620	density	_	
37-9	5621-5628	overlap	_	
37-10	5629-5633	with	_	
37-11	5634-5641	central	_	
37-12	5642-5645	hub	_	
37-13	5646-5653	regions	_	
37-14	5654-5656	in	_	
37-15	5657-5660	the	_	
37-16	5661-5666	brain	_	
37-17	5667-5674	network	_	
37-18	5675-5685	identified	_	
37-19	5686-5688	by	_	
37-20	5689-5691	RC	_	
37-21	5691-5692	,	_	
37-22	5693-5695	we	_	
37-23	5696-5700	also	_	
37-24	5701-5713	hypothesized	_	
37-25	5714-5718	that	_	
37-26	5719-5721	RC	_	
37-27	5722-5729	regions	_	
37-28	5730-5734	with	_	
37-29	5735-5741	higher	_	
37-30	5742-5745	CB1	_	
37-31	5746-5754	receptor	_	
37-32	5755-5762	density	_	
37-33	5763-5768	would	_	
37-34	5769-5776	exhibit	_	
37-35	5777-5788	alterations	_	
37-36	5789-5791	of	_	
37-37	5792-5797	SC-FC	_	
37-38	5798-5806	coupling	_	
37-39	5807-5809	in	_	
37-40	5810-5812	CB	_	
37-41	5813-5818	users	_	
37-42	5818-5819	.	_	

#Text=MATERIALS AND METHODS
#Text=Participants
#Text=Participants were recruited from the Indiana University campus and the surrounding community through flyers and advertisements in local publications.
38-1	5820-5829	MATERIALS	http://www.case.edu/ProvCaRe/provcare#StudyMethod[8]	
38-2	5830-5833	AND	http://www.case.edu/ProvCaRe/provcare#StudyMethod[8]	
38-3	5834-5841	METHODS	http://www.case.edu/ProvCaRe/provcare#StudyMethod[8]	
38-4	5842-5854	Participants	_	
38-5	5855-5867	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
38-6	5868-5872	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
38-7	5873-5882	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
38-8	5883-5887	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
38-9	5888-5891	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
38-10	5892-5899	Indiana	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
38-11	5900-5910	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
38-12	5911-5917	campus	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
38-13	5918-5921	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
38-14	5922-5925	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
38-15	5926-5937	surrounding	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
38-16	5938-5947	community	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
38-17	5948-5955	through	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
38-18	5956-5962	flyers	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
38-19	5963-5966	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
38-20	5967-5981	advertisements	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
38-21	5982-5984	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
38-22	5985-5990	local	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
38-23	5991-6003	publications	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
38-24	6003-6004	.	_	

#Text=Subjects who passed an initial phone screen they were invited into the laboratory for assessment.
39-1	6005-6013	Subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
39-2	6014-6017	who	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
39-3	6018-6024	passed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
39-4	6025-6027	an	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
39-5	6028-6035	initial	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
39-6	6036-6041	phone	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
39-7	6042-6048	screen	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
39-8	6049-6053	they	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
39-9	6054-6058	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
39-10	6059-6066	invited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
39-11	6067-6071	into	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
39-12	6072-6075	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
39-13	6076-6086	laboratory	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
39-14	6087-6090	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
39-15	6091-6101	assessment	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
39-16	6101-6102	.	_	

#Text=Subjects first provided verbal and written informed consent, after which demographic, cognitive, questionnaire, substance use information and a diagnostic interview were obtained.
40-1	6103-6111	Subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
40-2	6112-6117	first	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
40-3	6118-6126	provided	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
40-4	6127-6133	verbal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
40-5	6134-6137	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
40-6	6138-6145	written	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
40-7	6146-6154	informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
40-8	6155-6162	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
40-9	6162-6163	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
40-10	6164-6169	after	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
40-11	6170-6175	which	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
40-12	6176-6187	demographic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
40-13	6187-6188	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
40-14	6189-6198	cognitive	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
40-15	6198-6199	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
40-16	6200-6213	questionnaire	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
40-17	6213-6214	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
40-18	6215-6224	substance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
40-19	6225-6228	use	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
40-20	6229-6240	information	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
40-21	6241-6244	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
40-22	6245-6246	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
40-23	6247-6257	diagnostic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
40-24	6258-6267	interview	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
40-25	6268-6272	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
40-26	6273-6281	obtained	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
40-27	6281-6282	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	

#Text=All subjects were required to be 18 years of age or older, and free of any neurological disorder, head trauma with loss of consciousness greater than ten minutes, learning disability, and contraindication to MRI.
41-1	6283-6286	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-2	6287-6295	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-3	6296-6300	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-4	6301-6309	required	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-5	6310-6312	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-6	6313-6315	be	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-7	6316-6318	18	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-8	6319-6324	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-9	6325-6327	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-10	6328-6331	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-11	6332-6334	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-12	6335-6340	older	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-13	6340-6341	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-14	6342-6345	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-15	6346-6350	free	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-16	6351-6353	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-17	6354-6357	any	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-18	6358-6370	neurological	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-19	6371-6379	disorder	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-20	6379-6380	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-21	6381-6385	head	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-22	6386-6392	trauma	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-23	6393-6397	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-24	6398-6402	loss	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-25	6403-6405	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-26	6406-6419	consciousness	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-27	6420-6427	greater	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-28	6428-6432	than	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-29	6433-6436	ten	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-30	6437-6444	minutes	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-31	6444-6445	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-32	6446-6454	learning	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-33	6455-6465	disability	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-34	6465-6466	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-35	6467-6470	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-36	6471-6487	contraindication	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-37	6488-6490	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
41-38	6491-6494	MRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]|http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[13]	
41-39	6494-6495	.	_	

#Text=Subject demographic information is provided in Table 1.
42-1	6496-6503	Subject	_	
42-2	6504-6515	demographic	_	
42-3	6516-6527	information	_	
42-4	6528-6530	is	_	
42-5	6531-6539	provided	_	
42-6	6540-6542	in	_	
42-7	6543-6548	Table	_	
42-8	6549-6550	1	_	
42-9	6550-6551	.	_	

#Text=The research protocol was approved by Indiana University’s Institutional Review Board for the protection of human subjects.
43-1	6552-6555	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-2	6556-6564	research	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-3	6565-6573	protocol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-4	6574-6577	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-5	6578-6586	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-6	6587-6589	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-7	6590-6597	Indiana	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-8	6598-6608	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-9	6608-6609	’	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-10	6609-6610	s	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-11	6611-6624	Institutional	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-12	6625-6631	Review	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-13	6632-6637	Board	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-14	6638-6641	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-15	6642-6645	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-16	6646-6656	protection	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-17	6657-6659	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-18	6660-6665	human	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-19	6666-6674	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-20	6674-6675	.	_	

#Text=Thirty-one healthy control subjects without psychiatric disorders were recruited.
44-1	6676-6686	Thirty-one	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-2	6687-6694	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[16]	
44-3	6695-6702	control	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[16]	
44-4	6703-6711	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-5	6712-6719	without	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-6	6720-6731	psychiatric	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-7	6732-6741	disorders	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-8	6742-6746	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-9	6747-6756	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-10	6756-6757	.	_	

#Text=Exclusion criteria included absence of an Axis I disorder, a history of substance abuse or dependence, a positive urine screen for CB or other substances, use of CB in the past three months and more than 12 lifetime exposures to CB (mean lifetime exposures = 0.8).
45-1	6758-6767	Exclusion	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-2	6768-6776	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-3	6777-6785	included	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-4	6786-6793	absence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-5	6794-6796	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-6	6797-6799	an	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-7	6800-6804	Axis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-8	6805-6806	I	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-9	6807-6815	disorder	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-10	6815-6816	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-11	6817-6818	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-12	6819-6826	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-13	6827-6829	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-14	6830-6839	substance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-15	6840-6845	abuse	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-16	6846-6848	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-17	6849-6859	dependence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-18	6859-6860	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-19	6861-6862	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-20	6863-6871	positive	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-21	6872-6877	urine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-22	6878-6884	screen	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-23	6885-6888	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-24	6889-6891	CB	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-25	6892-6894	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-26	6895-6900	other	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-27	6901-6911	substances	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-28	6911-6912	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-29	6913-6916	use	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-30	6917-6919	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-31	6920-6922	CB	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-32	6923-6925	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-33	6926-6929	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-34	6930-6934	past	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-35	6935-6940	three	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-36	6941-6947	months	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-37	6948-6951	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-38	6952-6956	more	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-39	6957-6961	than	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-40	6962-6964	12	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-41	6965-6973	lifetime	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-42	6974-6983	exposures	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-43	6984-6986	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-44	6987-6989	CB	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-45	6990-6991	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-46	6991-6995	mean	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-47	6996-7004	lifetime	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-48	7005-7014	exposures	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-49	7015-7016	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-50	7017-7020	0.8	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-51	7020-7021	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
45-52	7021-7022	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	

#Text=All control participants were interviewed using the SCID-NP (non-patient version) to exclude individuals with psychiatric diagnoses.
46-1	7023-7026	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
46-2	7027-7034	control	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
46-3	7035-7047	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
46-4	7048-7052	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
46-5	7053-7064	interviewed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
46-6	7065-7070	using	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
46-7	7071-7074	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
46-8	7075-7082	SCID-NP	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
46-9	7083-7084	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
46-10	7084-7095	non-patient	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
46-11	7096-7103	version	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
46-12	7103-7104	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
46-13	7105-7107	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
46-14	7108-7115	exclude	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
46-15	7116-7127	individuals	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
46-16	7128-7132	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
46-17	7133-7144	psychiatric	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
46-18	7145-7154	diagnoses	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
46-19	7154-7155	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	

#Text=Thirty-seven current CB users were recruited who were recently using CB at least once per week, with mean monthly exposure of 32.6 and lifetime exposures > 45.
47-1	7156-7168	Thirty-seven	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
47-2	7169-7176	current	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
47-3	7177-7179	CB	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]|http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[19]	
47-4	7180-7185	users	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]|http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[19]	
47-5	7186-7190	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
47-6	7191-7200	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
47-7	7201-7204	who	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
47-8	7205-7209	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
47-9	7210-7218	recently	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
47-10	7219-7224	using	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
47-11	7225-7227	CB	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]|http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[20]	
47-12	7228-7230	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
47-13	7231-7236	least	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
47-14	7237-7241	once	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
47-15	7242-7245	per	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
47-16	7246-7250	week	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
47-17	7250-7251	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
47-18	7252-7256	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
47-19	7257-7261	mean	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
47-20	7262-7269	monthly	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
47-21	7270-7278	exposure	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
47-22	7279-7281	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
47-23	7282-7286	32.6	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
47-24	7287-7290	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
47-25	7291-7299	lifetime	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
47-26	7300-7309	exposures	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
47-27	7310-7311	>	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
47-28	7312-7314	45	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
47-29	7314-7315	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	

#Text=All users were free from the current Axis I disorders and any other illicit substance abuse or dependence other than CB use disorders.
48-1	7316-7319	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
48-2	7320-7325	users	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
48-3	7326-7330	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
48-4	7331-7335	free	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
48-5	7336-7340	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
48-6	7341-7344	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
48-7	7345-7352	current	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
48-8	7353-7357	Axis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
48-9	7358-7359	I	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
48-10	7360-7369	disorders	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
48-11	7370-7373	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
48-12	7374-7377	any	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
48-13	7378-7383	other	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
48-14	7384-7391	illicit	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
48-15	7392-7401	substance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
48-16	7402-7407	abuse	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
48-17	7408-7410	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
48-18	7411-7421	dependence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
48-19	7422-7427	other	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
48-20	7428-7432	than	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
48-21	7433-7435	CB	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]|http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[21]	
48-22	7436-7439	use	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]|http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[21]	
48-23	7440-7449	disorders	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]|http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[21]	
48-24	7449-7450	.	_	

#Text=Psychiatric diagnoses were ascertained with the Structured Clinical Interview for DSM-IV-TR (SCID-I) Research Version.
49-1	7451-7462	Psychiatric	_	
49-2	7463-7472	diagnoses	_	
49-3	7473-7477	were	_	
49-4	7478-7489	ascertained	_	
49-5	7490-7494	with	_	
49-6	7495-7498	the	_	
49-7	7499-7509	Structured	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[22]	
49-8	7510-7518	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[22]	
49-9	7519-7528	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[22]	
49-10	7529-7532	for	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[22]	
49-11	7533-7542	DSM-IV-TR	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[22]	
49-12	7543-7544	(	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[22]	
49-13	7544-7550	SCID-I	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[22]	
49-14	7550-7551	)	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[22]	
49-15	7552-7560	Research	_	
49-16	7561-7568	Version	_	
49-17	7568-7569	.	_	

#Text=A written drug use questionnaire and a six-month time line follow back assessment was used to estimate recent and past use of CB.
50-1	7570-7571	A	_	
50-2	7572-7579	written	_	
50-3	7580-7584	drug	_	
50-4	7585-7588	use	_	
50-5	7589-7602	questionnaire	_	
50-6	7603-7606	and	_	
50-7	7607-7608	a	_	
50-8	7609-7618	six-month	_	
50-9	7619-7623	time	_	
50-10	7624-7628	line	_	
50-11	7629-7635	follow	_	
50-12	7636-7640	back	_	
50-13	7641-7651	assessment	_	
50-14	7652-7655	was	_	
50-15	7656-7660	used	_	
50-16	7661-7663	to	_	
50-17	7664-7672	estimate	_	
50-18	7673-7679	recent	_	
50-19	7680-7683	and	_	
50-20	7684-7688	past	_	
50-21	7689-7692	use	_	
50-22	7693-7695	of	_	
50-23	7696-7698	CB	_	
50-24	7698-7699	.	_	

#Text=Three variables characterizing use of CB were chosen for statistical analyses: age of onset of first CB use, lifetime number of exposures to CB, and number of exposures to CB in the past month.
51-1	7700-7705	Three	_	
51-2	7706-7715	variables	_	
51-3	7716-7730	characterizing	_	
51-4	7731-7734	use	_	
51-5	7735-7737	of	_	
51-6	7738-7740	CB	_	
51-7	7741-7745	were	_	
51-8	7746-7752	chosen	_	
51-9	7753-7756	for	_	
51-10	7757-7768	statistical	_	
51-11	7769-7777	analyses	_	
51-12	7777-7778	:	_	
51-13	7779-7782	age	_	
51-14	7783-7785	of	_	
51-15	7786-7791	onset	_	
51-16	7792-7794	of	_	
51-17	7795-7800	first	_	
51-18	7801-7803	CB	_	
51-19	7804-7807	use	_	
51-20	7807-7808	,	_	
51-21	7809-7817	lifetime	_	
51-22	7818-7824	number	_	
51-23	7825-7827	of	_	
51-24	7828-7837	exposures	_	
51-25	7838-7840	to	_	
51-26	7841-7843	CB	_	
51-27	7843-7844	,	_	
51-28	7845-7848	and	_	
51-29	7849-7855	number	_	
51-30	7856-7858	of	_	
51-31	7859-7868	exposures	_	
51-32	7869-7871	to	_	
51-33	7872-7874	CB	_	
51-34	7875-7877	in	_	
51-35	7878-7881	the	_	
51-36	7882-7886	past	_	
51-37	7887-7892	month	_	
51-38	7892-7893	.	_	

#Text=Both age of onset and total lifetime exposures have been associated with risk for subsequent psychotic disorders, and thus represent potential predictors of brain network changes linked with vulnerability to psychosis.
52-1	7894-7898	Both	_	
52-2	7899-7902	age	_	
52-3	7903-7905	of	_	
52-4	7906-7911	onset	_	
52-5	7912-7915	and	_	
52-6	7916-7921	total	_	
52-7	7922-7930	lifetime	_	
52-8	7931-7940	exposures	_	
52-9	7941-7945	have	_	
52-10	7946-7950	been	_	
52-11	7951-7961	associated	_	
52-12	7962-7966	with	_	
52-13	7967-7971	risk	_	
52-14	7972-7975	for	_	
52-15	7976-7986	subsequent	_	
52-16	7987-7996	psychotic	_	
52-17	7997-8006	disorders	_	
52-18	8006-8007	,	_	
52-19	8008-8011	and	_	
52-20	8012-8016	thus	_	
52-21	8017-8026	represent	_	
52-22	8027-8036	potential	_	
52-23	8037-8047	predictors	_	
52-24	8048-8050	of	_	
52-25	8051-8056	brain	_	
52-26	8057-8064	network	_	
52-27	8065-8072	changes	_	
52-28	8073-8079	linked	_	
52-29	8080-8084	with	_	
52-30	8085-8098	vulnerability	_	
52-31	8099-8101	to	_	
52-32	8102-8111	psychosis	_	
52-33	8111-8112	.	_	

#Text=CB use in the past month assessed possible effects of CB metabolites on brain connectivity.
53-1	8113-8115	CB	_	
53-2	8116-8119	use	_	
53-3	8120-8122	in	_	
53-4	8123-8126	the	_	
53-5	8127-8131	past	_	
53-6	8132-8137	month	_	
53-7	8138-8146	assessed	_	
53-8	8147-8155	possible	_	
53-9	8156-8163	effects	_	
53-10	8164-8166	of	_	
53-11	8167-8169	CB	_	
53-12	8170-8181	metabolites	_	
53-13	8182-8184	on	_	
53-14	8185-8190	brain	_	
53-15	8191-8203	connectivity	_	
53-16	8203-8204	.	_	

#Text=The Wechsler Abbreviated Scale of Intelligence (WASI) was administered to estimate currently intellectual function.
54-1	8205-8208	The	_	
54-2	8209-8217	Wechsler	_	
54-3	8218-8229	Abbreviated	_	
54-4	8230-8235	Scale	_	
54-5	8236-8238	of	_	
54-6	8239-8251	Intelligence	_	
54-7	8252-8253	(	_	
54-8	8253-8257	WASI	_	
54-9	8257-8258	)	_	
54-10	8259-8262	was	_	
54-11	8263-8275	administered	_	
54-12	8276-8278	to	_	
54-13	8279-8287	estimate	_	
54-14	8288-8297	currently	_	
54-15	8298-8310	intellectual	_	
54-16	8311-8319	function	_	
54-17	8319-8320	.	_	

#Text=Groups did not significantly differ in age, IQ, alcohol use, gender or race (p > 0.05); however, the CB group had fewer years of education (14.0 vs. 15.4 years; Table 1).
55-1	8321-8327	Groups	_	
55-2	8328-8331	did	_	
55-3	8332-8335	not	_	
55-4	8336-8349	significantly	_	
55-5	8350-8356	differ	_	
55-6	8357-8359	in	_	
55-7	8360-8363	age	_	
55-8	8363-8364	,	_	
55-9	8365-8367	IQ	_	
55-10	8367-8368	,	_	
55-11	8369-8376	alcohol	_	
55-12	8377-8380	use	_	
55-13	8380-8381	,	_	
55-14	8382-8388	gender	_	
55-15	8389-8391	or	_	
55-16	8392-8396	race	_	
55-17	8397-8398	(	_	
55-18	8398-8399	p	_	
55-19	8400-8401	>	_	
55-20	8402-8406	0.05	_	
55-21	8406-8407	)	_	
55-22	8407-8408	;	_	
55-23	8409-8416	however	_	
55-24	8416-8417	,	_	
55-25	8418-8421	the	_	
55-26	8422-8424	CB	_	
55-27	8425-8430	group	_	
55-28	8431-8434	had	_	
55-29	8435-8440	fewer	_	
55-30	8441-8446	years	_	
55-31	8447-8449	of	_	
55-32	8450-8459	education	_	
55-33	8460-8461	(	_	
55-34	8461-8465	14.0	_	
55-35	8466-8468	vs	_	
55-36	8468-8469	.	_	
55-37	8470-8474	15.4	_	
55-38	8475-8480	years	_	
55-39	8480-8481	;	_	
55-40	8482-8487	Table	_	
55-41	8488-8489	1	_	
55-42	8489-8490	)	_	
55-43	8490-8491	.	_	

#Text=Subjects were asked to refrain from alcohol or CB use prior to the MRI scan.
56-1	8492-8500	Subjects	_	
56-2	8501-8505	were	_	
56-3	8506-8511	asked	_	
56-4	8512-8514	to	_	
56-5	8515-8522	refrain	_	
56-6	8523-8527	from	_	
56-7	8528-8535	alcohol	_	
56-8	8536-8538	or	_	
56-9	8539-8541	CB	_	
56-10	8542-8545	use	_	
56-11	8546-8551	prior	_	
56-12	8552-8554	to	_	
56-13	8555-8558	the	_	
56-14	8559-8562	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging	
56-15	8563-8567	scan	_	
56-16	8567-8568	.	_	

#Text=At screening, 11 subjects (including 1 control subject) identified themselves as a smoker on the Fagerstrom Nicotine Dependence Questionnaire, of which only 3 subjects (without controls) scored above a zero (two scored a 1 and one scored a 2), which is indicative of “very low dependence”.
57-1	8569-8571	At	_	
57-2	8572-8581	screening	_	
57-3	8581-8582	,	_	
57-4	8583-8585	11	_	
57-5	8586-8594	subjects	_	
57-6	8595-8596	(	_	
57-7	8596-8605	including	_	
57-8	8606-8607	1	_	
57-9	8608-8615	control	_	
57-10	8616-8623	subject	_	
57-11	8623-8624	)	_	
57-12	8625-8635	identified	_	
57-13	8636-8646	themselves	_	
57-14	8647-8649	as	_	
57-15	8650-8651	a	_	
57-16	8652-8658	smoker	_	
57-17	8659-8661	on	_	
57-18	8662-8665	the	_	
57-19	8666-8676	Fagerstrom	http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence[23]	
57-20	8677-8685	Nicotine	http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence[23]	
57-21	8686-8696	Dependence	http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence[23]	
57-22	8697-8710	Questionnaire	http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence[23]	
57-23	8710-8711	,	_	
57-24	8712-8714	of	_	
57-25	8715-8720	which	_	
57-26	8721-8725	only	_	
57-27	8726-8727	3	_	
57-28	8728-8736	subjects	_	
57-29	8737-8738	(	_	
57-30	8738-8745	without	_	
57-31	8746-8754	controls	_	
57-32	8754-8755	)	_	
57-33	8756-8762	scored	_	
57-34	8763-8768	above	_	
57-35	8769-8770	a	_	
57-36	8771-8775	zero	_	
57-37	8776-8777	(	_	
57-38	8777-8780	two	_	
57-39	8781-8787	scored	_	
57-40	8788-8789	a	_	
57-41	8790-8791	1	_	
57-42	8792-8795	and	_	
57-43	8796-8799	one	_	
57-44	8800-8806	scored	_	
57-45	8807-8808	a	_	
57-46	8809-8810	2	_	
57-47	8810-8811	)	_	
57-48	8811-8812	,	_	
57-49	8813-8818	which	_	
57-50	8819-8821	is	_	
57-51	8822-8832	indicative	_	
57-52	8833-8835	of	_	
57-53	8836-8837	“	_	
57-54	8837-8841	very	_	
57-55	8842-8845	low	_	
57-56	8846-8856	dependence	_	
57-57	8856-8857	”	_	
57-58	8857-8858	.	_	

#Text=At the time of MRI scan, nine subjects self-reported nicotine use within the past 7 days.
58-1	8859-8861	At	_	
58-2	8862-8865	the	_	
58-3	8866-8870	time	_	
58-4	8871-8873	of	_	
58-5	8874-8877	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging	
58-6	8878-8882	scan	_	
58-7	8882-8883	,	_	
58-8	8884-8888	nine	_	
58-9	8889-8897	subjects	_	
58-10	8898-8911	self-reported	_	
58-11	8912-8920	nicotine	_	
58-12	8921-8924	use	_	
58-13	8925-8931	within	_	
58-14	8932-8935	the	_	
58-15	8936-8940	past	_	
58-16	8941-8942	7	_	
58-17	8943-8947	days	_	
58-18	8947-8948	.	_	

#Text=MRI Acquisition
#Text=Image acquisition was performed on a 3T Siemens Tim-Trio MRI scanner.
59-1	8949-8952	MRI	_	
59-2	8953-8964	Acquisition	_	
59-3	8965-8970	Image	_	
59-4	8971-8982	acquisition	_	
59-5	8983-8986	was	_	
59-6	8987-8996	performed	_	
59-7	8997-8999	on	_	
59-8	9000-9001	a	_	
59-9	9002-9004	3T	_	
59-10	9005-9012	Siemens	_	
59-11	9013-9021	Tim-Trio	_	
59-12	9022-9025	MRI	_	
59-13	9026-9033	scanner	_	
59-14	9033-9034	.	_	

#Text=Foam pads were used to minimize head motion for all participants.
60-1	9035-9039	Foam	_	
60-2	9040-9044	pads	_	
60-3	9045-9049	were	_	
60-4	9050-9054	used	_	
60-5	9055-9057	to	_	
60-6	9058-9066	minimize	_	
60-7	9067-9071	head	_	
60-8	9072-9078	motion	_	
60-9	9079-9082	for	_	
60-10	9083-9086	all	_	
60-11	9087-9099	participants	_	
60-12	9099-9100	.	_	

#Text=Functional scans were acquired using a single-shot echo-planar-imaging (SS-EPI) sequence [repetition time (TR) = 813 ms; echo time (TE) = 28 ms; flip angle = 60°; 42 transverse slices; slice thickness 3.4 mm; field of view (FOV) = 220×220 mm2; imaging matrix = 64×64; in-plane voxel size = 3.44×3.44 mm2].
61-1	9101-9111	Functional	_	
61-2	9112-9117	scans	_	
61-3	9118-9122	were	_	
61-4	9123-9131	acquired	_	
61-5	9132-9137	using	_	
61-6	9138-9139	a	_	
61-7	9140-9151	single-shot	_	
61-8	9152-9171	echo-planar-imaging	_	
61-9	9172-9173	(	_	
61-10	9173-9179	SS-EPI	_	
61-11	9179-9180	)	_	
61-12	9181-9189	sequence	_	
61-13	9190-9191	[	_	
61-14	9191-9201	repetition	_	
61-15	9202-9206	time	_	
61-16	9207-9208	(	_	
61-17	9208-9210	TR	_	
61-18	9210-9211	)	_	
61-19	9212-9213	=	_	
61-20	9214-9217	813	_	
61-21	9218-9220	ms	_	
61-22	9220-9221	;	_	
61-23	9222-9226	echo	_	
61-24	9227-9231	time	_	
61-25	9232-9233	(	_	
61-26	9233-9235	TE	_	
61-27	9235-9236	)	_	
61-28	9237-9238	=	_	
61-29	9239-9241	28	_	
61-30	9242-9244	ms	_	
61-31	9244-9245	;	_	
61-32	9246-9250	flip	_	
61-33	9251-9256	angle	_	
61-34	9257-9258	=	_	
61-35	9259-9261	60	_	
61-36	9261-9262	°	_	
61-37	9262-9263	;	_	
61-38	9264-9266	42	_	
61-39	9267-9277	transverse	_	
61-40	9278-9284	slices	_	
61-41	9284-9285	;	_	
61-42	9286-9291	slice	_	
61-43	9292-9301	thickness	_	
61-44	9302-9305	3.4	_	
61-45	9306-9308	mm	_	
61-46	9308-9309	;	_	
61-47	9310-9315	field	_	
61-48	9316-9318	of	_	
61-49	9319-9323	view	_	
61-50	9324-9325	(	_	
61-51	9325-9328	FOV	_	
61-52	9328-9329	)	_	
61-53	9330-9331	=	_	
61-54	9332-9335	220	_	
61-55	9335-9336	×	_	
61-56	9336-9339	220	_	
61-57	9340-9343	mm2	_	
61-58	9343-9344	;	_	
61-59	9345-9352	imaging	_	
61-60	9353-9359	matrix	_	
61-61	9360-9361	=	_	
61-62	9362-9364	64	_	
61-63	9364-9365	×	_	
61-64	9365-9367	64	_	
61-65	9367-9368	;	_	
61-66	9369-9377	in-plane	_	
61-67	9378-9383	voxel	_	
61-68	9384-9388	size	_	
61-69	9389-9390	=	_	
61-70	9391-9395	3.44	_	
61-71	9395-9396	×	_	
61-72	9396-9400	3.44	_	
61-73	9401-9404	mm2	_	
61-74	9404-9405	]	_	
61-75	9405-9406	.	_	

#Text=Subjects were instructed to rest in the scanner looking at a fixation-cross on a screen via an LCD projector.
62-1	9407-9415	Subjects	_	
62-2	9416-9420	were	_	
62-3	9421-9431	instructed	_	
62-4	9432-9434	to	_	
62-5	9435-9439	rest	_	
62-6	9440-9442	in	_	
62-7	9443-9446	the	_	
62-8	9447-9454	scanner	_	
62-9	9455-9462	looking	_	
62-10	9463-9465	at	_	
62-11	9466-9467	a	_	
62-12	9468-9482	fixation-cross	_	
62-13	9483-9485	on	_	
62-14	9486-9487	a	_	
62-15	9488-9494	screen	_	
62-16	9495-9498	via	_	
62-17	9499-9501	an	_	
62-18	9502-9505	LCD	_	
62-19	9506-9515	projector	_	
62-20	9515-9516	.	_	

#Text=Scans for the first 10 sec were discarded to allow the T1-magnetisation equilibrium, resulting in a total of 1000 volumes (= 14 min).
63-1	9517-9522	Scans	_	
63-2	9523-9526	for	_	
63-3	9527-9530	the	_	
63-4	9531-9536	first	_	
63-5	9537-9539	10	_	
63-6	9540-9543	sec	_	
63-7	9544-9548	were	_	
63-8	9549-9558	discarded	_	
63-9	9559-9561	to	_	
63-10	9562-9567	allow	_	
63-11	9568-9571	the	_	
63-12	9572-9574	T1	_	
63-13	9574-9575	-	_	
63-14	9575-9588	magnetisation	_	
63-15	9589-9600	equilibrium	_	
63-16	9600-9601	,	_	
63-17	9602-9611	resulting	_	
63-18	9612-9614	in	_	
63-19	9615-9616	a	_	
63-20	9617-9622	total	_	
63-21	9623-9625	of	_	
63-22	9626-9630	1000	_	
63-23	9631-9638	volumes	_	
63-24	9639-9640	(	_	
63-25	9640-9641	=	_	
63-26	9642-9644	14	_	
63-27	9645-9648	min	_	
63-28	9648-9649	)	_	
63-29	9649-9650	.	_	

#Text=DTI scans were obtained (= 6 min 24 sec) using SS-EPI sequence [TR = 4.5 s; TE = 88 ms; flip angle = 90°; 72 transverse slices; slice thickness 2 mm; FOV = 256×256 mm2; imaging matrix = 128×128; in-plane voxel size = 2×2 mm2; 64 non-collinear directions; b-value of 1,000 s/mm2; 8 b0 images].
64-1	9651-9654	DTI	_	
64-2	9655-9660	scans	_	
64-3	9661-9665	were	_	
64-4	9666-9674	obtained	_	
64-5	9675-9676	(	_	
64-6	9676-9677	=	_	
64-7	9678-9679	6	_	
64-8	9680-9683	min	_	
64-9	9684-9686	24	_	
64-10	9687-9690	sec	_	
64-11	9690-9691	)	_	
64-12	9692-9697	using	_	
64-13	9698-9704	SS-EPI	_	
64-14	9705-9713	sequence	_	
64-15	9714-9715	[	_	
64-16	9715-9717	TR	_	
64-17	9718-9719	=	_	
64-18	9720-9723	4.5	_	
64-19	9724-9725	s	_	
64-20	9725-9726	;	_	
64-21	9727-9729	TE	_	
64-22	9730-9731	=	_	
64-23	9732-9734	88	_	
64-24	9735-9737	ms	_	
64-25	9737-9738	;	_	
64-26	9739-9743	flip	_	
64-27	9744-9749	angle	_	
64-28	9750-9751	=	_	
64-29	9752-9754	90	_	
64-30	9754-9755	°	_	
64-31	9755-9756	;	_	
64-32	9757-9759	72	_	
64-33	9760-9770	transverse	_	
64-34	9771-9777	slices	_	
64-35	9777-9778	;	_	
64-36	9779-9784	slice	_	
64-37	9785-9794	thickness	_	
64-38	9795-9796	2	_	
64-39	9797-9799	mm	_	
64-40	9799-9800	;	_	
64-41	9801-9804	FOV	_	
64-42	9805-9806	=	_	
64-43	9807-9810	256	_	
64-44	9810-9811	×	_	
64-45	9811-9814	256	_	
64-46	9815-9818	mm2	_	
64-47	9818-9819	;	_	
64-48	9820-9827	imaging	_	
64-49	9828-9834	matrix	_	
64-50	9835-9836	=	_	
64-51	9837-9840	128	_	
64-52	9840-9841	×	_	
64-53	9841-9844	128	_	
64-54	9844-9845	;	_	
64-55	9846-9854	in-plane	_	
64-56	9855-9860	voxel	_	
64-57	9861-9865	size	_	
64-58	9866-9867	=	_	
64-59	9868-9869	2	_	
64-60	9869-9870	×	_	
64-61	9870-9871	2	_	
64-62	9872-9875	mm2	_	
64-63	9875-9876	;	_	
64-64	9877-9879	64	_	
64-65	9880-9893	non-collinear	_	
64-66	9894-9904	directions	_	
64-67	9904-9905	;	_	
64-68	9906-9913	b-value	_	
64-69	9914-9916	of	_	
64-70	9917-9922	1,000	_	
64-71	9923-9924	s	_	
64-72	9924-9925	/	_	
64-73	9925-9928	mm2	_	
64-74	9928-9929	;	_	
64-75	9930-9931	8	_	
64-76	9932-9934	b0	_	
64-77	9935-9941	images	_	
64-78	9941-9942	]	_	
64-79	9942-9943	.	_	

#Text=DTI scans were repeated twice with opposite phase-encoding directions [anterior-to-posterior (AP) and posterior-to-anterior (PA)] to correct eddy-current and susceptibility induced image distortion (see Structural Connectivity).
65-1	9944-9947	DTI	_	
65-2	9948-9953	scans	_	
65-3	9954-9958	were	_	
65-4	9959-9967	repeated	_	
65-5	9968-9973	twice	_	
65-6	9974-9978	with	_	
65-7	9979-9987	opposite	_	
65-8	9988-10002	phase-encoding	_	
65-9	10003-10013	directions	_	
65-10	10014-10015	[	_	
65-11	10015-10036	anterior-to-posterior	_	
65-12	10037-10038	(	_	
65-13	10038-10040	AP	_	
65-14	10040-10041	)	_	
65-15	10042-10045	and	_	
65-16	10046-10067	posterior-to-anterior	_	
65-17	10068-10069	(	_	
65-18	10069-10071	PA	_	
65-19	10071-10072	)	_	
65-20	10072-10073	]	_	
65-21	10074-10076	to	_	
65-22	10077-10084	correct	_	
65-23	10085-10097	eddy-current	_	
65-24	10098-10101	and	_	
65-25	10102-10116	susceptibility	_	
65-26	10117-10124	induced	_	
65-27	10125-10130	image	_	
65-28	10131-10141	distortion	_	
65-29	10142-10143	(	_	
65-30	10143-10146	see	_	
65-31	10147-10157	Structural	_	
65-32	10158-10170	Connectivity	_	
65-33	10170-10171	)	_	
65-34	10171-10172	.	_	

#Text=Subsequently, high-resolution T1-weighted anatomical images were acquired in the sagittal plane using an inversion-recovery spoiled gradient recalled acquisition (IR-SPGR) sequence [TR = 1.8 s; TE = 2. 67 ms; inversion time = 0.9 s; flip angle 9°; imaging matrix = 256×256; 192 slices; voxel size = 1×1×1 mm3].
66-1	10173-10185	Subsequently	_	
66-2	10185-10186	,	_	
66-3	10187-10202	high-resolution	_	
66-4	10203-10205	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[24]	
66-5	10205-10206	-	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[24]	
66-6	10206-10214	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[24]	
66-7	10215-10225	anatomical	_	
66-8	10226-10232	images	_	
66-9	10233-10237	were	_	
66-10	10238-10246	acquired	_	
66-11	10247-10249	in	_	
66-12	10250-10253	the	_	
66-13	10254-10262	sagittal	_	
66-14	10263-10268	plane	_	
66-15	10269-10274	using	_	
66-16	10275-10277	an	_	
66-17	10278-10296	inversion-recovery	_	
66-18	10297-10304	spoiled	_	
66-19	10305-10313	gradient	_	
66-20	10314-10322	recalled	_	
66-21	10323-10334	acquisition	_	
66-22	10335-10336	(	_	
66-23	10336-10343	IR-SPGR	_	
66-24	10343-10344	)	_	
66-25	10345-10353	sequence	_	
66-26	10354-10355	[	_	
66-27	10355-10357	TR	_	
66-28	10358-10359	=	_	
66-29	10360-10363	1.8	_	
66-30	10364-10365	s	_	
66-31	10365-10366	;	_	
66-32	10367-10369	TE	_	
66-33	10370-10371	=	_	
66-34	10372-10373	2	_	
66-35	10373-10374	.	_	
66-36	10375-10377	67	_	
66-37	10378-10380	ms	_	
66-38	10380-10381	;	_	
66-39	10382-10391	inversion	_	
66-40	10392-10396	time	_	
66-41	10397-10398	=	_	
66-42	10399-10402	0.9	_	
66-43	10403-10404	s	_	
66-44	10404-10405	;	_	
66-45	10406-10410	flip	_	
66-46	10411-10416	angle	_	
66-47	10417-10418	9	_	
66-48	10418-10419	°	_	
66-49	10419-10420	;	_	
66-50	10421-10428	imaging	_	
66-51	10429-10435	matrix	_	
66-52	10436-10437	=	_	
66-53	10438-10441	256	_	
66-54	10441-10442	×	_	
66-55	10442-10445	256	_	
66-56	10445-10446	;	_	
66-57	10447-10450	192	_	
66-58	10451-10457	slices	_	
66-59	10457-10458	;	_	
66-60	10459-10464	voxel	_	
66-61	10465-10469	size	_	
66-62	10470-10471	=	_	
66-63	10472-10473	1	_	
66-64	10473-10474	×	_	
66-65	10474-10475	1	_	
66-66	10475-10476	×	_	
66-67	10476-10477	1	_	
66-68	10478-10481	mm3	_	
66-69	10481-10482	]	_	
66-70	10482-10483	.	_	

#Text=All scans were visually checked to ensure acceptable MRI quality.
67-1	10484-10487	All	_	
67-2	10488-10493	scans	_	
67-3	10494-10498	were	_	
67-4	10499-10507	visually	_	
67-5	10508-10515	checked	_	
67-6	10516-10518	to	_	
67-7	10519-10525	ensure	_	
67-8	10526-10536	acceptable	_	
67-9	10537-10540	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging	
67-10	10541-10548	quality	_	
67-11	10548-10549	.	_	

#Text=Anatomical Parcellation
#Text=Preprocessing of T1-weighted MRI was performed using Freesurfer (http://freesurfer.net).
68-1	10550-10560	Anatomical	_	
68-2	10561-10573	Parcellation	_	
68-3	10574-10587	Preprocessing	_	
68-4	10588-10590	of	_	
68-5	10591-10593	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[25]	
68-6	10593-10594	-	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[25]	
68-7	10594-10602	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[25]	
68-8	10603-10606	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging	
68-9	10607-10610	was	_	
68-10	10611-10620	performed	_	
68-11	10621-10626	using	_	
68-12	10627-10637	Freesurfer	_	
68-13	10638-10639	(	_	
68-14	10639-10643	http	_	
68-15	10643-10644	:	_	
68-16	10644-10645	/	_	
68-17	10645-10646	/	_	
68-18	10646-10660	freesurfer.net	_	
68-19	10660-10661	)	_	
68-20	10661-10662	.	_	

#Text=The cortical regions were parcellated into anatomically distinct 68 cortical and 14 subcortical regions using Desikan-Killiany atlas, and automatically subdivided into a set of 1014 smaller regions, each of which was a network node (Figure S1A) using Connectome Mapper.
69-1	10663-10666	The	_	
69-2	10667-10675	cortical	_	
69-3	10676-10683	regions	_	
69-4	10684-10688	were	_	
69-5	10689-10700	parcellated	_	
69-6	10701-10705	into	_	
69-7	10706-10718	anatomically	_	
69-8	10719-10727	distinct	_	
69-9	10728-10730	68	_	
69-10	10731-10739	cortical	_	
69-11	10740-10743	and	_	
69-12	10744-10746	14	_	
69-13	10747-10758	subcortical	_	
69-14	10759-10766	regions	_	
69-15	10767-10772	using	_	
69-16	10773-10789	Desikan-Killiany	_	
69-17	10790-10795	atlas	_	
69-18	10795-10796	,	_	
69-19	10797-10800	and	_	
69-20	10801-10814	automatically	_	
69-21	10815-10825	subdivided	_	
69-22	10826-10830	into	_	
69-23	10831-10832	a	_	
69-24	10833-10836	set	_	
69-25	10837-10839	of	_	
69-26	10840-10844	1014	_	
69-27	10845-10852	smaller	_	
69-28	10853-10860	regions	_	
69-29	10860-10861	,	_	
69-30	10862-10866	each	_	
69-31	10867-10869	of	_	
69-32	10870-10875	which	_	
69-33	10876-10879	was	_	
69-34	10880-10881	a	_	
69-35	10882-10889	network	_	
69-36	10890-10894	node	_	
69-37	10895-10896	(	_	
69-38	10896-10902	Figure	_	
69-39	10903-10906	S1A	_	
69-40	10906-10907	)	_	
69-41	10908-10913	using	_	
69-42	10914-10924	Connectome	_	
69-43	10925-10931	Mapper	_	
69-44	10931-10932	.	_	

#Text=This approach resulted in approximately identical node sizes across both hemispheres [mean ± SD = 0.68 ± 0.3 cm3].
70-1	10933-10937	This	_	
70-2	10938-10946	approach	_	
70-3	10947-10955	resulted	_	
70-4	10956-10958	in	_	
70-5	10959-10972	approximately	_	
70-6	10973-10982	identical	_	
70-7	10983-10987	node	_	
70-8	10988-10993	sizes	_	
70-9	10994-11000	across	_	
70-10	11001-11005	both	_	
70-11	11006-11017	hemispheres	_	
70-12	11018-11019	[	_	
70-13	11019-11023	mean	_	
70-14	11024-11025	±	_	
70-15	11026-11028	SD	_	
70-16	11029-11030	=	_	
70-17	11031-11035	0.68	_	
70-18	11036-11037	±	_	
70-19	11038-11041	0.3	_	
70-20	11042-11045	cm3	_	
70-21	11045-11046	]	_	
70-22	11046-11047	.	_	

#Text=DTI Preprocessing
#Text=DTI distortion correction was performed using the FSL toolbox (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki).
71-1	11048-11051	DTI	_	
71-2	11052-11065	Preprocessing	_	
71-3	11066-11069	DTI	_	
71-4	11070-11080	distortion	_	
71-5	11081-11091	correction	_	
71-6	11092-11095	was	_	
71-7	11096-11105	performed	_	
71-8	11106-11111	using	_	
71-9	11112-11115	the	_	
71-10	11116-11119	FSL	_	
71-11	11120-11127	toolbox	_	
71-12	11128-11129	(	_	
71-13	11129-11133	http	_	
71-14	11133-11134	:	_	
71-15	11134-11135	/	_	
71-16	11135-11136	/	_	
71-17	11136-11154	fsl.fmrib.ox.ac.uk	_	
71-18	11154-11155	/	_	
71-19	11155-11158	fsl	_	
71-20	11158-11159	/	_	
71-21	11159-11166	fslwiki	_	
71-22	11166-11167	)	_	
71-23	11167-11168	.	_	

#Text=Susceptibility-induced off-resonance field was estimated using two acquisitions with opposing polarities of the phase-encode blips (i.e., AP and PA directions) by TOPUP.
72-1	11169-11191	Susceptibility-induced	_	
72-2	11192-11205	off-resonance	_	
72-3	11206-11211	field	_	
72-4	11212-11215	was	_	
72-5	11216-11225	estimated	_	
72-6	11226-11231	using	_	
72-7	11232-11235	two	_	
72-8	11236-11248	acquisitions	_	
72-9	11249-11253	with	_	
72-10	11254-11262	opposing	_	
72-11	11263-11273	polarities	_	
72-12	11274-11276	of	_	
72-13	11277-11280	the	_	
72-14	11281-11293	phase-encode	_	
72-15	11294-11299	blips	_	
72-16	11300-11301	(	_	
72-17	11301-11304	i.e	_	
72-18	11304-11305	.	_	
72-19	11305-11306	,	_	
72-20	11307-11309	AP	_	
72-21	11310-11313	and	_	
72-22	11314-11316	PA	_	
72-23	11317-11327	directions	_	
72-24	11327-11328	)	_	
72-25	11329-11331	by	_	
72-26	11332-11337	TOPUP	_	
72-27	11337-11338	.	_	

#Text=Correction for the susceptibility, eddy current, and movement-related image distortions were performed using EDDY.
73-1	11339-11349	Correction	_	
73-2	11350-11353	for	_	
73-3	11354-11357	the	_	
73-4	11358-11372	susceptibility	_	
73-5	11372-11373	,	_	
73-6	11374-11378	eddy	_	
73-7	11379-11386	current	_	
73-8	11386-11387	,	_	
73-9	11388-11391	and	_	
73-10	11392-11408	movement-related	_	
73-11	11409-11414	image	_	
73-12	11415-11426	distortions	_	
73-13	11427-11431	were	_	
73-14	11432-11441	performed	_	
73-15	11442-11447	using	_	
73-16	11448-11452	EDDY	_	
73-17	11452-11453	.	_	

#Text=No significant difference between groups for head movements was found (mean ± SD in mm; CB: 1.0 ± 0.4; HC: 0.9 ± 0.1; t = 1.15, p = 0.25).
74-1	11454-11456	No	_	
74-2	11457-11468	significant	_	
74-3	11469-11479	difference	_	
74-4	11480-11487	between	_	
74-5	11488-11494	groups	_	
74-6	11495-11498	for	_	
74-7	11499-11503	head	_	
74-8	11504-11513	movements	_	
74-9	11514-11517	was	_	
74-10	11518-11523	found	_	
74-11	11524-11525	(	_	
74-12	11525-11529	mean	_	
74-13	11530-11531	±	_	
74-14	11532-11534	SD	_	
74-15	11535-11537	in	_	
74-16	11538-11540	mm	_	
74-17	11540-11541	;	_	
74-18	11542-11544	CB	_	
74-19	11544-11545	:	_	
74-20	11546-11549	1.0	_	
74-21	11550-11551	±	_	
74-22	11552-11555	0.4	_	
74-23	11555-11556	;	_	
74-24	11557-11559	HC	_	
74-25	11559-11560	:	_	
74-26	11561-11564	0.9	_	
74-27	11565-11566	±	_	
74-28	11567-11570	0.1	_	
74-29	11570-11571	;	_	
74-30	11572-11573	t	_	
74-31	11574-11575	=	_	
74-32	11576-11580	1.15	_	
74-33	11580-11581	,	_	
74-34	11582-11583	p	_	
74-35	11584-11585	=	_	
74-36	11586-11590	0.25	_	
74-37	11590-11591	)	_	
74-38	11591-11592	.	_	

#Text=A diffusion tensor was fitted at each voxel using nonlinear iterative method to avoid negative eigenvalues, and its directional uncertainty was computed using a 100-times jackknife resampling algorithm.
75-1	11593-11594	A	_	
75-2	11595-11604	diffusion	_	
75-3	11605-11611	tensor	_	
75-4	11612-11615	was	_	
75-5	11616-11622	fitted	_	
75-6	11623-11625	at	_	
75-7	11626-11630	each	_	
75-8	11631-11636	voxel	_	
75-9	11637-11642	using	_	
75-10	11643-11652	nonlinear	_	
75-11	11653-11662	iterative	_	
75-12	11663-11669	method	_	
75-13	11670-11672	to	_	
75-14	11673-11678	avoid	_	
75-15	11679-11687	negative	_	
75-16	11688-11699	eigenvalues	_	
75-17	11699-11700	,	_	
75-18	11701-11704	and	_	
75-19	11705-11708	its	_	
75-20	11709-11720	directional	_	
75-21	11721-11732	uncertainty	_	
75-22	11733-11736	was	_	
75-23	11737-11745	computed	_	
75-24	11746-11751	using	_	
75-25	11752-11753	a	_	
75-26	11754-11757	100	_	
75-27	11757-11758	-	_	
75-28	11758-11763	times	_	
75-29	11764-11773	jackknife	_	
75-30	11774-11784	resampling	_	
75-31	11785-11794	algorithm	_	
75-32	11794-11795	.	_	

#Text=Fiber tracts from the seeded white matter regions were generated using the probabilistic algorithm with voxel-wise directional uncertainty [fractional anisotropy (FA) > 0.1; direction change < 60°; tract length > 1 cm; 30 seeds per voxel; 1,000 Monte-Carlo iterations, generating 30,000 trials at each voxel].
76-1	11796-11801	Fiber	_	
76-2	11802-11808	tracts	_	
76-3	11809-11813	from	_	
76-4	11814-11817	the	_	
76-5	11818-11824	seeded	_	
76-6	11825-11830	white	_	
76-7	11831-11837	matter	_	
76-8	11838-11845	regions	_	
76-9	11846-11850	were	_	
76-10	11851-11860	generated	_	
76-11	11861-11866	using	_	
76-12	11867-11870	the	_	
76-13	11871-11884	probabilistic	_	
76-14	11885-11894	algorithm	_	
76-15	11895-11899	with	_	
76-16	11900-11910	voxel-wise	_	
76-17	11911-11922	directional	_	
76-18	11923-11934	uncertainty	_	
76-19	11935-11936	[	_	
76-20	11936-11946	fractional	_	
76-21	11947-11957	anisotropy	_	
76-22	11958-11959	(	_	
76-23	11959-11961	FA	_	
76-24	11961-11962	)	_	
76-25	11963-11964	>	_	
76-26	11965-11968	0.1	_	
76-27	11968-11969	;	_	
76-28	11970-11979	direction	_	
76-29	11980-11986	change	_	
76-30	11987-11988	<	_	
76-31	11989-11991	60	_	
76-32	11991-11992	°	_	
76-33	11992-11993	;	_	
76-34	11994-11999	tract	_	
76-35	12000-12006	length	_	
76-36	12007-12008	>	_	
76-37	12009-12010	1	_	
76-38	12011-12013	cm	_	
76-39	12013-12014	;	_	
76-40	12015-12017	30	_	
76-41	12018-12023	seeds	_	
76-42	12024-12027	per	_	
76-43	12028-12033	voxel	_	
76-44	12033-12034	;	_	
76-45	12035-12040	1,000	_	
76-46	12041-12052	Monte-Carlo	_	
76-47	12053-12063	iterations	_	
76-48	12063-12064	,	_	
76-49	12065-12075	generating	_	
76-50	12076-12082	30,000	_	
76-51	12083-12089	trials	_	
76-52	12090-12092	at	_	
76-53	12093-12097	each	_	
76-54	12098-12103	voxel	_	
76-55	12103-12104	]	_	
76-56	12104-12105	.	_	

#Text=Consistent with previous investigations, structural connectivity (SC) between any pair of nodes was defined as a normalized weight computed by the number of streamlines between interconnected regions (Figure S1B).
77-1	12106-12116	Consistent	_	
77-2	12117-12121	with	_	
77-3	12122-12130	previous	_	
77-4	12131-12145	investigations	_	
77-5	12145-12146	,	_	
77-6	12147-12157	structural	_	
77-7	12158-12170	connectivity	_	
77-8	12171-12172	(	_	
77-9	12172-12174	SC	_	
77-10	12174-12175	)	_	
77-11	12176-12183	between	_	
77-12	12184-12187	any	_	
77-13	12188-12192	pair	_	
77-14	12193-12195	of	_	
77-15	12196-12201	nodes	_	
77-16	12202-12205	was	_	
77-17	12206-12213	defined	_	
77-18	12214-12216	as	_	
77-19	12217-12218	a	_	
77-20	12219-12229	normalized	_	
77-21	12230-12236	weight	_	
77-22	12237-12245	computed	_	
77-23	12246-12248	by	_	
77-24	12249-12252	the	_	
77-25	12253-12259	number	_	
77-26	12260-12262	of	_	
77-27	12263-12274	streamlines	_	
77-28	12275-12282	between	_	
77-29	12283-12297	interconnected	_	
77-30	12298-12305	regions	_	
77-31	12306-12307	(	_	
77-32	12307-12313	Figure	_	
77-33	12314-12317	S1B	_	
77-34	12317-12318	)	_	
77-35	12318-12319	.	_	

#Text=Resting-State fMRI Preprocessing
#Text=Resting-state fMRI was preprocessed similar to standard functional connectivity preprocessing using AFNI (http://afni.nimh.nih.gov); de-spiking, slice timing correction, motion correction, normalization to a Talairach template, within-run intensity normalization to a whole-brain mode value of 1000, removal of nuisance time series [6 motions, white matter and ventricular signals (eroded by one voxel), with their derivatives] using linear regression, temporal band-pass filtering (0.009–0.08 Hz), spatial smoothing only in the gray matter mask (6-mm full width at half maximum).
78-1	12320-12333	Resting-State	_	
78-2	12334-12338	fMRI	_	
78-3	12339-12352	Preprocessing	_	
78-4	12353-12366	Resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[26]	
78-5	12367-12371	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[26]	
78-6	12372-12375	was	_	
78-7	12376-12388	preprocessed	_	
78-8	12389-12396	similar	_	
78-9	12397-12399	to	_	
78-10	12400-12408	standard	_	
78-11	12409-12419	functional	_	
78-12	12420-12432	connectivity	_	
78-13	12433-12446	preprocessing	_	
78-14	12447-12452	using	_	
78-15	12453-12457	AFNI	_	
78-16	12458-12459	(	_	
78-17	12459-12463	http	_	
78-18	12463-12464	:	_	
78-19	12464-12465	/	_	
78-20	12465-12466	/	_	
78-21	12466-12483	afni.nimh.nih.gov	_	
78-22	12483-12484	)	_	
78-23	12484-12485	;	_	
78-24	12486-12496	de-spiking	_	
78-25	12496-12497	,	_	
78-26	12498-12503	slice	_	
78-27	12504-12510	timing	_	
78-28	12511-12521	correction	_	
78-29	12521-12522	,	_	
78-30	12523-12529	motion	_	
78-31	12530-12540	correction	_	
78-32	12540-12541	,	_	
78-33	12542-12555	normalization	_	
78-34	12556-12558	to	_	
78-35	12559-12560	a	_	
78-36	12561-12570	Talairach	_	
78-37	12571-12579	template	_	
78-38	12579-12580	,	_	
78-39	12581-12591	within-run	_	
78-40	12592-12601	intensity	_	
78-41	12602-12615	normalization	_	
78-42	12616-12618	to	_	
78-43	12619-12620	a	_	
78-44	12621-12632	whole-brain	_	
78-45	12633-12637	mode	_	
78-46	12638-12643	value	_	
78-47	12644-12646	of	_	
78-48	12647-12651	1000	_	
78-49	12651-12652	,	_	
78-50	12653-12660	removal	_	
78-51	12661-12663	of	_	
78-52	12664-12672	nuisance	_	
78-53	12673-12677	time	_	
78-54	12678-12684	series	_	
78-55	12685-12686	[	_	
78-56	12686-12687	6	_	
78-57	12688-12695	motions	_	
78-58	12695-12696	,	_	
78-59	12697-12702	white	_	
78-60	12703-12709	matter	_	
78-61	12710-12713	and	_	
78-62	12714-12725	ventricular	_	
78-63	12726-12733	signals	_	
78-64	12734-12735	(	_	
78-65	12735-12741	eroded	_	
78-66	12742-12744	by	_	
78-67	12745-12748	one	_	
78-68	12749-12754	voxel	_	
78-69	12754-12755	)	_	
78-70	12755-12756	,	_	
78-71	12757-12761	with	_	
78-72	12762-12767	their	_	
78-73	12768-12779	derivatives	_	
78-74	12779-12780	]	_	
78-75	12781-12786	using	_	
78-76	12787-12793	linear	_	
78-77	12794-12804	regression	_	
78-78	12804-12805	,	_	
78-79	12806-12814	temporal	_	
78-80	12815-12824	band-pass	_	
78-81	12825-12834	filtering	_	
78-82	12835-12836	(	_	
78-83	12836-12841	0.009	_	
78-84	12841-12842	–	_	
78-85	12842-12846	0.08	_	
78-86	12847-12849	Hz	_	
78-87	12849-12850	)	_	
78-88	12850-12851	,	_	
78-89	12852-12859	spatial	_	
78-90	12860-12869	smoothing	_	
78-91	12870-12874	only	_	
78-92	12875-12877	in	_	
78-93	12878-12881	the	_	
78-94	12882-12886	gray	_	
78-95	12887-12893	matter	_	
78-96	12894-12898	mask	_	
78-97	12899-12900	(	_	
78-98	12900-12901	6	_	
78-99	12901-12902	-	_	
78-100	12902-12904	mm	_	
78-101	12905-12909	full	_	
78-102	12910-12915	width	_	
78-103	12916-12918	at	_	
78-104	12919-12923	half	_	
78-105	12924-12931	maximum	_	
78-106	12931-12932	)	_	
78-107	12932-12933	.	_	

#Text=A whole brain signal was not included in nuisance covariates given on-going controversy regarding its value.
79-1	12934-12935	A	_	
79-2	12936-12941	whole	_	
79-3	12942-12947	brain	_	
79-4	12948-12954	signal	_	
79-5	12955-12958	was	_	
79-6	12959-12962	not	_	
79-7	12963-12971	included	_	
79-8	12972-12974	in	_	
79-9	12975-12983	nuisance	_	
79-10	12984-12994	covariates	_	
79-11	12995-13000	given	_	
79-12	13001-13009	on-going	_	
79-13	13010-13021	controversy	_	
79-14	13022-13031	regarding	_	
79-15	13032-13035	its	_	
79-16	13036-13041	value	_	
79-17	13041-13042	.	_	

#Text=Volumes with high motion were censored to decrease potential motion-induced bias of functional connectivity.
80-1	13043-13050	Volumes	_	
80-2	13051-13055	with	_	
80-3	13056-13060	high	_	
80-4	13061-13067	motion	_	
80-5	13068-13072	were	_	
80-6	13073-13081	censored	_	
80-7	13082-13084	to	_	
80-8	13085-13093	decrease	_	
80-9	13094-13103	potential	_	
80-10	13104-13118	motion-induced	_	
80-11	13119-13123	bias	_	
80-12	13124-13126	of	_	
80-13	13127-13137	functional	_	
80-14	13138-13150	connectivity	_	
80-15	13150-13151	.	_	

#Text=We used thresholds with a frame-wise displacement (FD) of 0.5 and a percentage of BOLD signal changes over the whole brain of 0.5, above which scans (including 1 backward and 2 forward volumes) were removed.
81-1	13152-13154	We	_	
81-2	13155-13159	used	_	
81-3	13160-13170	thresholds	_	
81-4	13171-13175	with	_	
81-5	13176-13177	a	_	
81-6	13178-13188	frame-wise	_	
81-7	13189-13201	displacement	_	
81-8	13202-13203	(	_	
81-9	13203-13205	FD	_	
81-10	13205-13206	)	_	
81-11	13207-13209	of	_	
81-12	13210-13213	0.5	_	
81-13	13214-13217	and	_	
81-14	13218-13219	a	_	
81-15	13220-13230	percentage	_	
81-16	13231-13233	of	_	
81-17	13234-13238	BOLD	_	
81-18	13239-13245	signal	_	
81-19	13246-13253	changes	_	
81-20	13254-13258	over	_	
81-21	13259-13262	the	_	
81-22	13263-13268	whole	_	
81-23	13269-13274	brain	_	
81-24	13275-13277	of	_	
81-25	13278-13281	0.5	_	
81-26	13281-13282	,	_	
81-27	13283-13288	above	_	
81-28	13289-13294	which	_	
81-29	13295-13300	scans	_	
81-30	13301-13302	(	_	
81-31	13302-13311	including	_	
81-32	13312-13313	1	_	
81-33	13314-13322	backward	_	
81-34	13323-13326	and	_	
81-35	13327-13328	2	_	
81-36	13329-13336	forward	_	
81-37	13337-13344	volumes	_	
81-38	13344-13345	)	_	
81-39	13346-13350	were	_	
81-40	13351-13358	removed	_	
81-41	13358-13359	.	_	

#Text=No significant difference was found in the number of censored volumes from 1,000 resting-state scans between two groups (mean ± SD; CB: 32.2 ± 76.6; HC: 17.2 ± 26.0; t = 0.47, p = 0.64).
82-1	13360-13362	No	_	
82-2	13363-13374	significant	_	
82-3	13375-13385	difference	_	
82-4	13386-13389	was	_	
82-5	13390-13395	found	_	
82-6	13396-13398	in	_	
82-7	13399-13402	the	_	
82-8	13403-13409	number	_	
82-9	13410-13412	of	_	
82-10	13413-13421	censored	_	
82-11	13422-13429	volumes	_	
82-12	13430-13434	from	_	
82-13	13435-13440	1,000	_	
82-14	13441-13454	resting-state	_	
82-15	13455-13460	scans	_	
82-16	13461-13468	between	_	
82-17	13469-13472	two	_	
82-18	13473-13479	groups	_	
82-19	13480-13481	(	_	
82-20	13481-13485	mean	_	
82-21	13486-13487	±	_	
82-22	13488-13490	SD	_	
82-23	13490-13491	;	_	
82-24	13492-13494	CB	_	
82-25	13494-13495	:	_	
82-26	13496-13500	32.2	_	
82-27	13501-13502	±	_	
82-28	13503-13507	76.6	_	
82-29	13507-13508	;	_	
82-30	13509-13511	HC	_	
82-31	13511-13512	:	_	
82-32	13513-13517	17.2	_	
82-33	13518-13519	±	_	
82-34	13520-13524	26.0	_	
82-35	13524-13525	;	_	
82-36	13526-13527	t	_	
82-37	13528-13529	=	_	
82-38	13530-13534	0.47	_	
82-39	13534-13535	,	_	
82-40	13536-13537	p	_	
82-41	13538-13539	=	_	
82-42	13540-13544	0.64	_	
82-43	13544-13545	)	_	
82-44	13545-13546	.	_	

#Text=Structural and Functional Connectivity
#Text=Consistent with previous investigations, structural connectivity (SC) between any pair of nodes was defined as a normalized weight computed by the number of streamlines between interconnected regions (Figure S1B).
83-1	13547-13557	Structural	_	
83-2	13558-13561	and	_	
83-3	13562-13572	Functional	_	
83-4	13573-13585	Connectivity	_	
83-5	13586-13596	Consistent	_	
83-6	13597-13601	with	_	
83-7	13602-13610	previous	_	
83-8	13611-13625	investigations	_	
83-9	13625-13626	,	_	
83-10	13627-13637	structural	_	
83-11	13638-13650	connectivity	_	
83-12	13651-13652	(	_	
83-13	13652-13654	SC	_	
83-14	13654-13655	)	_	
83-15	13656-13663	between	_	
83-16	13664-13667	any	_	
83-17	13668-13672	pair	_	
83-18	13673-13675	of	_	
83-19	13676-13681	nodes	_	
83-20	13682-13685	was	_	
83-21	13686-13693	defined	_	
83-22	13694-13696	as	_	
83-23	13697-13698	a	_	
83-24	13699-13709	normalized	_	
83-25	13710-13716	weight	_	
83-26	13717-13725	computed	_	
83-27	13726-13728	by	_	
83-28	13729-13732	the	_	
83-29	13733-13739	number	_	
83-30	13740-13742	of	_	
83-31	13743-13754	streamlines	_	
83-32	13755-13762	between	_	
83-33	13763-13777	interconnected	_	
83-34	13778-13785	regions	_	
83-35	13786-13787	(	_	
83-36	13787-13793	Figure	_	
83-37	13794-13797	S1B	_	
83-38	13797-13798	)	_	
83-39	13798-13799	.	_	

#Text=Functional connectivity (FC) was estimated using Pearson’s correlation coefficient (r) between mean BOLD time-series from all pairs of 1014 brain regions and converted to z-scores using Fisher’s r-to-z transformation (Figure S1B).
84-1	13800-13810	Functional	_	
84-2	13811-13823	connectivity	_	
84-3	13824-13825	(	_	
84-4	13825-13827	FC	_	
84-5	13827-13828	)	_	
84-6	13829-13832	was	_	
84-7	13833-13842	estimated	_	
84-8	13843-13848	using	_	
84-9	13849-13856	Pearson	_	
84-10	13856-13857	’	_	
84-11	13857-13858	s	_	
84-12	13859-13870	correlation	_	
84-13	13871-13882	coefficient	_	
84-14	13883-13884	(	_	
84-15	13884-13885	r	_	
84-16	13885-13886	)	_	
84-17	13887-13894	between	_	
84-18	13895-13899	mean	_	
84-19	13900-13904	BOLD	_	
84-20	13905-13916	time-series	_	
84-21	13917-13921	from	_	
84-22	13922-13925	all	_	
84-23	13926-13931	pairs	_	
84-24	13932-13934	of	_	
84-25	13935-13939	1014	_	
84-26	13940-13945	brain	_	
84-27	13946-13953	regions	_	
84-28	13954-13957	and	_	
84-29	13958-13967	converted	_	
84-30	13968-13970	to	_	
84-31	13971-13979	z-scores	_	
84-32	13980-13985	using	_	
84-33	13986-13992	Fisher	_	
84-34	13992-13993	’	_	
84-35	13993-13994	s	_	
84-36	13995-14001	r-to-z	_	
84-37	14002-14016	transformation	_	
84-38	14017-14018	(	_	
84-39	14018-14024	Figure	_	
84-40	14025-14028	S1B	_	
84-41	14028-14029	)	_	
84-42	14029-14030	.	_	

#Text=Structural-Functional Coupling
#Text=All nonzero elements of the structural connectivity matrix (i.e., the upper triangular part of 1,014×1,014 SC matrix) were extracted and rescaled to a Gaussian distribution (mean ± SD = 0.5 ± 0.1).
85-1	14031-14052	Structural-Functional	_	
85-2	14053-14061	Coupling	_	
85-3	14062-14065	All	_	
85-4	14066-14073	nonzero	_	
85-5	14074-14082	elements	_	
85-6	14083-14085	of	_	
85-7	14086-14089	the	_	
85-8	14090-14100	structural	_	
85-9	14101-14113	connectivity	_	
85-10	14114-14120	matrix	_	
85-11	14121-14122	(	_	
85-12	14122-14125	i.e	_	
85-13	14125-14126	.	_	
85-14	14126-14127	,	_	
85-15	14128-14131	the	_	
85-16	14132-14137	upper	_	
85-17	14138-14148	triangular	_	
85-18	14149-14153	part	_	
85-19	14154-14156	of	_	
85-20	14157-14162	1,014	_	
85-21	14162-14163	×	_	
85-22	14163-14168	1,014	_	
85-23	14169-14171	SC	_	
85-24	14172-14178	matrix	_	
85-25	14178-14179	)	_	
85-26	14180-14184	were	_	
85-27	14185-14194	extracted	_	
85-28	14195-14198	and	_	
85-29	14199-14207	rescaled	_	
85-30	14208-14210	to	_	
85-31	14211-14212	a	_	
85-32	14213-14221	Gaussian	_	
85-33	14222-14234	distribution	_	
85-34	14235-14236	(	_	
85-35	14236-14240	mean	_	
85-36	14241-14242	±	_	
85-37	14243-14245	SD	_	
85-38	14246-14247	=	_	
85-39	14248-14251	0.5	_	
85-40	14252-14253	±	_	
85-41	14254-14257	0.1	_	
85-42	14257-14258	)	_	
85-43	14258-14259	.	_	

#Text=This rescaling step was motivated by the observation that structural connectivity weights computed from streamline counts often shows a highly skewed (e.g., exponential) distribution, which is unlikely to reflect physiologically meaningful coupling strength; rescaling preserves the rank order of tract weights.
86-1	14260-14264	This	_	
86-2	14265-14274	rescaling	_	
86-3	14275-14279	step	_	
86-4	14280-14283	was	_	
86-5	14284-14293	motivated	_	
86-6	14294-14296	by	_	
86-7	14297-14300	the	_	
86-8	14301-14312	observation	_	
86-9	14313-14317	that	_	
86-10	14318-14328	structural	_	
86-11	14329-14341	connectivity	_	
86-12	14342-14349	weights	_	
86-13	14350-14358	computed	_	
86-14	14359-14363	from	_	
86-15	14364-14374	streamline	_	
86-16	14375-14381	counts	_	
86-17	14382-14387	often	_	
86-18	14388-14393	shows	_	
86-19	14394-14395	a	_	
86-20	14396-14402	highly	_	
86-21	14403-14409	skewed	_	
86-22	14410-14411	(	_	
86-23	14411-14414	e.g	_	
86-24	14414-14415	.	_	
86-25	14415-14416	,	_	
86-26	14417-14428	exponential	_	
86-27	14428-14429	)	_	
86-28	14430-14442	distribution	_	
86-29	14442-14443	,	_	
86-30	14444-14449	which	_	
86-31	14450-14452	is	_	
86-32	14453-14461	unlikely	_	
86-33	14462-14464	to	_	
86-34	14465-14472	reflect	_	
86-35	14473-14488	physiologically	_	
86-36	14489-14499	meaningful	_	
86-37	14500-14508	coupling	_	
86-38	14509-14517	strength	_	
86-39	14517-14518	;	_	
86-40	14519-14528	rescaling	_	
86-41	14529-14538	preserves	_	
86-42	14539-14542	the	_	
86-43	14543-14547	rank	_	
86-44	14548-14553	order	_	
86-45	14554-14556	of	_	
86-46	14557-14562	tract	_	
86-47	14563-14570	weights	_	
86-48	14570-14571	.	_	

#Text=Coupling between structural connectivity and its functional counterparts was computed as a Pearson’s correlation coefficient between these two measures.
87-1	14572-14580	Coupling	_	
87-2	14581-14588	between	_	
87-3	14589-14599	structural	_	
87-4	14600-14612	connectivity	_	
87-5	14613-14616	and	_	
87-6	14617-14620	its	_	
87-7	14621-14631	functional	_	
87-8	14632-14644	counterparts	_	
87-9	14645-14648	was	_	
87-10	14649-14657	computed	_	
87-11	14658-14660	as	_	
87-12	14661-14662	a	_	
87-13	14663-14670	Pearson	_	
87-14	14670-14671	’	_	
87-15	14671-14672	s	_	
87-16	14673-14684	correlation	_	
87-17	14685-14696	coefficient	_	
87-18	14697-14704	between	_	
87-19	14705-14710	these	_	
87-20	14711-14714	two	_	
87-21	14715-14723	measures	_	
87-22	14723-14724	.	_	

#Text=While the structural–functional coupling was decreased in some disease states representing a progress of the disease-related structural–functional impairment, it has also been suggested to be increased in more stringent functional interaction restrained with underlying anatomical connections reflecting both the normal development and the disease.
88-1	14725-14730	While	_	
88-2	14731-14734	the	_	
88-3	14735-14756	structural–functional	_	
88-4	14757-14765	coupling	_	
88-5	14766-14769	was	_	
88-6	14770-14779	decreased	_	
88-7	14780-14782	in	_	
88-8	14783-14787	some	_	
88-9	14788-14795	disease	_	
88-10	14796-14802	states	_	
88-11	14803-14815	representing	_	
88-12	14816-14817	a	_	
88-13	14818-14826	progress	_	
88-14	14827-14829	of	_	
88-15	14830-14833	the	_	
88-16	14834-14849	disease-related	_	
88-17	14850-14871	structural–functional	_	
88-18	14872-14882	impairment	_	
88-19	14882-14883	,	_	
88-20	14884-14886	it	_	
88-21	14887-14890	has	_	
88-22	14891-14895	also	_	
88-23	14896-14900	been	_	
88-24	14901-14910	suggested	_	
88-25	14911-14913	to	_	
88-26	14914-14916	be	_	
88-27	14917-14926	increased	_	
88-28	14927-14929	in	_	
88-29	14930-14934	more	_	
88-30	14935-14944	stringent	_	
88-31	14945-14955	functional	_	
88-32	14956-14967	interaction	_	
88-33	14968-14978	restrained	_	
88-34	14979-14983	with	_	
88-35	14984-14994	underlying	_	
88-36	14995-15005	anatomical	_	
88-37	15006-15017	connections	_	
88-38	15018-15028	reflecting	_	
88-39	15029-15033	both	_	
88-40	15034-15037	the	_	
88-41	15038-15044	normal	_	
88-42	15045-15056	development	_	
88-43	15057-15060	and	_	
88-44	15061-15064	the	_	
88-45	15065-15072	disease	_	
88-46	15072-15073	.	_	

#Text=Distance Dependence of Connectivity Measures
#Text=As described previously, associations between the connection distance (measured by fiber distance between two regions) and connectivity measures were computed, in which distance measures were converted to the log-transformed distance for SC and the inverse of the fiber distance between regions for FC, respectively.
89-1	15074-15082	Distance	_	
89-2	15083-15093	Dependence	_	
89-3	15094-15096	of	_	
89-4	15097-15109	Connectivity	_	
89-5	15110-15118	Measures	_	
89-6	15119-15121	As	_	
89-7	15122-15131	described	_	
89-8	15132-15142	previously	_	
89-9	15142-15143	,	_	
89-10	15144-15156	associations	_	
89-11	15157-15164	between	_	
89-12	15165-15168	the	_	
89-13	15169-15179	connection	_	
89-14	15180-15188	distance	_	
89-15	15189-15190	(	_	
89-16	15190-15198	measured	_	
89-17	15199-15201	by	_	
89-18	15202-15207	fiber	_	
89-19	15208-15216	distance	_	
89-20	15217-15224	between	_	
89-21	15225-15228	two	_	
89-22	15229-15236	regions	_	
89-23	15236-15237	)	_	
89-24	15238-15241	and	_	
89-25	15242-15254	connectivity	_	
89-26	15255-15263	measures	_	
89-27	15264-15268	were	_	
89-28	15269-15277	computed	_	
89-29	15277-15278	,	_	
89-30	15279-15281	in	_	
89-31	15282-15287	which	_	
89-32	15288-15296	distance	_	
89-33	15297-15305	measures	_	
89-34	15306-15310	were	_	
89-35	15311-15320	converted	_	
89-36	15321-15323	to	_	
89-37	15324-15327	the	_	
89-38	15328-15343	log-transformed	_	
89-39	15344-15352	distance	_	
89-40	15353-15356	for	_	
89-41	15357-15359	SC	_	
89-42	15360-15363	and	_	
89-43	15364-15367	the	_	
89-44	15368-15375	inverse	_	
89-45	15376-15378	of	_	
89-46	15379-15382	the	_	
89-47	15383-15388	fiber	_	
89-48	15389-15397	distance	_	
89-49	15398-15405	between	_	
89-50	15406-15413	regions	_	
89-51	15414-15417	for	_	
89-52	15418-15420	FC	_	
89-53	15420-15421	,	_	
89-54	15422-15434	respectively	_	
89-55	15434-15435	.	_	

#Text=Network Characteristics
#Text=To investigate structural substrates of the SC-FC coupling between two groups, global network properties of the structural connectivity were additionally computed using the Brain Connectivity Toolbox (https://sites.google.com/site/bctnet), which collects representative measures for network integration [characteristic path length (λ) and global efficiency (GE)], segregation [clustering coefficient (γ) and modularity (Q)], and their combination or balance [small-worldness (σ)].
90-1	15436-15443	Network	_	
90-2	15444-15459	Characteristics	_	
90-3	15460-15462	To	_	
90-4	15463-15474	investigate	_	
90-5	15475-15485	structural	_	
90-6	15486-15496	substrates	_	
90-7	15497-15499	of	_	
90-8	15500-15503	the	_	
90-9	15504-15509	SC-FC	_	
90-10	15510-15518	coupling	_	
90-11	15519-15526	between	_	
90-12	15527-15530	two	_	
90-13	15531-15537	groups	_	
90-14	15537-15538	,	_	
90-15	15539-15545	global	_	
90-16	15546-15553	network	_	
90-17	15554-15564	properties	_	
90-18	15565-15567	of	_	
90-19	15568-15571	the	_	
90-20	15572-15582	structural	_	
90-21	15583-15595	connectivity	_	
90-22	15596-15600	were	_	
90-23	15601-15613	additionally	_	
90-24	15614-15622	computed	_	
90-25	15623-15628	using	_	
90-26	15629-15632	the	_	
90-27	15633-15638	Brain	_	
90-28	15639-15651	Connectivity	_	
90-29	15652-15659	Toolbox	_	
90-30	15660-15661	(	_	
90-31	15661-15666	https	_	
90-32	15666-15667	:	_	
90-33	15667-15668	/	_	
90-34	15668-15669	/	_	
90-35	15669-15685	sites.google.com	_	
90-36	15685-15686	/	_	
90-37	15686-15690	site	_	
90-38	15690-15691	/	_	
90-39	15691-15697	bctnet	_	
90-40	15697-15698	)	_	
90-41	15698-15699	,	_	
90-42	15700-15705	which	_	
90-43	15706-15714	collects	_	
90-44	15715-15729	representative	_	
90-45	15730-15738	measures	_	
90-46	15739-15742	for	_	
90-47	15743-15750	network	_	
90-48	15751-15762	integration	_	
90-49	15763-15764	[	_	
90-50	15764-15778	characteristic	_	
90-51	15779-15783	path	_	
90-52	15784-15790	length	_	
90-53	15791-15792	(	_	
90-54	15792-15793	λ	_	
90-55	15793-15794	)	_	
90-56	15795-15798	and	_	
90-57	15799-15805	global	_	
90-58	15806-15816	efficiency	_	
90-59	15817-15818	(	_	
90-60	15818-15820	GE	_	
90-61	15820-15821	)	_	
90-62	15821-15822	]	_	
90-63	15822-15823	,	_	
90-64	15824-15835	segregation	_	
90-65	15836-15837	[	_	
90-66	15837-15847	clustering	_	
90-67	15848-15859	coefficient	_	
90-68	15860-15861	(	_	
90-69	15861-15862	γ	_	
90-70	15862-15863	)	_	
90-71	15864-15867	and	_	
90-72	15868-15878	modularity	_	
90-73	15879-15880	(	_	
90-74	15880-15881	Q	_	
90-75	15881-15882	)	_	
90-76	15882-15883	]	_	
90-77	15883-15884	,	_	
90-78	15885-15888	and	_	
90-79	15889-15894	their	_	
90-80	15895-15906	combination	_	
90-81	15907-15909	or	_	
90-82	15910-15917	balance	_	
90-83	15918-15919	[	_	
90-84	15919-15934	small-worldness	_	
90-85	15935-15936	(	_	
90-86	15936-15937	σ	_	
90-87	15937-15938	)	_	
90-88	15938-15939	]	_	
90-89	15939-15940	.	_	

#Text=To compute normalized measures [i.e., characteristic path length (λ), global efficiency (GE), clustering coefficient (γ) and small-worldness (σ)], 1000 instances of randomly rewired null model matrices (preserving the connections weights, the number of connections, edges, and degree sequences) were generated.
91-1	15941-15943	To	_	
91-2	15944-15951	compute	_	
91-3	15952-15962	normalized	_	
91-4	15963-15971	measures	_	
91-5	15972-15973	[	_	
91-6	15973-15976	i.e	_	
91-7	15976-15977	.	_	
91-8	15977-15978	,	_	
91-9	15979-15993	characteristic	_	
91-10	15994-15998	path	_	
91-11	15999-16005	length	_	
91-12	16006-16007	(	_	
91-13	16007-16008	λ	_	
91-14	16008-16009	)	_	
91-15	16009-16010	,	_	
91-16	16011-16017	global	_	
91-17	16018-16028	efficiency	_	
91-18	16029-16030	(	_	
91-19	16030-16032	GE	_	
91-20	16032-16033	)	_	
91-21	16033-16034	,	_	
91-22	16035-16045	clustering	_	
91-23	16046-16057	coefficient	_	
91-24	16058-16059	(	_	
91-25	16059-16060	γ	_	
91-26	16060-16061	)	_	
91-27	16062-16065	and	_	
91-28	16066-16081	small-worldness	_	
91-29	16082-16083	(	_	
91-30	16083-16084	σ	_	
91-31	16084-16085	)	_	
91-32	16085-16086	]	_	
91-33	16086-16087	,	_	
91-34	16088-16092	1000	_	
91-35	16093-16102	instances	_	
91-36	16103-16105	of	_	
91-37	16106-16114	randomly	_	
91-38	16115-16122	rewired	_	
91-39	16123-16127	null	_	
91-40	16128-16133	model	_	
91-41	16134-16142	matrices	_	
91-42	16143-16144	(	_	
91-43	16144-16154	preserving	_	
91-44	16155-16158	the	_	
91-45	16159-16170	connections	_	
91-46	16171-16178	weights	_	
91-47	16178-16179	,	_	
91-48	16180-16183	the	_	
91-49	16184-16190	number	_	
91-50	16191-16193	of	_	
91-51	16194-16205	connections	_	
91-52	16205-16206	,	_	
91-53	16207-16212	edges	_	
91-54	16212-16213	,	_	
91-55	16214-16217	and	_	
91-56	16218-16224	degree	_	
91-57	16225-16234	sequences	_	
91-58	16234-16235	)	_	
91-59	16236-16240	were	_	
91-60	16241-16250	generated	_	
91-61	16250-16251	.	_	

#Text=Rich-club Organization
#Text=To subsequently examine the regional impact of SC-FC coupling, a rich-club (RC) in the structural network was defined as a set of high-degree (i.e., “rich”) nodes which were also densely interconnected, more so than expected based on a random null model.
92-1	16252-16261	Rich-club	_	
92-2	16262-16274	Organization	_	
92-3	16275-16277	To	_	
92-4	16278-16290	subsequently	_	
92-5	16291-16298	examine	_	
92-6	16299-16302	the	_	
92-7	16303-16311	regional	_	
92-8	16312-16318	impact	_	
92-9	16319-16321	of	_	
92-10	16322-16327	SC-FC	_	
92-11	16328-16336	coupling	_	
92-12	16336-16337	,	_	
92-13	16338-16339	a	_	
92-14	16340-16349	rich-club	_	
92-15	16350-16351	(	_	
92-16	16351-16353	RC	_	
92-17	16353-16354	)	_	
92-18	16355-16357	in	_	
92-19	16358-16361	the	_	
92-20	16362-16372	structural	_	
92-21	16373-16380	network	_	
92-22	16381-16384	was	_	
92-23	16385-16392	defined	_	
92-24	16393-16395	as	_	
92-25	16396-16397	a	_	
92-26	16398-16401	set	_	
92-27	16402-16404	of	_	
92-28	16405-16416	high-degree	_	
92-29	16417-16418	(	_	
92-30	16418-16421	i.e	_	
92-31	16421-16422	.	_	
92-32	16422-16423	,	_	
92-33	16424-16425	“	_	
92-34	16425-16429	rich	_	
92-35	16429-16430	”	_	
92-36	16430-16431	)	_	
92-37	16432-16437	nodes	_	
92-38	16438-16443	which	_	
92-39	16444-16448	were	_	
92-40	16449-16453	also	_	
92-41	16454-16461	densely	_	
92-42	16462-16476	interconnected	_	
92-43	16476-16477	,	_	
92-44	16478-16482	more	_	
92-45	16483-16485	so	_	
92-46	16486-16490	than	_	
92-47	16491-16499	expected	_	
92-48	16500-16505	based	_	
92-49	16506-16508	on	_	
92-50	16509-16510	a	_	
92-51	16511-16517	random	_	
92-52	16518-16522	null	_	
92-53	16523-16528	model	_	
92-54	16528-16529	.	_	

#Text=Weighted RC organization was quantified for each individual.
93-1	16530-16538	Weighted	_	
93-2	16539-16541	RC	_	
93-3	16542-16554	organization	_	
93-4	16555-16558	was	_	
93-5	16559-16569	quantified	_	
93-6	16570-16573	for	_	
93-7	16574-16578	each	_	
93-8	16579-16589	individual	_	
93-9	16589-16590	.	_	

#Text=After all weights (w) in the SC matrix were ranked (wranked), the weighted RC coefficient (𝜙) was computed as a function of node degree (k: the number of connections at each node) by , in which W>k and E>k mean the sum of weights and the number of connections for >k nodes, respectively.
94-1	16591-16596	After	_	
94-2	16597-16600	all	_	
94-3	16601-16608	weights	_	
94-4	16609-16610	(	_	
94-5	16610-16611	w	_	
94-6	16611-16612	)	_	
94-7	16613-16615	in	_	
94-8	16616-16619	the	_	
94-9	16620-16622	SC	_	
94-10	16623-16629	matrix	_	
94-11	16630-16634	were	_	
94-12	16635-16641	ranked	_	
94-13	16642-16643	(	_	
94-14	16643-16650	wranked	_	
94-15	16650-16651	)	_	
94-16	16651-16652	,	_	
94-17	16653-16656	the	_	
94-18	16657-16665	weighted	_	
94-19	16666-16668	RC	_	
94-20	16669-16680	coefficient	_	
94-21	16681-16682	(	_	
94-22	16682-16684	𝜙	_	
94-23	16684-16685	)	_	
94-24	16686-16689	was	_	
94-25	16690-16698	computed	_	
94-26	16699-16701	as	_	
94-27	16702-16703	a	_	
94-28	16704-16712	function	_	
94-29	16713-16715	of	_	
94-30	16716-16720	node	_	
94-31	16721-16727	degree	_	
94-32	16728-16729	(	_	
94-33	16729-16730	k	_	
94-34	16730-16731	:	_	
94-35	16732-16735	the	_	
94-36	16736-16742	number	_	
94-37	16743-16745	of	_	
94-38	16746-16757	connections	_	
94-39	16758-16760	at	_	
94-40	16761-16765	each	_	
94-41	16766-16770	node	_	
94-42	16770-16771	)	_	
94-43	16772-16774	by	_	
94-44	16775-16776	,	_	
94-45	16777-16779	in	_	
94-46	16780-16785	which	_	
94-47	16786-16787	W	_	
94-48	16787-16788	>	_	
94-49	16788-16789	k	_	
94-50	16790-16793	and	_	
94-51	16794-16795	E	_	
94-52	16795-16796	>	_	
94-53	16796-16797	k	_	
94-54	16798-16802	mean	_	
94-55	16803-16806	the	_	
94-56	16807-16810	sum	_	
94-57	16811-16813	of	_	
94-58	16814-16821	weights	_	
94-59	16822-16825	and	_	
94-60	16826-16829	the	_	
94-61	16830-16836	number	_	
94-62	16837-16839	of	_	
94-63	16840-16851	connections	_	
94-64	16852-16855	for	_	
94-65	16856-16857	>	_	
94-66	16857-16858	k	_	
94-67	16859-16864	nodes	_	
94-68	16864-16865	,	_	
94-69	16866-16878	respectively	_	
94-70	16878-16879	.	_	

#Text=The computed RC coefficient, ϕ(k) , was normalized to the mean RC coefficient from 1,000 random null matrices to test whether the actual density of interconnections significantly exceeded that of the null model.
95-1	16880-16883	The	_	
95-2	16884-16892	computed	_	
95-3	16893-16895	RC	_	
95-4	16896-16907	coefficient	_	
95-5	16907-16908	,	_	
95-6	16909-16910	ϕ	_	
95-7	16910-16911	(	_	
95-8	16911-16912	k	_	
95-9	16912-16913	)	_	
95-10	16914-16915	,	_	
95-11	16916-16919	was	_	
95-12	16920-16930	normalized	_	
95-13	16931-16933	to	_	
95-14	16934-16937	the	_	
95-15	16938-16942	mean	_	
95-16	16943-16945	RC	_	
95-17	16946-16957	coefficient	_	
95-18	16958-16962	from	_	
95-19	16963-16968	1,000	_	
95-20	16969-16975	random	_	
95-21	16976-16980	null	_	
95-22	16981-16989	matrices	_	
95-23	16990-16992	to	_	
95-24	16993-16997	test	_	
95-25	16998-17005	whether	_	
95-26	17006-17009	the	_	
95-27	17010-17016	actual	_	
95-28	17017-17024	density	_	
95-29	17025-17027	of	_	
95-30	17028-17044	interconnections	_	
95-31	17045-17058	significantly	_	
95-32	17059-17067	exceeded	_	
95-33	17068-17072	that	_	
95-34	17073-17075	of	_	
95-35	17076-17079	the	_	
95-36	17080-17084	null	_	
95-37	17085-17090	model	_	
95-38	17090-17091	.	_	

#Text=Because the degree distributions of the SC matrices differed across individuals, all node degrees were normalized to allow the comparison of equal-sized networks for CB users and healthy non-users (Figure S1C).
96-1	17092-17099	Because	_	
96-2	17100-17103	the	_	
96-3	17104-17110	degree	_	
96-4	17111-17124	distributions	_	
96-5	17125-17127	of	_	
96-6	17128-17131	the	_	
96-7	17132-17134	SC	_	
96-8	17135-17143	matrices	_	
96-9	17144-17152	differed	_	
96-10	17153-17159	across	_	
96-11	17160-17171	individuals	_	
96-12	17171-17172	,	_	
96-13	17173-17176	all	_	
96-14	17177-17181	node	_	
96-15	17182-17189	degrees	_	
96-16	17190-17194	were	_	
96-17	17195-17205	normalized	_	
96-18	17206-17208	to	_	
96-19	17209-17214	allow	_	
96-20	17215-17218	the	_	
96-21	17219-17229	comparison	_	
96-22	17230-17232	of	_	
96-23	17233-17244	equal-sized	_	
96-24	17245-17253	networks	_	
96-25	17254-17257	for	_	
96-26	17258-17260	CB	_	
96-27	17261-17266	users	_	
96-28	17267-17270	and	_	
96-29	17271-17278	healthy	_	
96-30	17279-17288	non-users	_	
96-31	17289-17290	(	_	
96-32	17290-17296	Figure	_	
96-33	17297-17300	S1C	_	
96-34	17300-17301	)	_	
96-35	17301-17302	.	_	

#Text=From the normalized degree distribution across the subjects, we defined RC regions with the top 10% node degree (> 32) as in the previous studies 
#Text=Statistical Analysis
#Text=Nonparametric randomized permutation testing (10,000 permutations) was used for group comparisons for global and regional SC-FC coupling, RC coefficient, and network metrics.
97-1	17303-17307	From	_	
97-2	17308-17311	the	_	
97-3	17312-17322	normalized	_	
97-4	17323-17329	degree	_	
97-5	17330-17342	distribution	_	
97-6	17343-17349	across	_	
97-7	17350-17353	the	_	
97-8	17354-17362	subjects	_	
97-9	17362-17363	,	_	
97-10	17364-17366	we	_	
97-11	17367-17374	defined	_	
97-12	17375-17377	RC	_	
97-13	17378-17385	regions	_	
97-14	17386-17390	with	_	
97-15	17391-17394	the	_	
97-16	17395-17398	top	_	
97-17	17399-17402	10%	_	
97-18	17403-17407	node	_	
97-19	17408-17414	degree	_	
97-20	17415-17416	(	_	
97-21	17416-17417	>	_	
97-22	17418-17420	32	_	
97-23	17420-17421	)	_	
97-24	17422-17424	as	_	
97-25	17425-17427	in	_	
97-26	17428-17431	the	_	
97-27	17432-17440	previous	_	
97-28	17441-17448	studies	_	
97-29	17450-17461	Statistical	_	
97-30	17462-17470	Analysis	_	
97-31	17471-17484	Nonparametric	_	
97-32	17485-17495	randomized	_	
97-33	17496-17507	permutation	_	
97-34	17508-17515	testing	_	
97-35	17516-17517	(	_	
97-36	17517-17523	10,000	_	
97-37	17524-17536	permutations	_	
97-38	17536-17537	)	_	
97-39	17538-17541	was	_	
97-40	17542-17546	used	_	
97-41	17547-17550	for	_	
97-42	17551-17556	group	_	
97-43	17557-17568	comparisons	_	
97-44	17569-17572	for	_	
97-45	17573-17579	global	_	
97-46	17580-17583	and	_	
97-47	17584-17592	regional	_	
97-48	17593-17598	SC-FC	_	
97-49	17599-17607	coupling	_	
97-50	17607-17608	,	_	
97-51	17609-17611	RC	_	
97-52	17612-17623	coefficient	_	
97-53	17623-17624	,	_	
97-54	17625-17628	and	_	
97-55	17629-17636	network	_	
97-56	17637-17644	metrics	_	
97-57	17644-17645	.	_	

#Text=The associations between SC-FC coupling and network metrics were compared using a two-tailed Fisher’s z-test with false-discovery rate (FDR) corrected p < 0.05.
98-1	17646-17649	The	_	
98-2	17650-17662	associations	_	
98-3	17663-17670	between	_	
98-4	17671-17676	SC-FC	_	
98-5	17677-17685	coupling	_	
98-6	17686-17689	and	_	
98-7	17690-17697	network	_	
98-8	17698-17705	metrics	_	
98-9	17706-17710	were	_	
98-10	17711-17719	compared	_	
98-11	17720-17725	using	_	
98-12	17726-17727	a	_	
98-13	17728-17738	two-tailed	_	
98-14	17739-17745	Fisher	_	
98-15	17745-17746	’	_	
98-16	17746-17747	s	_	
98-17	17748-17754	z-test	_	
98-18	17755-17759	with	_	
98-19	17760-17775	false-discovery	_	
98-20	17776-17780	rate	_	
98-21	17781-17782	(	_	
98-22	17782-17785	FDR	_	
98-23	17785-17786	)	_	
98-24	17787-17796	corrected	_	
98-25	17797-17798	p	_	
98-26	17799-17800	<	_	
98-27	17801-17805	0.05	_	
98-28	17805-17806	.	_	

#Text=Statistical comparisons between groups include educational length, age, sex, and alcohol use as covariates.
99-1	17807-17818	Statistical	_	
99-2	17819-17830	comparisons	_	
99-3	17831-17838	between	_	
99-4	17839-17845	groups	_	
99-5	17846-17853	include	_	
99-6	17854-17865	educational	_	
99-7	17866-17872	length	_	
99-8	17872-17873	,	_	
99-9	17874-17877	age	_	
99-10	17877-17878	,	_	
99-11	17879-17882	sex	_	
99-12	17882-17883	,	_	
99-13	17884-17887	and	_	
99-14	17888-17895	alcohol	_	
99-15	17896-17899	use	_	
99-16	17900-17902	as	_	
99-17	17903-17913	covariates	_	
99-18	17913-17914	.	_	

#Text=RESULTS
#Text=Preserved Global SC-FC Coupling in CB Users
#Text=SC and FC across the subjects showed a positive correlation (r = 0.34, p < 10−10; Figure 1A), consistent with a previous study.
100-1	17915-17922	RESULTS	_	
100-2	17923-17932	Preserved	_	
100-3	17933-17939	Global	_	
100-4	17940-17945	SC-FC	_	
100-5	17946-17954	Coupling	_	
100-6	17955-17957	in	_	
100-7	17958-17960	CB	_	
100-8	17961-17966	Users	_	
100-9	17967-17969	SC	_	
100-10	17970-17973	and	_	
100-11	17974-17976	FC	_	
100-12	17977-17983	across	_	
100-13	17984-17987	the	_	
100-14	17988-17996	subjects	_	
100-15	17997-18003	showed	_	
100-16	18004-18005	a	_	
100-17	18006-18014	positive	_	
100-18	18015-18026	correlation	_	
100-19	18027-18028	(	_	
100-20	18028-18029	r	_	
100-21	18030-18031	=	_	
100-22	18032-18036	0.34	_	
100-23	18036-18037	,	_	
100-24	18038-18039	p	_	
100-25	18040-18041	<	_	
100-26	18042-18044	10	_	
100-27	18044-18045	−	_	
100-28	18045-18047	10	_	
100-29	18047-18048	;	_	
100-30	18049-18055	Figure	_	
100-31	18056-18058	1A	_	
100-32	18058-18059	)	_	
100-33	18059-18060	,	_	
100-34	18061-18071	consistent	_	
100-35	18072-18076	with	_	
100-36	18077-18078	a	_	
100-37	18079-18087	previous	_	
100-38	18088-18093	study	_	
100-39	18093-18094	.	_	

#Text=The magnitude of this correlation did not differ significantly between groups (t = 0.41, p = 0.34, Cohen’s d = 0.13; Figure 1B), suggesting that the global SC-FC association of the CB users did not differ from healthy non-users.
101-1	18095-18098	The	_	
101-2	18099-18108	magnitude	_	
101-3	18109-18111	of	_	
101-4	18112-18116	this	_	
101-5	18117-18128	correlation	_	
101-6	18129-18132	did	_	
101-7	18133-18136	not	_	
101-8	18137-18143	differ	_	
101-9	18144-18157	significantly	_	
101-10	18158-18165	between	_	
101-11	18166-18172	groups	_	
101-12	18173-18174	(	_	
101-13	18174-18175	t	_	
101-14	18176-18177	=	_	
101-15	18178-18182	0.41	_	
101-16	18182-18183	,	_	
101-17	18184-18185	p	_	
101-18	18186-18187	=	_	
101-19	18188-18192	0.34	_	
101-20	18192-18193	,	_	
101-21	18194-18199	Cohen	_	
101-22	18199-18200	’	_	
101-23	18200-18201	s	_	
101-24	18202-18203	d	_	
101-25	18204-18205	=	_	
101-26	18206-18210	0.13	_	
101-27	18210-18211	;	_	
101-28	18212-18218	Figure	_	
101-29	18219-18221	1B	_	
101-30	18221-18222	)	_	
101-31	18222-18223	,	_	
101-32	18224-18234	suggesting	_	
101-33	18235-18239	that	_	
101-34	18240-18243	the	_	
101-35	18244-18250	global	_	
101-36	18251-18256	SC-FC	_	
101-37	18257-18268	association	_	
101-38	18269-18271	of	_	
101-39	18272-18275	the	_	
101-40	18276-18278	CB	_	
101-41	18279-18284	users	_	
101-42	18285-18288	did	_	
101-43	18289-18292	not	_	
101-44	18293-18299	differ	_	
101-45	18300-18304	from	_	
101-46	18305-18312	healthy	_	
101-47	18313-18322	non-users	_	
101-48	18322-18323	.	_	

#Text=No significant differences were found in the group comparison of global network measures for both SC and FC networks (all p > 0.05) – i.e., characteristic path length (λ), global efficiency (GE), clustering coefficient (γ), modularity (Q), and small-worldness (σ), suggesting the intact global network architecture from the sole connectivity in both HC and CB groups.
102-1	18324-18326	No	_	
102-2	18327-18338	significant	_	
102-3	18339-18350	differences	_	
102-4	18351-18355	were	_	
102-5	18356-18361	found	_	
102-6	18362-18364	in	_	
102-7	18365-18368	the	_	
102-8	18369-18374	group	_	
102-9	18375-18385	comparison	_	
102-10	18386-18388	of	_	
102-11	18389-18395	global	_	
102-12	18396-18403	network	_	
102-13	18404-18412	measures	_	
102-14	18413-18416	for	_	
102-15	18417-18421	both	_	
102-16	18422-18424	SC	_	
102-17	18425-18428	and	_	
102-18	18429-18431	FC	_	
102-19	18432-18440	networks	_	
102-20	18441-18442	(	_	
102-21	18442-18445	all	_	
102-22	18446-18447	p	_	
102-23	18448-18449	>	_	
102-24	18450-18454	0.05	_	
102-25	18454-18455	)	_	
102-26	18456-18457	–	_	
102-27	18458-18461	i.e	_	
102-28	18461-18462	.	_	
102-29	18462-18463	,	_	
102-30	18464-18478	characteristic	_	
102-31	18479-18483	path	_	
102-32	18484-18490	length	_	
102-33	18491-18492	(	_	
102-34	18492-18493	λ	_	
102-35	18493-18494	)	_	
102-36	18494-18495	,	_	
102-37	18496-18502	global	_	
102-38	18503-18513	efficiency	_	
102-39	18514-18515	(	_	
102-40	18515-18517	GE	_	
102-41	18517-18518	)	_	
102-42	18518-18519	,	_	
102-43	18520-18530	clustering	_	
102-44	18531-18542	coefficient	_	
102-45	18543-18544	(	_	
102-46	18544-18545	γ	_	
102-47	18545-18546	)	_	
102-48	18546-18547	,	_	
102-49	18548-18558	modularity	_	
102-50	18559-18560	(	_	
102-51	18560-18561	Q	_	
102-52	18561-18562	)	_	
102-53	18562-18563	,	_	
102-54	18564-18567	and	_	
102-55	18568-18583	small-worldness	_	
102-56	18584-18585	(	_	
102-57	18585-18586	σ	_	
102-58	18586-18587	)	_	
102-59	18587-18588	,	_	
102-60	18589-18599	suggesting	_	
102-61	18600-18603	the	_	
102-62	18604-18610	intact	_	
102-63	18611-18617	global	_	
102-64	18618-18625	network	_	
102-65	18626-18638	architecture	_	
102-66	18639-18643	from	_	
102-67	18644-18647	the	_	
102-68	18648-18652	sole	_	
102-69	18653-18665	connectivity	_	
102-70	18666-18668	in	_	
102-71	18669-18673	both	_	
102-72	18674-18676	HC	_	
102-73	18677-18680	and	_	
102-74	18681-18683	CB	_	
102-75	18684-18690	groups	_	
102-76	18690-18691	.	_	

#Text=Disrupted Association Between Structural Network Measures and SC-FC Coupling in CB Users
#Text=SC-FC coupling in non-users was positively associated with network efficiency (GE: r = 0.44, p = 0.02; Figure 1C) and negatively associated with path length (λ: r = −0.38, p = 0.04; Figure 1D).
103-1	18692-18701	Disrupted	_	
103-2	18702-18713	Association	_	
103-3	18714-18721	Between	_	
103-4	18722-18732	Structural	_	
103-5	18733-18740	Network	_	
103-6	18741-18749	Measures	_	
103-7	18750-18753	and	_	
103-8	18754-18759	SC-FC	_	
103-9	18760-18768	Coupling	_	
103-10	18769-18771	in	_	
103-11	18772-18774	CB	_	
103-12	18775-18780	Users	_	
103-13	18781-18786	SC-FC	_	
103-14	18787-18795	coupling	_	
103-15	18796-18798	in	_	
103-16	18799-18808	non-users	_	
103-17	18809-18812	was	_	
103-18	18813-18823	positively	_	
103-19	18824-18834	associated	_	
103-20	18835-18839	with	_	
103-21	18840-18847	network	_	
103-22	18848-18858	efficiency	_	
103-23	18859-18860	(	_	
103-24	18860-18862	GE	_	
103-25	18862-18863	:	_	
103-26	18864-18865	r	_	
103-27	18866-18867	=	_	
103-28	18868-18872	0.44	_	
103-29	18872-18873	,	_	
103-30	18874-18875	p	_	
103-31	18876-18877	=	_	
103-32	18878-18882	0.02	_	
103-33	18882-18883	;	_	
103-34	18884-18890	Figure	_	
103-35	18891-18893	1C	_	
103-36	18893-18894	)	_	
103-37	18895-18898	and	_	
103-38	18899-18909	negatively	_	
103-39	18910-18920	associated	_	
103-40	18921-18925	with	_	
103-41	18926-18930	path	_	
103-42	18931-18937	length	_	
103-43	18938-18939	(	_	
103-44	18939-18940	λ	_	
103-45	18940-18941	:	_	
103-46	18942-18943	r	_	
103-47	18944-18945	=	_	
103-48	18946-18947	−	_	
103-49	18947-18951	0.38	_	
103-50	18951-18952	,	_	
103-51	18953-18954	p	_	
103-52	18955-18956	=	_	
103-53	18957-18961	0.04	_	
103-54	18961-18962	;	_	
103-55	18963-18969	Figure	_	
103-56	18970-18972	1D	_	
103-57	18972-18973	)	_	
103-58	18973-18974	.	_	

#Text=These associations were absent in the CB users (r = −0.32, p = 0.07 for GE; r = 0.21, p = 0.24 for λ), and were statistically different between groups (p = 0.001 for GE; and p = 0.019 for λ).
104-1	18975-18980	These	_	
104-2	18981-18993	associations	_	
104-3	18994-18998	were	_	
104-4	18999-19005	absent	_	
104-5	19006-19008	in	_	
104-6	19009-19012	the	_	
104-7	19013-19015	CB	_	
104-8	19016-19021	users	_	
104-9	19022-19023	(	_	
104-10	19023-19024	r	_	
104-11	19025-19026	=	_	
104-12	19027-19028	−	_	
104-13	19028-19032	0.32	_	
104-14	19032-19033	,	_	
104-15	19034-19035	p	_	
104-16	19036-19037	=	_	
104-17	19038-19042	0.07	_	
104-18	19043-19046	for	_	
104-19	19047-19049	GE	_	
104-20	19049-19050	;	_	
104-21	19051-19052	r	_	
104-22	19053-19054	=	_	
104-23	19055-19059	0.21	_	
104-24	19059-19060	,	_	
104-25	19061-19062	p	_	
104-26	19063-19064	=	_	
104-27	19065-19069	0.24	_	
104-28	19070-19073	for	_	
104-29	19074-19075	λ	_	
104-30	19075-19076	)	_	
104-31	19076-19077	,	_	
104-32	19078-19081	and	_	
104-33	19082-19086	were	_	
104-34	19087-19100	statistically	_	
104-35	19101-19110	different	_	
104-36	19111-19118	between	_	
104-37	19119-19125	groups	_	
104-38	19126-19127	(	_	
104-39	19127-19128	p	_	
104-40	19129-19130	=	_	
104-41	19131-19136	0.001	_	
104-42	19137-19140	for	_	
104-43	19141-19143	GE	_	
104-44	19143-19144	;	_	
104-45	19145-19148	and	_	
104-46	19149-19150	p	_	
104-47	19151-19152	=	_	
104-48	19153-19158	0.019	_	
104-49	19159-19162	for	_	
104-50	19163-19164	λ	_	
104-51	19164-19165	)	_	
104-52	19165-19166	.	_	

#Text=This difference suggested impaired network-coupling in the connectomes of CB users.
105-1	19167-19171	This	_	
105-2	19172-19182	difference	_	
105-3	19183-19192	suggested	_	
105-4	19193-19201	impaired	_	
105-5	19202-19218	network-coupling	_	
105-6	19219-19221	in	_	
105-7	19222-19225	the	_	
105-8	19226-19237	connectomes	_	
105-9	19238-19240	of	_	
105-10	19241-19243	CB	_	
105-11	19244-19249	users	_	
105-12	19249-19250	.	_	

#Text=In contrast, γ, Q and σ did not show any significant associations within- or between-groups (all p > 0.10).
106-1	19251-19253	In	_	
106-2	19254-19262	contrast	_	
106-3	19262-19263	,	_	
106-4	19264-19265	γ	_	
106-5	19265-19266	,	_	
106-6	19267-19268	Q	_	
106-7	19269-19272	and	_	
106-8	19273-19274	σ	_	
106-9	19275-19278	did	_	
106-10	19279-19282	not	_	
106-11	19283-19287	show	_	
106-12	19288-19291	any	_	
106-13	19292-19303	significant	_	
106-14	19304-19316	associations	_	
106-15	19317-19323	within	_	
106-16	19323-19324	-	_	
106-17	19325-19327	or	_	
106-18	19328-19342	between-groups	_	
106-19	19343-19344	(	_	
106-20	19344-19347	all	_	
106-21	19348-19349	p	_	
106-22	19350-19351	>	_	
106-23	19352-19356	0.10	_	
106-24	19356-19357	)	_	
106-25	19357-19358	.	_	

#Text=Distance Dependence of Network-Coupling Association
#Text=SC had a linear association with the log-transformed distance (r = −0.49, p < 10−10; Figure 2A) and FC was linearly related to the inverse of the fiber distance between regions (r = 0.59, p < 10−10; Figure 2B), which suggests a potential distance dependence in the network-coupling associations.
107-1	19359-19367	Distance	_	
107-2	19368-19378	Dependence	_	
107-3	19379-19381	of	_	
107-4	19382-19398	Network-Coupling	_	
107-5	19399-19410	Association	_	
107-6	19411-19413	SC	_	
107-7	19414-19417	had	_	
107-8	19418-19419	a	_	
107-9	19420-19426	linear	_	
107-10	19427-19438	association	_	
107-11	19439-19443	with	_	
107-12	19444-19447	the	_	
107-13	19448-19463	log-transformed	_	
107-14	19464-19472	distance	_	
107-15	19473-19474	(	_	
107-16	19474-19475	r	_	
107-17	19476-19477	=	_	
107-18	19478-19479	−	_	
107-19	19479-19483	0.49	_	
107-20	19483-19484	,	_	
107-21	19485-19486	p	_	
107-22	19487-19488	<	_	
107-23	19489-19491	10	_	
107-24	19491-19492	−	_	
107-25	19492-19494	10	_	
107-26	19494-19495	;	_	
107-27	19496-19502	Figure	_	
107-28	19503-19505	2A	_	
107-29	19505-19506	)	_	
107-30	19507-19510	and	_	
107-31	19511-19513	FC	_	
107-32	19514-19517	was	_	
107-33	19518-19526	linearly	_	
107-34	19527-19534	related	_	
107-35	19535-19537	to	_	
107-36	19538-19541	the	_	
107-37	19542-19549	inverse	_	
107-38	19550-19552	of	_	
107-39	19553-19556	the	_	
107-40	19557-19562	fiber	_	
107-41	19563-19571	distance	_	
107-42	19572-19579	between	_	
107-43	19580-19587	regions	_	
107-44	19588-19589	(	_	
107-45	19589-19590	r	_	
107-46	19591-19592	=	_	
107-47	19593-19597	0.59	_	
107-48	19597-19598	,	_	
107-49	19599-19600	p	_	
107-50	19601-19602	<	_	
107-51	19603-19605	10	_	
107-52	19605-19606	−	_	
107-53	19606-19608	10	_	
107-54	19608-19609	;	_	
107-55	19610-19616	Figure	_	
107-56	19617-19619	2B	_	
107-57	19619-19620	)	_	
107-58	19620-19621	,	_	
107-59	19622-19627	which	_	
107-60	19628-19636	suggests	_	
107-61	19637-19638	a	_	
107-62	19639-19648	potential	_	
107-63	19649-19657	distance	_	
107-64	19658-19668	dependence	_	
107-65	19669-19671	in	_	
107-66	19672-19675	the	_	
107-67	19676-19692	network-coupling	_	
107-68	19693-19705	associations	_	
107-69	19705-19706	.	_	

#Text=Subsequent analysis revealed that shorter connections (=Q1, the lower 25% of connection lengths, <~54 mm; Figure 2C) showed significant correlations only for the healthy non-users (r = 0.42, p = 0.03 for GE; and r = −0.39, p = 0.03 for λ).
108-1	19707-19717	Subsequent	_	
108-2	19718-19726	analysis	_	
108-3	19727-19735	revealed	_	
108-4	19736-19740	that	_	
108-5	19741-19748	shorter	_	
108-6	19749-19760	connections	_	
108-7	19761-19762	(	_	
108-8	19762-19763	=	_	
108-9	19763-19765	Q1	_	
108-10	19765-19766	,	_	
108-11	19767-19770	the	_	
108-12	19771-19776	lower	_	
108-13	19777-19780	25%	_	
108-14	19781-19783	of	_	
108-15	19784-19794	connection	_	
108-16	19795-19802	lengths	_	
108-17	19802-19803	,	_	
108-18	19804-19805	<	_	
108-19	19805-19806	~	_	
108-20	19806-19808	54	_	
108-21	19809-19811	mm	_	
108-22	19811-19812	;	_	
108-23	19813-19819	Figure	_	
108-24	19820-19822	2C	_	
108-25	19822-19823	)	_	
108-26	19824-19830	showed	_	
108-27	19831-19842	significant	_	
108-28	19843-19855	correlations	_	
108-29	19856-19860	only	_	
108-30	19861-19864	for	_	
108-31	19865-19868	the	_	
108-32	19869-19876	healthy	_	
108-33	19877-19886	non-users	_	
108-34	19887-19888	(	_	
108-35	19888-19889	r	_	
108-36	19890-19891	=	_	
108-37	19892-19896	0.42	_	
108-38	19896-19897	,	_	
108-39	19898-19899	p	_	
108-40	19900-19901	=	_	
108-41	19902-19906	0.03	_	
108-42	19907-19910	for	_	
108-43	19911-19913	GE	_	
108-44	19913-19914	;	_	
108-45	19915-19918	and	_	
108-46	19919-19920	r	_	
108-47	19921-19922	=	_	
108-48	19923-19924	−	_	
108-49	19924-19928	0.39	_	
108-50	19928-19929	,	_	
108-51	19930-19931	p	_	
108-52	19932-19933	=	_	
108-53	19934-19938	0.03	_	
108-54	19939-19942	for	_	
108-55	19943-19944	λ	_	
108-56	19944-19945	)	_	
108-57	19945-19946	.	_	

#Text=CB users exhibited between-group differences with GE and λ (p = 0.02 for GE; and p = 0.03 for λ) in terms of the network-coupling associations (Figure 2D–F), which suggests a specific impairment for short connections.
109-1	19947-19949	CB	_	
109-2	19950-19955	users	_	
109-3	19956-19965	exhibited	_	
109-4	19966-19979	between-group	_	
109-5	19980-19991	differences	_	
109-6	19992-19996	with	_	
109-7	19997-19999	GE	_	
109-8	20000-20003	and	_	
109-9	20004-20005	λ	_	
109-10	20006-20007	(	_	
109-11	20007-20008	p	_	
109-12	20009-20010	=	_	
109-13	20011-20015	0.02	_	
109-14	20016-20019	for	_	
109-15	20020-20022	GE	_	
109-16	20022-20023	;	_	
109-17	20024-20027	and	_	
109-18	20028-20029	p	_	
109-19	20030-20031	=	_	
109-20	20032-20036	0.03	_	
109-21	20037-20040	for	_	
109-22	20041-20042	λ	_	
109-23	20042-20043	)	_	
109-24	20044-20046	in	_	
109-25	20047-20052	terms	_	
109-26	20053-20055	of	_	
109-27	20056-20059	the	_	
109-28	20060-20076	network-coupling	_	
109-29	20077-20089	associations	_	
109-30	20090-20091	(	_	
109-31	20091-20097	Figure	_	
109-32	20098-20102	2D–F	_	
109-33	20102-20103	)	_	
109-34	20103-20104	,	_	
109-35	20105-20110	which	_	
109-36	20111-20119	suggests	_	
109-37	20120-20121	a	_	
109-38	20122-20130	specific	_	
109-39	20131-20141	impairment	_	
109-40	20142-20145	for	_	
109-41	20146-20151	short	_	
109-42	20152-20163	connections	_	
109-43	20163-20164	.	_	

#Text=Disrupted Rich-Club Organization in CB Users
#Text=With RC regions of SC network identified as the top 10% highly connected nodes (Figure 3A), the RC coefficient showed a typical RC organization for both groups.
110-1	20165-20174	Disrupted	_	
110-2	20175-20184	Rich-Club	_	
110-3	20185-20197	Organization	_	
110-4	20198-20200	in	_	
110-5	20201-20203	CB	_	
110-6	20204-20209	Users	_	
110-7	20210-20214	With	_	
110-8	20215-20217	RC	_	
110-9	20218-20225	regions	_	
110-10	20226-20228	of	_	
110-11	20229-20231	SC	_	
110-12	20232-20239	network	_	
110-13	20240-20250	identified	_	
110-14	20251-20253	as	_	
110-15	20254-20257	the	_	
110-16	20258-20261	top	_	
110-17	20262-20265	10%	_	
110-18	20266-20272	highly	_	
110-19	20273-20282	connected	_	
110-20	20283-20288	nodes	_	
110-21	20289-20290	(	_	
110-22	20290-20296	Figure	_	
110-23	20297-20299	3A	_	
110-24	20299-20300	)	_	
110-25	20300-20301	,	_	
110-26	20302-20305	the	_	
110-27	20306-20308	RC	_	
110-28	20309-20320	coefficient	_	
110-29	20321-20327	showed	_	
110-30	20328-20329	a	_	
110-31	20330-20337	typical	_	
110-32	20338-20340	RC	_	
110-33	20341-20353	organization	_	
110-34	20354-20357	for	_	
110-35	20358-20362	both	_	
110-36	20363-20369	groups	_	
110-37	20369-20370	.	_	

#Text=However, the CB users showed a decreased RC coefficient compared to non-users (Figure 3B).
111-1	20371-20378	However	_	
111-2	20378-20379	,	_	
111-3	20380-20383	the	_	
111-4	20384-20386	CB	_	
111-5	20387-20392	users	_	
111-6	20393-20399	showed	_	
111-7	20400-20401	a	_	
111-8	20402-20411	decreased	_	
111-9	20412-20414	RC	_	
111-10	20415-20426	coefficient	_	
111-11	20427-20435	compared	_	
111-12	20436-20438	to	_	
111-13	20439-20448	non-users	_	
111-14	20449-20450	(	_	
111-15	20450-20456	Figure	_	
111-16	20457-20459	3B	_	
111-17	20459-20460	)	_	
111-18	20460-20461	.	_	

#Text=RC nodes consistently found for both groups resembled those found in previous studies (Figure 3C).
112-1	20462-20464	RC	_	
112-2	20465-20470	nodes	_	
112-3	20471-20483	consistently	_	
112-4	20484-20489	found	_	
112-5	20490-20493	for	_	
112-6	20494-20498	both	_	
112-7	20499-20505	groups	_	
112-8	20506-20515	resembled	_	
112-9	20516-20521	those	_	
112-10	20522-20527	found	_	
112-11	20528-20530	in	_	
112-12	20531-20539	previous	_	
112-13	20540-20547	studies	_	
112-14	20548-20549	(	_	
112-15	20549-20555	Figure	_	
112-16	20556-20558	3C	_	
112-17	20558-20559	)	_	
112-18	20559-20560	.	_	

#Text=Subcortical Alteration in the Regional SC-FC Coupling
#Text=RC probability for the hippocampus, caudate, and pallidum (Figure 3D) was distributed around abnormal RC intervals (i.e., regions with the top 10% node degree) in CB users (cf.
113-1	20561-20572	Subcortical	_	
113-2	20573-20583	Alteration	_	
113-3	20584-20586	in	_	
113-4	20587-20590	the	_	
113-5	20591-20599	Regional	_	
113-6	20600-20605	SC-FC	_	
113-7	20606-20614	Coupling	_	
113-8	20615-20617	RC	_	
113-9	20618-20629	probability	_	
113-10	20630-20633	for	_	
113-11	20634-20637	the	_	
113-12	20638-20649	hippocampus	_	
113-13	20649-20650	,	_	
113-14	20651-20658	caudate	_	
113-15	20658-20659	,	_	
113-16	20660-20663	and	_	
113-17	20664-20672	pallidum	_	
113-18	20673-20674	(	_	
113-19	20674-20680	Figure	_	
113-20	20681-20683	3D	_	
113-21	20683-20684	)	_	
113-22	20685-20688	was	_	
113-23	20689-20700	distributed	_	
113-24	20701-20707	around	_	
113-25	20708-20716	abnormal	_	
113-26	20717-20719	RC	_	
113-27	20720-20729	intervals	_	
113-28	20730-20731	(	_	
113-29	20731-20734	i.e	_	
113-30	20734-20735	.	_	
113-31	20735-20736	,	_	
113-32	20737-20744	regions	_	
113-33	20745-20749	with	_	
113-34	20750-20753	the	_	
113-35	20754-20757	top	_	
113-36	20758-20761	10%	_	
113-37	20762-20766	node	_	
113-38	20767-20773	degree	_	
113-39	20773-20774	)	_	
113-40	20775-20777	in	_	
113-41	20778-20780	CB	_	
113-42	20781-20786	users	_	
113-43	20787-20788	(	_	
113-44	20788-20790	cf	_	
113-45	20790-20791	.	_	

#Text=Figure 3B) suggesting disrupted SC network organization in these subcortical areas.
114-1	20792-20798	Figure	_	
114-2	20799-20801	3B	_	
114-3	20801-20802	)	_	
114-4	20803-20813	suggesting	_	
114-5	20814-20823	disrupted	_	
114-6	20824-20826	SC	_	
114-7	20827-20834	network	_	
114-8	20835-20847	organization	_	
114-9	20848-20850	in	_	
114-10	20851-20856	these	_	
114-11	20857-20868	subcortical	_	
114-12	20869-20874	areas	_	
114-13	20874-20875	.	_	

#Text=No other cortical regions showed such a distribution of RC probability (Figure S2).
115-1	20876-20878	No	_	
115-2	20879-20884	other	_	
115-3	20885-20893	cortical	_	
115-4	20894-20901	regions	_	
115-5	20902-20908	showed	_	
115-6	20909-20913	such	_	
115-7	20914-20915	a	_	
115-8	20916-20928	distribution	_	
115-9	20929-20931	of	_	
115-10	20932-20934	RC	_	
115-11	20935-20946	probability	_	
115-12	20947-20948	(	_	
115-13	20948-20954	Figure	_	
115-14	20955-20957	S2	_	
115-15	20957-20958	)	_	
115-16	20958-20959	.	_	

#Text=CB users had significantly increased regional SC-FC coupling at the right hippocampus (CB: 0.23 ± 0.11; HC: 0.18 ± 0.10; p = 0.04) and decreased coupling at the caudate (CB: 0.15 ± 0.10; HC: 0.23 ± 0.10; p = 0.002 in the right hemisphere; CB: 0.15 ± 0.10; HC: 0.19 ± 0.11; p = 0.03 in left hemisphere; Figure 3E).
116-1	20960-20962	CB	_	
116-2	20963-20968	users	_	
116-3	20969-20972	had	_	
116-4	20973-20986	significantly	_	
116-5	20987-20996	increased	_	
116-6	20997-21005	regional	_	
116-7	21006-21011	SC-FC	_	
116-8	21012-21020	coupling	_	
116-9	21021-21023	at	_	
116-10	21024-21027	the	_	
116-11	21028-21033	right	_	
116-12	21034-21045	hippocampus	_	
116-13	21046-21047	(	_	
116-14	21047-21049	CB	_	
116-15	21049-21050	:	_	
116-16	21051-21055	0.23	_	
116-17	21056-21057	±	_	
116-18	21058-21062	0.11	_	
116-19	21062-21063	;	_	
116-20	21064-21066	HC	_	
116-21	21066-21067	:	_	
116-22	21068-21072	0.18	_	
116-23	21073-21074	±	_	
116-24	21075-21079	0.10	_	
116-25	21079-21080	;	_	
116-26	21081-21082	p	_	
116-27	21083-21084	=	_	
116-28	21085-21089	0.04	_	
116-29	21089-21090	)	_	
116-30	21091-21094	and	_	
116-31	21095-21104	decreased	_	
116-32	21105-21113	coupling	_	
116-33	21114-21116	at	_	
116-34	21117-21120	the	_	
116-35	21121-21128	caudate	_	
116-36	21129-21130	(	_	
116-37	21130-21132	CB	_	
116-38	21132-21133	:	_	
116-39	21134-21138	0.15	_	
116-40	21139-21140	±	_	
116-41	21141-21145	0.10	_	
116-42	21145-21146	;	_	
116-43	21147-21149	HC	_	
116-44	21149-21150	:	_	
116-45	21151-21155	0.23	_	
116-46	21156-21157	±	_	
116-47	21158-21162	0.10	_	
116-48	21162-21163	;	_	
116-49	21164-21165	p	_	
116-50	21166-21167	=	_	
116-51	21168-21173	0.002	_	
116-52	21174-21176	in	_	
116-53	21177-21180	the	_	
116-54	21181-21186	right	_	
116-55	21187-21197	hemisphere	_	
116-56	21197-21198	;	_	
116-57	21199-21201	CB	_	
116-58	21201-21202	:	_	
116-59	21203-21207	0.15	_	
116-60	21208-21209	±	_	
116-61	21210-21214	0.10	_	
116-62	21214-21215	;	_	
116-63	21216-21218	HC	_	
116-64	21218-21219	:	_	
116-65	21220-21224	0.19	_	
116-66	21225-21226	±	_	
116-67	21227-21231	0.11	_	
116-68	21231-21232	;	_	
116-69	21233-21234	p	_	
116-70	21235-21236	=	_	
116-71	21237-21241	0.03	_	
116-72	21242-21244	in	_	
116-73	21245-21249	left	_	
116-74	21250-21260	hemisphere	_	
116-75	21260-21261	;	_	
116-76	21262-21268	Figure	_	
116-77	21269-21271	3E	_	
116-78	21271-21272	)	_	
116-79	21272-21273	.	_	

#Text=Clinical Metrics
#Text=No significant associations were found between metrics of SC–FC coupling and clinical variables (all p > 0.05) – i.e., lifetime CB use, age of the first CB use, or the recent use (i.e., the number of uses over the past 30 days).
117-1	21274-21282	Clinical	_	
117-2	21283-21290	Metrics	_	
117-3	21291-21293	No	_	
117-4	21294-21305	significant	_	
117-5	21306-21318	associations	_	
117-6	21319-21323	were	_	
117-7	21324-21329	found	_	
117-8	21330-21337	between	_	
117-9	21338-21345	metrics	_	
117-10	21346-21348	of	_	
117-11	21349-21354	SC–FC	_	
117-12	21355-21363	coupling	_	
117-13	21364-21367	and	_	
117-14	21368-21376	clinical	_	
117-15	21377-21386	variables	_	
117-16	21387-21388	(	_	
117-17	21388-21391	all	_	
117-18	21392-21393	p	_	
117-19	21394-21395	>	_	
117-20	21396-21400	0.05	_	
117-21	21400-21401	)	_	
117-22	21402-21403	–	_	
117-23	21404-21407	i.e	_	
117-24	21407-21408	.	_	
117-25	21408-21409	,	_	
117-26	21410-21418	lifetime	_	
117-27	21419-21421	CB	_	
117-28	21422-21425	use	_	
117-29	21425-21426	,	_	
117-30	21427-21430	age	_	
117-31	21431-21433	of	_	
117-32	21434-21437	the	_	
117-33	21438-21443	first	_	
117-34	21444-21446	CB	_	
117-35	21447-21450	use	_	
117-36	21450-21451	,	_	
117-37	21452-21454	or	_	
117-38	21455-21458	the	_	
117-39	21459-21465	recent	_	
117-40	21466-21469	use	_	
117-41	21470-21471	(	_	
117-42	21471-21474	i.e	_	
117-43	21474-21475	.	_	
117-44	21475-21476	,	_	
117-45	21477-21480	the	_	
117-46	21481-21487	number	_	
117-47	21488-21490	of	_	
117-48	21491-21495	uses	_	
117-49	21496-21500	over	_	
117-50	21501-21504	the	_	
117-51	21505-21509	past	_	
117-52	21510-21512	30	_	
117-53	21513-21517	days	_	
117-54	21517-21518	)	_	
117-55	21518-21519	.	_	

#Text=DISCUSSION
#Text=This study investigated structural-functional associations in current CB users in early adulthood.
118-1	21520-21530	DISCUSSION	_	
118-2	21531-21535	This	_	
118-3	21536-21541	study	_	
118-4	21542-21554	investigated	_	
118-5	21555-21576	structural-functional	_	
118-6	21577-21589	associations	_	
118-7	21590-21592	in	_	
118-8	21593-21600	current	_	
118-9	21601-21603	CB	_	
118-10	21604-21609	users	_	
118-11	21610-21612	in	_	
118-12	21613-21618	early	_	
118-13	21619-21628	adulthood	_	
118-14	21628-21629	.	_	

#Text=There were four main findings: (i) the global level of structural-functional (SC-FC) coupling was preserved in recent CB users, suggesting an overall intact “macroscopic” connectivity pattern across the brain of CB users; (ii) SC-FC coupling was associated with several topological characteristics of SC in non-users, such as global network efficiency (GE) and path length (λ), and these associations were not observed in CB users; (iii) the association between SC-FC coupling and network properties was most striking for relatively shorter connections, implying a lesser degree of functional and structural communication within local regions in CB users; and (iv) impaired regional SC-FC coupling was found in the hippocampus and caudate of CB users, suggesting greater disturbances in these regions with higher levels of cannabinoid receptors.
119-1	21630-21635	There	_	
119-2	21636-21640	were	_	
119-3	21641-21645	four	_	
119-4	21646-21650	main	_	
119-5	21651-21659	findings	_	
119-6	21659-21660	:	_	
119-7	21661-21662	(	_	
119-8	21662-21663	i	_	
119-9	21663-21664	)	_	
119-10	21665-21668	the	_	
119-11	21669-21675	global	_	
119-12	21676-21681	level	_	
119-13	21682-21684	of	_	
119-14	21685-21706	structural-functional	_	
119-15	21707-21708	(	_	
119-16	21708-21713	SC-FC	_	
119-17	21713-21714	)	_	
119-18	21715-21723	coupling	_	
119-19	21724-21727	was	_	
119-20	21728-21737	preserved	_	
119-21	21738-21740	in	_	
119-22	21741-21747	recent	_	
119-23	21748-21750	CB	_	
119-24	21751-21756	users	_	
119-25	21756-21757	,	_	
119-26	21758-21768	suggesting	_	
119-27	21769-21771	an	_	
119-28	21772-21779	overall	_	
119-29	21780-21786	intact	_	
119-30	21787-21788	“	_	
119-31	21788-21799	macroscopic	_	
119-32	21799-21800	”	_	
119-33	21801-21813	connectivity	_	
119-34	21814-21821	pattern	_	
119-35	21822-21828	across	_	
119-36	21829-21832	the	_	
119-37	21833-21838	brain	_	
119-38	21839-21841	of	_	
119-39	21842-21844	CB	_	
119-40	21845-21850	users	_	
119-41	21850-21851	;	_	
119-42	21852-21853	(	_	
119-43	21853-21855	ii	_	
119-44	21855-21856	)	_	
119-45	21857-21862	SC-FC	_	
119-46	21863-21871	coupling	_	
119-47	21872-21875	was	_	
119-48	21876-21886	associated	_	
119-49	21887-21891	with	_	
119-50	21892-21899	several	_	
119-51	21900-21911	topological	_	
119-52	21912-21927	characteristics	_	
119-53	21928-21930	of	_	
119-54	21931-21933	SC	_	
119-55	21934-21936	in	_	
119-56	21937-21946	non-users	_	
119-57	21946-21947	,	_	
119-58	21948-21952	such	_	
119-59	21953-21955	as	_	
119-60	21956-21962	global	_	
119-61	21963-21970	network	_	
119-62	21971-21981	efficiency	_	
119-63	21982-21983	(	_	
119-64	21983-21985	GE	_	
119-65	21985-21986	)	_	
119-66	21987-21990	and	_	
119-67	21991-21995	path	_	
119-68	21996-22002	length	_	
119-69	22003-22004	(	_	
119-70	22004-22005	λ	_	
119-71	22005-22006	)	_	
119-72	22006-22007	,	_	
119-73	22008-22011	and	_	
119-74	22012-22017	these	_	
119-75	22018-22030	associations	_	
119-76	22031-22035	were	_	
119-77	22036-22039	not	_	
119-78	22040-22048	observed	_	
119-79	22049-22051	in	_	
119-80	22052-22054	CB	_	
119-81	22055-22060	users	_	
119-82	22060-22061	;	_	
119-83	22062-22063	(	_	
119-84	22063-22066	iii	_	
119-85	22066-22067	)	_	
119-86	22068-22071	the	_	
119-87	22072-22083	association	_	
119-88	22084-22091	between	_	
119-89	22092-22097	SC-FC	_	
119-90	22098-22106	coupling	_	
119-91	22107-22110	and	_	
119-92	22111-22118	network	_	
119-93	22119-22129	properties	_	
119-94	22130-22133	was	_	
119-95	22134-22138	most	_	
119-96	22139-22147	striking	_	
119-97	22148-22151	for	_	
119-98	22152-22162	relatively	_	
119-99	22163-22170	shorter	_	
119-100	22171-22182	connections	_	
119-101	22182-22183	,	_	
119-102	22184-22192	implying	_	
119-103	22193-22194	a	_	
119-104	22195-22201	lesser	_	
119-105	22202-22208	degree	_	
119-106	22209-22211	of	_	
119-107	22212-22222	functional	_	
119-108	22223-22226	and	_	
119-109	22227-22237	structural	_	
119-110	22238-22251	communication	_	
119-111	22252-22258	within	_	
119-112	22259-22264	local	_	
119-113	22265-22272	regions	_	
119-114	22273-22275	in	_	
119-115	22276-22278	CB	_	
119-116	22279-22284	users	_	
119-117	22284-22285	;	_	
119-118	22286-22289	and	_	
119-119	22290-22291	(	_	
119-120	22291-22293	iv	_	
119-121	22293-22294	)	_	
119-122	22295-22303	impaired	_	
119-123	22304-22312	regional	_	
119-124	22313-22318	SC-FC	_	
119-125	22319-22327	coupling	_	
119-126	22328-22331	was	_	
119-127	22332-22337	found	_	
119-128	22338-22340	in	_	
119-129	22341-22344	the	_	
119-130	22345-22356	hippocampus	_	
119-131	22357-22360	and	_	
119-132	22361-22368	caudate	_	
119-133	22369-22371	of	_	
119-134	22372-22374	CB	_	
119-135	22375-22380	users	_	
119-136	22380-22381	,	_	
119-137	22382-22392	suggesting	_	
119-138	22393-22400	greater	_	
119-139	22401-22413	disturbances	_	
119-140	22414-22416	in	_	
119-141	22417-22422	these	_	
119-142	22423-22430	regions	_	
119-143	22431-22435	with	_	
119-144	22436-22442	higher	_	
119-145	22443-22449	levels	_	
119-146	22450-22452	of	_	
119-147	22453-22464	cannabinoid	_	
119-148	22465-22474	receptors	_	
119-149	22474-22475	.	_	

#Text=All results remained significant after accounting for potential confounding variables, including age, education, sex and alcohol consumption.
120-1	22476-22479	All	_	
120-2	22480-22487	results	_	
120-3	22488-22496	remained	_	
120-4	22497-22508	significant	_	
120-5	22509-22514	after	_	
120-6	22515-22525	accounting	_	
120-7	22526-22529	for	_	
120-8	22530-22539	potential	_	
120-9	22540-22551	confounding	_	
120-10	22552-22561	variables	_	
120-11	22561-22562	,	_	
120-12	22563-22572	including	_	
120-13	22573-22576	age	_	
120-14	22576-22577	,	_	
120-15	22578-22587	education	_	
120-16	22587-22588	,	_	
120-17	22589-22592	sex	_	
120-18	22593-22596	and	_	
120-19	22597-22604	alcohol	_	
120-20	22605-22616	consumption	_	
120-21	22616-22617	.	_	

#Text=CB users as well as healthy non-users had a significant positive correlation between global SC and FC (i.e., globally preserved SC-FC coupling; Figure 1A-B), which is consistent with previous SC-FC coupling studies in the sensorimotor system, default-mode network, cortical rich-club (RC) members, structural core regions, and the whole brain of healthy subjects.
121-1	22618-22620	CB	_	
121-2	22621-22626	users	_	
121-3	22627-22629	as	_	
121-4	22630-22634	well	_	
121-5	22635-22637	as	_	
121-6	22638-22645	healthy	_	
121-7	22646-22655	non-users	_	
121-8	22656-22659	had	_	
121-9	22660-22661	a	_	
121-10	22662-22673	significant	_	
121-11	22674-22682	positive	_	
121-12	22683-22694	correlation	_	
121-13	22695-22702	between	_	
121-14	22703-22709	global	_	
121-15	22710-22712	SC	_	
121-16	22713-22716	and	_	
121-17	22717-22719	FC	_	
121-18	22720-22721	(	_	
121-19	22721-22724	i.e	_	
121-20	22724-22725	.	_	
121-21	22725-22726	,	_	
121-22	22727-22735	globally	_	
121-23	22736-22745	preserved	_	
121-24	22746-22751	SC-FC	_	
121-25	22752-22760	coupling	_	
121-26	22760-22761	;	_	
121-27	22762-22768	Figure	_	
121-28	22769-22773	1A-B	_	
121-29	22773-22774	)	_	
121-30	22774-22775	,	_	
121-31	22776-22781	which	_	
121-32	22782-22784	is	_	
121-33	22785-22795	consistent	_	
121-34	22796-22800	with	_	
121-35	22801-22809	previous	_	
121-36	22810-22815	SC-FC	_	
121-37	22816-22824	coupling	_	
121-38	22825-22832	studies	_	
121-39	22833-22835	in	_	
121-40	22836-22839	the	_	
121-41	22840-22852	sensorimotor	_	
121-42	22853-22859	system	_	
121-43	22859-22860	,	_	
121-44	22861-22873	default-mode	_	
121-45	22874-22881	network	_	
121-46	22881-22882	,	_	
121-47	22883-22891	cortical	_	
121-48	22892-22901	rich-club	_	
121-49	22902-22903	(	_	
121-50	22903-22905	RC	_	
121-51	22905-22906	)	_	
121-52	22907-22914	members	_	
121-53	22914-22915	,	_	
121-54	22916-22926	structural	_	
121-55	22927-22931	core	_	
121-56	22932-22939	regions	_	
121-57	22939-22940	,	_	
121-58	22941-22944	and	_	
121-59	22945-22948	the	_	
121-60	22949-22954	whole	_	
121-61	22955-22960	brain	_	
121-62	22961-22963	of	_	
121-63	22964-22971	healthy	_	
121-64	22972-22980	subjects	_	
121-65	22980-22981	.	_	

#Text=Notably, the level of SC-FC coupling did not differ between groups (Figure 1A), which may reflect an intact global pattern of SC-FC association in CB users.
122-1	22982-22989	Notably	_	
122-2	22989-22990	,	_	
122-3	22991-22994	the	_	
122-4	22995-23000	level	_	
122-5	23001-23003	of	_	
122-6	23004-23009	SC-FC	_	
122-7	23010-23018	coupling	_	
122-8	23019-23022	did	_	
122-9	23023-23026	not	_	
122-10	23027-23033	differ	_	
122-11	23034-23041	between	_	
122-12	23042-23048	groups	_	
122-13	23049-23050	(	_	
122-14	23050-23056	Figure	_	
122-15	23057-23059	1A	_	
122-16	23059-23060	)	_	
122-17	23060-23061	,	_	
122-18	23062-23067	which	_	
122-19	23068-23071	may	_	
122-20	23072-23079	reflect	_	
122-21	23080-23082	an	_	
122-22	23083-23089	intact	_	
122-23	23090-23096	global	_	
122-24	23097-23104	pattern	_	
122-25	23105-23107	of	_	
122-26	23108-23113	SC-FC	_	
122-27	23114-23125	association	_	
122-28	23126-23128	in	_	
122-29	23129-23131	CB	_	
122-30	23132-23137	users	_	
122-31	23137-23138	.	_	

#Text=CB might be associated with more pronounced local brain connectivity alterations rather than alterations in the whole brain network, reflecting by the heterogeneous distribution of cannabinoid receptors in the brain.
123-1	23139-23141	CB	_	
123-2	23142-23147	might	_	
123-3	23148-23150	be	_	
123-4	23151-23161	associated	_	
123-5	23162-23166	with	_	
123-6	23167-23171	more	_	
123-7	23172-23182	pronounced	_	
123-8	23183-23188	local	_	
123-9	23189-23194	brain	_	
123-10	23195-23207	connectivity	_	
123-11	23208-23219	alterations	_	
123-12	23220-23226	rather	_	
123-13	23227-23231	than	_	
123-14	23232-23243	alterations	_	
123-15	23244-23246	in	_	
123-16	23247-23250	the	_	
123-17	23251-23256	whole	_	
123-18	23257-23262	brain	_	
123-19	23263-23270	network	_	
123-20	23270-23271	,	_	
123-21	23272-23282	reflecting	_	
123-22	23283-23285	by	_	
123-23	23286-23289	the	_	
123-24	23290-23303	heterogeneous	_	
123-25	23304-23316	distribution	_	
123-26	23317-23319	of	_	
123-27	23320-23331	cannabinoid	_	
123-28	23332-23341	receptors	_	
123-29	23342-23344	in	_	
123-30	23345-23348	the	_	
123-31	23349-23354	brain	_	
123-32	23354-23355	.	_	

#Text=SC-FC coupling was significantly associated with structural network measures related to communication of neural information such as the global efficiency (GE) and characteristic path length (λ) (Figure 1B).
124-1	23356-23361	SC-FC	_	
124-2	23362-23370	coupling	_	
124-3	23371-23374	was	_	
124-4	23375-23388	significantly	_	
124-5	23389-23399	associated	_	
124-6	23400-23404	with	_	
124-7	23405-23415	structural	_	
124-8	23416-23423	network	_	
124-9	23424-23432	measures	_	
124-10	23433-23440	related	_	
124-11	23441-23443	to	_	
124-12	23444-23457	communication	_	
124-13	23458-23460	of	_	
124-14	23461-23467	neural	_	
124-15	23468-23479	information	_	
124-16	23480-23484	such	_	
124-17	23485-23487	as	_	
124-18	23488-23491	the	_	
124-19	23492-23498	global	_	
124-20	23499-23509	efficiency	_	
124-21	23510-23511	(	_	
124-22	23511-23513	GE	_	
124-23	23513-23514	)	_	
124-24	23515-23518	and	_	
124-25	23519-23533	characteristic	_	
124-26	23534-23538	path	_	
124-27	23539-23545	length	_	
124-28	23546-23547	(	_	
124-29	23547-23548	λ	_	
124-30	23548-23549	)	_	
124-31	23550-23551	(	_	
124-32	23551-23557	Figure	_	
124-33	23558-23560	1B	_	
124-34	23560-23561	)	_	
124-35	23561-23562	.	_	

#Text=These relationships suggest that structural network organization optimized for communication flow is associated with globally stronger SC-FC interaction.
125-1	23563-23568	These	_	
125-2	23569-23582	relationships	_	
125-3	23583-23590	suggest	_	
125-4	23591-23595	that	_	
125-5	23596-23606	structural	_	
125-6	23607-23614	network	_	
125-7	23615-23627	organization	_	
125-8	23628-23637	optimized	_	
125-9	23638-23641	for	_	
125-10	23642-23655	communication	_	
125-11	23656-23660	flow	_	
125-12	23661-23663	is	_	
125-13	23664-23674	associated	_	
125-14	23675-23679	with	_	
125-15	23680-23688	globally	_	
125-16	23689-23697	stronger	_	
125-17	23698-23703	SC-FC	_	
125-18	23704-23715	interaction	_	
125-19	23715-23716	.	_	

#Text=Specifically, a more efficient brain network with shorter path length also exhibited higher SC-FC coupling in the healthy non-users.
126-1	23717-23729	Specifically	_	
126-2	23729-23730	,	_	
126-3	23731-23732	a	_	
126-4	23733-23737	more	_	
126-5	23738-23747	efficient	_	
126-6	23748-23753	brain	_	
126-7	23754-23761	network	_	
126-8	23762-23766	with	_	
126-9	23767-23774	shorter	_	
126-10	23775-23779	path	_	
126-11	23780-23786	length	_	
126-12	23787-23791	also	_	
126-13	23792-23801	exhibited	_	
126-14	23802-23808	higher	_	
126-15	23809-23814	SC-FC	_	
126-16	23815-23823	coupling	_	
126-17	23824-23826	in	_	
126-18	23827-23830	the	_	
126-19	23831-23838	healthy	_	
126-20	23839-23848	non-users	_	
126-21	23848-23849	.	_	

#Text=This relationship has also been observed in the course of brain maturation.
127-1	23850-23854	This	_	
127-2	23855-23867	relationship	_	
127-3	23868-23871	has	_	
127-4	23872-23876	also	_	
127-5	23877-23881	been	_	
127-6	23882-23890	observed	_	
127-7	23891-23893	in	_	
127-8	23894-23897	the	_	
127-9	23898-23904	course	_	
127-10	23905-23907	of	_	
127-11	23908-23913	brain	_	
127-12	23914-23924	maturation	_	
127-13	23924-23925	.	_	

#Text=Our findings converge with other evidence that such an optimal SC-FC relationship is associated with well-integrated network properties (i.e., higher global efficiency and shorter characteristic path length), which indicates that more efficient brain architecture with shorter path lengths may be beneficial for better neural information transfer in the brain.
128-1	23926-23929	Our	_	
128-2	23930-23938	findings	_	
128-3	23939-23947	converge	_	
128-4	23948-23952	with	_	
128-5	23953-23958	other	_	
128-6	23959-23967	evidence	_	
128-7	23968-23972	that	_	
128-8	23973-23977	such	_	
128-9	23978-23980	an	_	
128-10	23981-23988	optimal	_	
128-11	23989-23994	SC-FC	_	
128-12	23995-24007	relationship	_	
128-13	24008-24010	is	_	
128-14	24011-24021	associated	_	
128-15	24022-24026	with	_	
128-16	24027-24042	well-integrated	_	
128-17	24043-24050	network	_	
128-18	24051-24061	properties	_	
128-19	24062-24063	(	_	
128-20	24063-24066	i.e	_	
128-21	24066-24067	.	_	
128-22	24067-24068	,	_	
128-23	24069-24075	higher	_	
128-24	24076-24082	global	_	
128-25	24083-24093	efficiency	_	
128-26	24094-24097	and	_	
128-27	24098-24105	shorter	_	
128-28	24106-24120	characteristic	_	
128-29	24121-24125	path	_	
128-30	24126-24132	length	_	
128-31	24132-24133	)	_	
128-32	24133-24134	,	_	
128-33	24135-24140	which	_	
128-34	24141-24150	indicates	_	
128-35	24151-24155	that	_	
128-36	24156-24160	more	_	
128-37	24161-24170	efficient	_	
128-38	24171-24176	brain	_	
128-39	24177-24189	architecture	_	
128-40	24190-24194	with	_	
128-41	24195-24202	shorter	_	
128-42	24203-24207	path	_	
128-43	24208-24215	lengths	_	
128-44	24216-24219	may	_	
128-45	24220-24222	be	_	
128-46	24223-24233	beneficial	_	
128-47	24234-24237	for	_	
128-48	24238-24244	better	_	
128-49	24245-24251	neural	_	
128-50	24252-24263	information	_	
128-51	24264-24272	transfer	_	
128-52	24273-24275	in	_	
128-53	24276-24279	the	_	
128-54	24280-24285	brain	_	
128-55	24285-24286	.	_	

#Text=In CB users, however, similar associations between the network topology and SC-FC coupling were absent.
129-1	24287-24289	In	_	
129-2	24290-24292	CB	_	
129-3	24293-24298	users	_	
129-4	24298-24299	,	_	
129-5	24300-24307	however	_	
129-6	24307-24308	,	_	
129-7	24309-24316	similar	_	
129-8	24317-24329	associations	_	
129-9	24330-24337	between	_	
129-10	24338-24341	the	_	
129-11	24342-24349	network	_	
129-12	24350-24358	topology	_	
129-13	24359-24362	and	_	
129-14	24363-24368	SC-FC	_	
129-15	24369-24377	coupling	_	
129-16	24378-24382	were	_	
129-17	24383-24389	absent	_	
129-18	24389-24390	.	_	

#Text=This attenuated correlation suggests that spatial patterns of FC constrained with SC could be altered while the overall association between SC and FC is preserved.
130-1	24391-24395	This	_	
130-2	24396-24406	attenuated	_	
130-3	24407-24418	correlation	_	
130-4	24419-24427	suggests	_	
130-5	24428-24432	that	_	
130-6	24433-24440	spatial	_	
130-7	24441-24449	patterns	_	
130-8	24450-24452	of	_	
130-9	24453-24455	FC	_	
130-10	24456-24467	constrained	_	
130-11	24468-24472	with	_	
130-12	24473-24475	SC	_	
130-13	24476-24481	could	_	
130-14	24482-24484	be	_	
130-15	24485-24492	altered	_	
130-16	24493-24498	while	_	
130-17	24499-24502	the	_	
130-18	24503-24510	overall	_	
130-19	24511-24522	association	_	
130-20	24523-24530	between	_	
130-21	24531-24533	SC	_	
130-22	24534-24537	and	_	
130-23	24538-24540	FC	_	
130-24	24541-24543	is	_	
130-25	24544-24553	preserved	_	
130-26	24553-24554	.	_	

#Text=Previous studies showed that FC strength is likely to be higher at shorter distances between brain regions.
131-1	24555-24563	Previous	_	
131-2	24564-24571	studies	_	
131-3	24572-24578	showed	_	
131-4	24579-24583	that	_	
131-5	24584-24586	FC	_	
131-6	24587-24595	strength	_	
131-7	24596-24598	is	_	
131-8	24599-24605	likely	_	
131-9	24606-24608	to	_	
131-10	24609-24611	be	_	
131-11	24612-24618	higher	_	
131-12	24619-24621	at	_	
131-13	24622-24629	shorter	_	
131-14	24630-24639	distances	_	
131-15	24640-24647	between	_	
131-16	24648-24653	brain	_	
131-17	24654-24661	regions	_	
131-18	24661-24662	.	_	

#Text=Moreover, other studies indicate that the SC-FC relationship is mediated by the distance between interconnected regions.
132-1	24663-24671	Moreover	_	
132-2	24671-24672	,	_	
132-3	24673-24678	other	_	
132-4	24679-24686	studies	_	
132-5	24687-24695	indicate	_	
132-6	24696-24700	that	_	
132-7	24701-24704	the	_	
132-8	24705-24710	SC-FC	_	
132-9	24711-24723	relationship	_	
132-10	24724-24726	is	_	
132-11	24727-24735	mediated	_	
132-12	24736-24738	by	_	
132-13	24739-24742	the	_	
132-14	24743-24751	distance	_	
132-15	24752-24759	between	_	
132-16	24760-24774	interconnected	_	
132-17	24775-24782	regions	_	
132-18	24782-24783	.	_	

#Text=Replicating these previous findings, the SC-FC coupling of non-users was more directly related to the network measures (i.e., global efficiency and characteristic path length) for shorter network connections, but this was not the case for users (Figure 2).
133-1	24784-24795	Replicating	_	
133-2	24796-24801	these	_	
133-3	24802-24810	previous	_	
133-4	24811-24819	findings	_	
133-5	24819-24820	,	_	
133-6	24821-24824	the	_	
133-7	24825-24830	SC-FC	_	
133-8	24831-24839	coupling	_	
133-9	24840-24842	of	_	
133-10	24843-24852	non-users	_	
133-11	24853-24856	was	_	
133-12	24857-24861	more	_	
133-13	24862-24870	directly	_	
133-14	24871-24878	related	_	
133-15	24879-24881	to	_	
133-16	24882-24885	the	_	
133-17	24886-24893	network	_	
133-18	24894-24902	measures	_	
133-19	24903-24904	(	_	
133-20	24904-24907	i.e	_	
133-21	24907-24908	.	_	
133-22	24908-24909	,	_	
133-23	24910-24916	global	_	
133-24	24917-24927	efficiency	_	
133-25	24928-24931	and	_	
133-26	24932-24946	characteristic	_	
133-27	24947-24951	path	_	
133-28	24952-24958	length	_	
133-29	24958-24959	)	_	
133-30	24960-24963	for	_	
133-31	24964-24971	shorter	_	
133-32	24972-24979	network	_	
133-33	24980-24991	connections	_	
133-34	24991-24992	,	_	
133-35	24993-24996	but	_	
133-36	24997-25001	this	_	
133-37	25002-25005	was	_	
133-38	25006-25009	not	_	
133-39	25010-25013	the	_	
133-40	25014-25018	case	_	
133-41	25019-25022	for	_	
133-42	25023-25028	users	_	
133-43	25029-25030	(	_	
133-44	25030-25036	Figure	_	
133-45	25037-25038	2	_	
133-46	25038-25039	)	_	
133-47	25039-25040	.	_	

#Text=Network characteristics were also disrupted in CB users, suggesting that local brain regions with short connections were more affected within the whole brain connectome.
134-1	25041-25048	Network	_	
134-2	25049-25064	characteristics	_	
134-3	25065-25069	were	_	
134-4	25070-25074	also	_	
134-5	25075-25084	disrupted	_	
134-6	25085-25087	in	_	
134-7	25088-25090	CB	_	
134-8	25091-25096	users	_	
134-9	25096-25097	,	_	
134-10	25098-25108	suggesting	_	
134-11	25109-25113	that	_	
134-12	25114-25119	local	_	
134-13	25120-25125	brain	_	
134-14	25126-25133	regions	_	
134-15	25134-25138	with	_	
134-16	25139-25144	short	_	
134-17	25145-25156	connections	_	
134-18	25157-25161	were	_	
134-19	25162-25166	more	_	
134-20	25167-25175	affected	_	
134-21	25176-25182	within	_	
134-22	25183-25186	the	_	
134-23	25187-25192	whole	_	
134-24	25193-25198	brain	_	
134-25	25199-25209	connectome	_	
134-26	25209-25210	.	_	

#Text=Stronger expression of RC organization was found mainly in the subcortical regions as well as distributed cortical areas, highly consistent with previous RC studies in adults, children, and newborns.
135-1	25211-25219	Stronger	_	
135-2	25220-25230	expression	_	
135-3	25231-25233	of	_	
135-4	25234-25236	RC	_	
135-5	25237-25249	organization	_	
135-6	25250-25253	was	_	
135-7	25254-25259	found	_	
135-8	25260-25266	mainly	_	
135-9	25267-25269	in	_	
135-10	25270-25273	the	_	
135-11	25274-25285	subcortical	_	
135-12	25286-25293	regions	_	
135-13	25294-25296	as	_	
135-14	25297-25301	well	_	
135-15	25302-25304	as	_	
135-16	25305-25316	distributed	_	
135-17	25317-25325	cortical	_	
135-18	25326-25331	areas	_	
135-19	25331-25332	,	_	
135-20	25333-25339	highly	_	
135-21	25340-25350	consistent	_	
135-22	25351-25355	with	_	
135-23	25356-25364	previous	_	
135-24	25365-25367	RC	_	
135-25	25368-25375	studies	_	
135-26	25376-25378	in	_	
135-27	25379-25385	adults	_	
135-28	25385-25386	,	_	
135-29	25387-25395	children	_	
135-30	25395-25396	,	_	
135-31	25397-25400	and	_	
135-32	25401-25409	newborns	_	
135-33	25409-25410	.	_	

#Text=Our finding of reduced RC connectivity in CB users (Figure 3B) suggests potential connectome abnormalities, particularly around hub regions central to the integration of information transfer among distributed brain regions.
136-1	25411-25414	Our	_	
136-2	25415-25422	finding	_	
136-3	25423-25425	of	_	
136-4	25426-25433	reduced	_	
136-5	25434-25436	RC	_	
136-6	25437-25449	connectivity	_	
136-7	25450-25452	in	_	
136-8	25453-25455	CB	_	
136-9	25456-25461	users	_	
136-10	25462-25463	(	_	
136-11	25463-25469	Figure	_	
136-12	25470-25472	3B	_	
136-13	25472-25473	)	_	
136-14	25474-25482	suggests	_	
136-15	25483-25492	potential	_	
136-16	25493-25503	connectome	_	
136-17	25504-25517	abnormalities	_	
136-18	25517-25518	,	_	
136-19	25519-25531	particularly	_	
136-20	25532-25538	around	_	
136-21	25539-25542	hub	_	
136-22	25543-25550	regions	_	
136-23	25551-25558	central	_	
136-24	25559-25561	to	_	
136-25	25562-25565	the	_	
136-26	25566-25577	integration	_	
136-27	25578-25580	of	_	
136-28	25581-25592	information	_	
136-29	25593-25601	transfer	_	
136-30	25602-25607	among	_	
136-31	25608-25619	distributed	_	
136-32	25620-25625	brain	_	
136-33	25626-25633	regions	_	
136-34	25633-25634	.	_	

#Text=Interestingly, abnormal RC connectivity was found in the hippocampus, caudate, and pallidum (Figure 3D), regions of dense distribution of CB1 receptors in the brain.
137-1	25635-25648	Interestingly	_	
137-2	25648-25649	,	_	
137-3	25650-25658	abnormal	_	
137-4	25659-25661	RC	_	
137-5	25662-25674	connectivity	_	
137-6	25675-25678	was	_	
137-7	25679-25684	found	_	
137-8	25685-25687	in	_	
137-9	25688-25691	the	_	
137-10	25692-25703	hippocampus	_	
137-11	25703-25704	,	_	
137-12	25705-25712	caudate	_	
137-13	25712-25713	,	_	
137-14	25714-25717	and	_	
137-15	25718-25726	pallidum	_	
137-16	25727-25728	(	_	
137-17	25728-25734	Figure	_	
137-18	25735-25737	3D	_	
137-19	25737-25738	)	_	
137-20	25738-25739	,	_	
137-21	25740-25747	regions	_	
137-22	25748-25750	of	_	
137-23	25751-25756	dense	_	
137-24	25757-25769	distribution	_	
137-25	25770-25772	of	_	
137-26	25773-25776	CB1	_	
137-27	25777-25786	receptors	_	
137-28	25787-25789	in	_	
137-29	25790-25793	the	_	
137-30	25794-25799	brain	_	
137-31	25799-25800	.	_	

#Text=In addition, the hippocampus and dorsal striatum play important roles in contextual learning and habit formation that maintain addictive behaviors.
138-1	25801-25803	In	_	
138-2	25804-25812	addition	_	
138-3	25812-25813	,	_	
138-4	25814-25817	the	_	
138-5	25818-25829	hippocampus	_	
138-6	25830-25833	and	_	
138-7	25834-25840	dorsal	_	
138-8	25841-25849	striatum	_	
138-9	25850-25854	play	_	
138-10	25855-25864	important	_	
138-11	25865-25870	roles	_	
138-12	25871-25873	in	_	
138-13	25874-25884	contextual	_	
138-14	25885-25893	learning	_	
138-15	25894-25897	and	_	
138-16	25898-25903	habit	_	
138-17	25904-25913	formation	_	
138-18	25914-25918	that	_	
138-19	25919-25927	maintain	_	
138-20	25928-25937	addictive	_	
138-21	25938-25947	behaviors	_	
138-22	25947-25948	.	_	

#Text=In the present data, the hippocampus of CB users showed higher regional SC-FC coupling, while the caudate of users had a reduced coupling level (Figure 3E).
139-1	25949-25951	In	_	
139-2	25952-25955	the	_	
139-3	25956-25963	present	_	
139-4	25964-25968	data	_	
139-5	25968-25969	,	_	
139-6	25970-25973	the	_	
139-7	25974-25985	hippocampus	_	
139-8	25986-25988	of	_	
139-9	25989-25991	CB	_	
139-10	25992-25997	users	_	
139-11	25998-26004	showed	_	
139-12	26005-26011	higher	_	
139-13	26012-26020	regional	_	
139-14	26021-26026	SC-FC	_	
139-15	26027-26035	coupling	_	
139-16	26035-26036	,	_	
139-17	26037-26042	while	_	
139-18	26043-26046	the	_	
139-19	26047-26054	caudate	_	
139-20	26055-26057	of	_	
139-21	26058-26063	users	_	
139-22	26064-26067	had	_	
139-23	26068-26069	a	_	
139-24	26070-26077	reduced	_	
139-25	26078-26086	coupling	_	
139-26	26087-26092	level	_	
139-27	26093-26094	(	_	
139-28	26094-26100	Figure	_	
139-29	26101-26103	3E	_	
139-30	26103-26104	)	_	
139-31	26104-26105	.	_	

#Text=The hippocampus is a region with one of the highest CB1 receptor expression levels, and CB-related structural and functional changes have frequently been found in this region in both human and animal models.
140-1	26106-26109	The	_	
140-2	26110-26121	hippocampus	_	
140-3	26122-26124	is	_	
140-4	26125-26126	a	_	
140-5	26127-26133	region	_	
140-6	26134-26138	with	_	
140-7	26139-26142	one	_	
140-8	26143-26145	of	_	
140-9	26146-26149	the	_	
140-10	26150-26157	highest	_	
140-11	26158-26161	CB1	_	
140-12	26162-26170	receptor	_	
140-13	26171-26181	expression	_	
140-14	26182-26188	levels	_	
140-15	26188-26189	,	_	
140-16	26190-26193	and	_	
140-17	26194-26204	CB-related	_	
140-18	26205-26215	structural	_	
140-19	26216-26219	and	_	
140-20	26220-26230	functional	_	
140-21	26231-26238	changes	_	
140-22	26239-26243	have	_	
140-23	26244-26254	frequently	_	
140-24	26255-26259	been	_	
140-25	26260-26265	found	_	
140-26	26266-26268	in	_	
140-27	26269-26273	this	_	
140-28	26274-26280	region	_	
140-29	26281-26283	in	_	
140-30	26284-26288	both	_	
140-31	26289-26294	human	_	
140-32	26295-26298	and	_	
140-33	26299-26305	animal	_	
140-34	26306-26312	models	_	
140-35	26312-26313	.	_	

#Text=One interpretation for the study findings could be that increased SC-FC coupling in users may indicate that functional interaction through the hippocampus was influenced by CB use and was consequently more likely to depend on the underlying structural connections indicating less dynamic brain function, as similar to a previous study on schizophrenia.
141-1	26314-26317	One	_	
141-2	26318-26332	interpretation	_	
141-3	26333-26336	for	_	
141-4	26337-26340	the	_	
141-5	26341-26346	study	_	
141-6	26347-26355	findings	_	
141-7	26356-26361	could	_	
141-8	26362-26364	be	_	
141-9	26365-26369	that	_	
141-10	26370-26379	increased	_	
141-11	26380-26385	SC-FC	_	
141-12	26386-26394	coupling	_	
141-13	26395-26397	in	_	
141-14	26398-26403	users	_	
141-15	26404-26407	may	_	
141-16	26408-26416	indicate	_	
141-17	26417-26421	that	_	
141-18	26422-26432	functional	_	
141-19	26433-26444	interaction	_	
141-20	26445-26452	through	_	
141-21	26453-26456	the	_	
141-22	26457-26468	hippocampus	_	
141-23	26469-26472	was	_	
141-24	26473-26483	influenced	_	
141-25	26484-26486	by	_	
141-26	26487-26489	CB	_	
141-27	26490-26493	use	_	
141-28	26494-26497	and	_	
141-29	26498-26501	was	_	
141-30	26502-26514	consequently	_	
141-31	26515-26519	more	_	
141-32	26520-26526	likely	_	
141-33	26527-26529	to	_	
141-34	26530-26536	depend	_	
141-35	26537-26539	on	_	
141-36	26540-26543	the	_	
141-37	26544-26554	underlying	_	
141-38	26555-26565	structural	_	
141-39	26566-26577	connections	_	
141-40	26578-26588	indicating	_	
141-41	26589-26593	less	_	
141-42	26594-26601	dynamic	_	
141-43	26602-26607	brain	_	
141-44	26608-26616	function	_	
141-45	26616-26617	,	_	
141-46	26618-26620	as	_	
141-47	26621-26628	similar	_	
141-48	26629-26631	to	_	
141-49	26632-26633	a	_	
141-50	26634-26642	previous	_	
141-51	26643-26648	study	_	
141-52	26649-26651	on	_	
141-53	26652-26665	schizophrenia	_	
141-54	26665-26666	.	_	

#Text=On the other hand, reduced coupling of the caudate nucleus of the basal ganglia may reflect cannabinoid modulation of dopaminergic neurons since CB1 receptors are abundant in dopaminergic pathways (e.g., the striatum).
142-1	26667-26669	On	_	
142-2	26670-26673	the	_	
142-3	26674-26679	other	_	
142-4	26680-26684	hand	_	
142-5	26684-26685	,	_	
142-6	26686-26693	reduced	_	
142-7	26694-26702	coupling	_	
142-8	26703-26705	of	_	
142-9	26706-26709	the	_	
142-10	26710-26717	caudate	_	
142-11	26718-26725	nucleus	_	
142-12	26726-26728	of	_	
142-13	26729-26732	the	_	
142-14	26733-26738	basal	_	
142-15	26739-26746	ganglia	_	
142-16	26747-26750	may	_	
142-17	26751-26758	reflect	_	
142-18	26759-26770	cannabinoid	_	
142-19	26771-26781	modulation	_	
142-20	26782-26784	of	_	
142-21	26785-26797	dopaminergic	_	
142-22	26798-26805	neurons	_	
142-23	26806-26811	since	_	
142-24	26812-26815	CB1	_	
142-25	26816-26825	receptors	_	
142-26	26826-26829	are	_	
142-27	26830-26838	abundant	_	
142-28	26839-26841	in	_	
142-29	26842-26854	dopaminergic	_	
142-30	26855-26863	pathways	_	
142-31	26864-26865	(	_	
142-32	26865-26868	e.g	_	
142-33	26868-26869	.	_	
142-34	26869-26870	,	_	
142-35	26871-26874	the	_	
142-36	26875-26883	striatum	_	
142-37	26883-26884	)	_	
142-38	26884-26885	.	_	

#Text=Further, CB use reduces the level of dopamine in the striatum, reducing dopamine synthesis in the dorsal striatum including the caudate.
143-1	26886-26893	Further	_	
143-2	26893-26894	,	_	
143-3	26895-26897	CB	_	
143-4	26898-26901	use	_	
143-5	26902-26909	reduces	_	
143-6	26910-26913	the	_	
143-7	26914-26919	level	_	
143-8	26920-26922	of	_	
143-9	26923-26931	dopamine	_	
143-10	26932-26934	in	_	
143-11	26935-26938	the	_	
143-12	26939-26947	striatum	_	
143-13	26947-26948	,	_	
143-14	26949-26957	reducing	_	
143-15	26958-26966	dopamine	_	
143-16	26967-26976	synthesis	_	
143-17	26977-26979	in	_	
143-18	26980-26983	the	_	
143-19	26984-26990	dorsal	_	
143-20	26991-26999	striatum	_	
143-21	27000-27009	including	_	
143-22	27010-27013	the	_	
143-23	27014-27021	caudate	_	
143-24	27021-27022	.	_	

#Text=Therefore, decreased SC-FC coupling in the caudate of CB users may indicate decoupled interactions of SC and FC.
144-1	27023-27032	Therefore	_	
144-2	27032-27033	,	_	
144-3	27034-27043	decreased	_	
144-4	27044-27049	SC-FC	_	
144-5	27050-27058	coupling	_	
144-6	27059-27061	in	_	
144-7	27062-27065	the	_	
144-8	27066-27073	caudate	_	
144-9	27074-27076	of	_	
144-10	27077-27079	CB	_	
144-11	27080-27085	users	_	
144-12	27086-27089	may	_	
144-13	27090-27098	indicate	_	
144-14	27099-27108	decoupled	_	
144-15	27109-27121	interactions	_	
144-16	27122-27124	of	_	
144-17	27125-27127	SC	_	
144-18	27128-27131	and	_	
144-19	27132-27134	FC	_	
144-20	27134-27135	.	_	

#Text=Reduced resting-state FC has been found in the right hippocampus and the right caudate of chronic CB users [mean ± SD = 21 ± 2 years], suggesting attenuated frontal and sensory inputs to those regions.
145-1	27136-27143	Reduced	_	
145-2	27144-27157	resting-state	_	
145-3	27158-27160	FC	_	
145-4	27161-27164	has	_	
145-5	27165-27169	been	_	
145-6	27170-27175	found	_	
145-7	27176-27178	in	_	
145-8	27179-27182	the	_	
145-9	27183-27188	right	_	
145-10	27189-27200	hippocampus	_	
145-11	27201-27204	and	_	
145-12	27205-27208	the	_	
145-13	27209-27214	right	_	
145-14	27215-27222	caudate	_	
145-15	27223-27225	of	_	
145-16	27226-27233	chronic	_	
145-17	27234-27236	CB	_	
145-18	27237-27242	users	_	
145-19	27243-27244	[	_	
145-20	27244-27248	mean	_	
145-21	27249-27250	±	_	
145-22	27251-27253	SD	_	
145-23	27254-27255	=	_	
145-24	27256-27258	21	_	
145-25	27259-27260	±	_	
145-26	27261-27262	2	_	
145-27	27263-27268	years	_	
145-28	27268-27269	]	_	
145-29	27269-27270	,	_	
145-30	27271-27281	suggesting	_	
145-31	27282-27292	attenuated	_	
145-32	27293-27300	frontal	_	
145-33	27301-27304	and	_	
145-34	27305-27312	sensory	_	
145-35	27313-27319	inputs	_	
145-36	27320-27322	to	_	
145-37	27323-27328	those	_	
145-38	27329-27336	regions	_	
145-39	27336-27337	.	_	

#Text=On the other hand, findings with greater FC have also been reported in the hippocampus of non-dependent CB users at rest and in the dorsal striatum including the caudate during cognitive tasks, suggesting compensatory processes.
146-1	27338-27340	On	_	
146-2	27341-27344	the	_	
146-3	27345-27350	other	_	
146-4	27351-27355	hand	_	
146-5	27355-27356	,	_	
146-6	27357-27365	findings	_	
146-7	27366-27370	with	_	
146-8	27371-27378	greater	_	
146-9	27379-27381	FC	_	
146-10	27382-27386	have	_	
146-11	27387-27391	also	_	
146-12	27392-27396	been	_	
146-13	27397-27405	reported	_	
146-14	27406-27408	in	_	
146-15	27409-27412	the	_	
146-16	27413-27424	hippocampus	_	
146-17	27425-27427	of	_	
146-18	27428-27441	non-dependent	_	
146-19	27442-27444	CB	_	
146-20	27445-27450	users	_	
146-21	27451-27453	at	_	
146-22	27454-27458	rest	_	
146-23	27459-27462	and	_	
146-24	27463-27465	in	_	
146-25	27466-27469	the	_	
146-26	27470-27476	dorsal	_	
146-27	27477-27485	striatum	_	
146-28	27486-27495	including	_	
146-29	27496-27499	the	_	
146-30	27500-27507	caudate	_	
146-31	27508-27514	during	_	
146-32	27515-27524	cognitive	_	
146-33	27525-27530	tasks	_	
146-34	27530-27531	,	_	
146-35	27532-27542	suggesting	_	
146-36	27543-27555	compensatory	_	
146-37	27556-27565	processes	_	
146-38	27565-27566	.	_	

#Text=Our findings further suggest that current CB users have altered SC-FC coupling in the hippocampus and caudate.
147-1	27567-27570	Our	_	
147-2	27571-27579	findings	_	
147-3	27580-27587	further	_	
147-4	27588-27595	suggest	_	
147-5	27596-27600	that	_	
147-6	27601-27608	current	_	
147-7	27609-27611	CB	_	
147-8	27612-27617	users	_	
147-9	27618-27622	have	_	
147-10	27623-27630	altered	_	
147-11	27631-27636	SC-FC	_	
147-12	27637-27645	coupling	_	
147-13	27646-27648	in	_	
147-14	27649-27652	the	_	
147-15	27653-27664	hippocampus	_	
147-16	27665-27668	and	_	
147-17	27669-27676	caudate	_	
147-18	27676-27677	.	_	

#Text=No significant associations were found between the coupling measures and clinical variables (i.e., lifetime CB use, age of the first CB use, or the number of uses over the past 30 days).
148-1	27678-27680	No	_	
148-2	27681-27692	significant	_	
148-3	27693-27705	associations	_	
148-4	27706-27710	were	_	
148-5	27711-27716	found	_	
148-6	27717-27724	between	_	
148-7	27725-27728	the	_	
148-8	27729-27737	coupling	_	
148-9	27738-27746	measures	_	
148-10	27747-27750	and	_	
148-11	27751-27759	clinical	_	
148-12	27760-27769	variables	_	
148-13	27770-27771	(	_	
148-14	27771-27774	i.e	_	
148-15	27774-27775	.	_	
148-16	27775-27776	,	_	
148-17	27777-27785	lifetime	_	
148-18	27786-27788	CB	_	
148-19	27789-27792	use	_	
148-20	27792-27793	,	_	
148-21	27794-27797	age	_	
148-22	27798-27800	of	_	
148-23	27801-27804	the	_	
148-24	27805-27810	first	_	
148-25	27811-27813	CB	_	
148-26	27814-27817	use	_	
148-27	27817-27818	,	_	
148-28	27819-27821	or	_	
148-29	27822-27825	the	_	
148-30	27826-27832	number	_	
148-31	27833-27835	of	_	
148-32	27836-27840	uses	_	
148-33	27841-27845	over	_	
148-34	27846-27849	the	_	
148-35	27850-27854	past	_	
148-36	27855-27857	30	_	
148-37	27858-27862	days	_	
148-38	27862-27863	)	_	
148-39	27863-27864	.	_	

#Text=Alterations in coupling may predate exposure to cannabis use and reflect genetic or environmental factors that increase risk for substance use.
149-1	27865-27876	Alterations	_	
149-2	27877-27879	in	_	
149-3	27880-27888	coupling	_	
149-4	27889-27892	may	_	
149-5	27893-27900	predate	_	
149-6	27901-27909	exposure	_	
149-7	27910-27912	to	_	
149-8	27913-27921	cannabis	_	
149-9	27922-27925	use	_	
149-10	27926-27929	and	_	
149-11	27930-27937	reflect	_	
149-12	27938-27945	genetic	_	
149-13	27946-27948	or	_	
149-14	27949-27962	environmental	_	
149-15	27963-27970	factors	_	
149-16	27971-27975	that	_	
149-17	27976-27984	increase	_	
149-18	27985-27989	risk	_	
149-19	27990-27993	for	_	
149-20	27994-28003	substance	_	
149-21	28004-28007	use	_	
149-22	28007-28008	.	_	

#Text=It has been estimated that 50 to 70% of the variation in CB use can be attributed to genetic factors and about 20% of variation reflect shared environmental factors. found that predispositional factors accounted for the relationship between amygdala volume and CB use.
150-1	28009-28011	It	_	
150-2	28012-28015	has	_	
150-3	28016-28020	been	_	
150-4	28021-28030	estimated	_	
150-5	28031-28035	that	_	
150-6	28036-28038	50	_	
150-7	28039-28041	to	_	
150-8	28042-28045	70%	_	
150-9	28046-28048	of	_	
150-10	28049-28052	the	_	
150-11	28053-28062	variation	_	
150-12	28063-28065	in	_	
150-13	28066-28068	CB	_	
150-14	28069-28072	use	_	
150-15	28073-28076	can	_	
150-16	28077-28079	be	_	
150-17	28080-28090	attributed	_	
150-18	28091-28093	to	_	
150-19	28094-28101	genetic	_	
150-20	28102-28109	factors	_	
150-21	28110-28113	and	_	
150-22	28114-28119	about	_	
150-23	28120-28123	20%	_	
150-24	28124-28126	of	_	
150-25	28127-28136	variation	_	
150-26	28137-28144	reflect	_	
150-27	28145-28151	shared	_	
150-28	28152-28165	environmental	_	
150-29	28166-28173	factors	_	
150-30	28173-28174	.	_	
150-31	28175-28180	found	_	
150-32	28181-28185	that	_	
150-33	28186-28202	predispositional	_	
150-34	28203-28210	factors	_	
150-35	28211-28220	accounted	_	
150-36	28221-28224	for	_	
150-37	28225-28228	the	_	
150-38	28229-28241	relationship	_	
150-39	28242-28249	between	_	
150-40	28250-28258	amygdala	_	
150-41	28259-28265	volume	_	
150-42	28266-28269	and	_	
150-43	28270-28272	CB	_	
150-44	28273-28276	use	_	
150-45	28276-28277	.	_	

#Text=Twin studies indicated that CB users showed IQ deficits that were apparent prior to initiation of CB use and could be attributed to familial factors.
151-1	28278-28282	Twin	_	
151-2	28283-28290	studies	_	
151-3	28291-28300	indicated	_	
151-4	28301-28305	that	_	
151-5	28306-28308	CB	_	
151-6	28309-28314	users	_	
151-7	28315-28321	showed	_	
151-8	28322-28324	IQ	_	
151-9	28325-28333	deficits	_	
151-10	28334-28338	that	_	
151-11	28339-28343	were	_	
151-12	28344-28352	apparent	_	
151-13	28353-28358	prior	_	
151-14	28359-28361	to	_	
151-15	28362-28372	initiation	_	
151-16	28373-28375	of	_	
151-17	28376-28378	CB	_	
151-18	28379-28382	use	_	
151-19	28383-28386	and	_	
151-20	28387-28392	could	_	
151-21	28393-28395	be	_	
151-22	28396-28406	attributed	_	
151-23	28407-28409	to	_	
151-24	28410-28418	familial	_	
151-25	28419-28426	factors	_	
151-26	28426-28427	.	_	

#Text=A recent genome-wide association study identified single-nucleotide polymorphisms at three genomic locations associated with risk for CB dependence.
152-1	28428-28429	A	_	
152-2	28430-28436	recent	_	
152-3	28437-28448	genome-wide	_	
152-4	28449-28460	association	_	
152-5	28461-28466	study	_	
152-6	28467-28477	identified	_	
152-7	28478-28495	single-nucleotide	_	
152-8	28496-28509	polymorphisms	_	
152-9	28510-28512	at	_	
152-10	28513-28518	three	_	
152-11	28519-28526	genomic	_	
152-12	28527-28536	locations	_	
152-13	28537-28547	associated	_	
152-14	28548-28552	with	_	
152-15	28553-28557	risk	_	
152-16	28558-28561	for	_	
152-17	28562-28564	CB	_	
152-18	28565-28575	dependence	_	
152-19	28575-28576	.	_	

#Text=Thus, genetic and predisposing environmental factors may be associated with neurobehavioral changes in CB users, perhaps including SC-FC coupling.
153-1	28577-28581	Thus	_	
153-2	28581-28582	,	_	
153-3	28583-28590	genetic	_	
153-4	28591-28594	and	_	
153-5	28595-28607	predisposing	_	
153-6	28608-28621	environmental	_	
153-7	28622-28629	factors	_	
153-8	28630-28633	may	_	
153-9	28634-28636	be	_	
153-10	28637-28647	associated	_	
153-11	28648-28652	with	_	
153-12	28653-28668	neurobehavioral	_	
153-13	28669-28676	changes	_	
153-14	28677-28679	in	_	
153-15	28680-28682	CB	_	
153-16	28683-28688	users	_	
153-17	28688-28689	,	_	
153-18	28690-28697	perhaps	_	
153-19	28698-28707	including	_	
153-20	28708-28713	SC-FC	_	
153-21	28714-28722	coupling	_	
153-22	28722-28723	.	_	

#Text=The recently initiated NIH Adolescent and Brain Cognitive Development Study, which will follow 10,000 healthy children into adulthood in conjunction with periodic brain imaging, may allow a better understanding of the contributions of genetic factors, environmental factors and CB use on brain network organization and dynamics.
154-1	28724-28727	The	_	
154-2	28728-28736	recently	_	
154-3	28737-28746	initiated	_	
154-4	28747-28750	NIH	_	
154-5	28751-28761	Adolescent	_	
154-6	28762-28765	and	_	
154-7	28766-28771	Brain	_	
154-8	28772-28781	Cognitive	_	
154-9	28782-28793	Development	_	
154-10	28794-28799	Study	_	
154-11	28799-28800	,	_	
154-12	28801-28806	which	_	
154-13	28807-28811	will	_	
154-14	28812-28818	follow	_	
154-15	28819-28825	10,000	_	
154-16	28826-28833	healthy	_	
154-17	28834-28842	children	_	
154-18	28843-28847	into	_	
154-19	28848-28857	adulthood	_	
154-20	28858-28860	in	_	
154-21	28861-28872	conjunction	_	
154-22	28873-28877	with	_	
154-23	28878-28886	periodic	_	
154-24	28887-28892	brain	_	
154-25	28893-28900	imaging	_	
154-26	28900-28901	,	_	
154-27	28902-28905	may	_	
154-28	28906-28911	allow	_	
154-29	28912-28913	a	_	
154-30	28914-28920	better	_	
154-31	28921-28934	understanding	_	
154-32	28935-28937	of	_	
154-33	28938-28941	the	_	
154-34	28942-28955	contributions	_	
154-35	28956-28958	of	_	
154-36	28959-28966	genetic	_	
154-37	28967-28974	factors	_	
154-38	28974-28975	,	_	
154-39	28976-28989	environmental	_	
154-40	28990-28997	factors	_	
154-41	28998-29001	and	_	
154-42	29002-29004	CB	_	
154-43	29005-29008	use	_	
154-44	29009-29011	on	_	
154-45	29012-29017	brain	_	
154-46	29018-29025	network	_	
154-47	29026-29038	organization	_	
154-48	29039-29042	and	_	
154-49	29043-29051	dynamics	_	
154-50	29051-29052	.	_	

#Text=The lack of correlation between connectivity and coupling measures to CB use may also be related to the difficulty in quantifying exposure to psychoactive compounds in cannabis, the relatively short time of exposure to cannabis in this young adult sample and the exclusion of CB users with any other psychiatric or substance use disorder.
155-1	29053-29056	The	_	
155-2	29057-29061	lack	_	
155-3	29062-29064	of	_	
155-4	29065-29076	correlation	_	
155-5	29077-29084	between	_	
155-6	29085-29097	connectivity	_	
155-7	29098-29101	and	_	
155-8	29102-29110	coupling	_	
155-9	29111-29119	measures	_	
155-10	29120-29122	to	_	
155-11	29123-29125	CB	_	
155-12	29126-29129	use	_	
155-13	29130-29133	may	_	
155-14	29134-29138	also	_	
155-15	29139-29141	be	_	
155-16	29142-29149	related	_	
155-17	29150-29152	to	_	
155-18	29153-29156	the	_	
155-19	29157-29167	difficulty	_	
155-20	29168-29170	in	_	
155-21	29171-29182	quantifying	_	
155-22	29183-29191	exposure	_	
155-23	29192-29194	to	_	
155-24	29195-29207	psychoactive	_	
155-25	29208-29217	compounds	_	
155-26	29218-29220	in	_	
155-27	29221-29229	cannabis	_	
155-28	29229-29230	,	_	
155-29	29231-29234	the	_	
155-30	29235-29245	relatively	_	
155-31	29246-29251	short	_	
155-32	29252-29256	time	_	
155-33	29257-29259	of	_	
155-34	29260-29268	exposure	_	
155-35	29269-29271	to	_	
155-36	29272-29280	cannabis	_	
155-37	29281-29283	in	_	
155-38	29284-29288	this	_	
155-39	29289-29294	young	_	
155-40	29295-29300	adult	_	
155-41	29301-29307	sample	_	
155-42	29308-29311	and	_	
155-43	29312-29315	the	_	
155-44	29316-29325	exclusion	_	
155-45	29326-29328	of	_	
155-46	29329-29331	CB	_	
155-47	29332-29337	users	_	
155-48	29338-29342	with	_	
155-49	29343-29346	any	_	
155-50	29347-29352	other	_	
155-51	29353-29364	psychiatric	_	
155-52	29365-29367	or	_	
155-53	29368-29377	substance	_	
155-54	29378-29381	use	_	
155-55	29382-29390	disorder	_	
155-56	29390-29391	.	_	

#Text=Variability in THC and cannabidiol (CBD) dosage in cannabis products, differences in mode of administration and individual differences in metabolism of cannabinoids are difficult or impossible to assess by self-report methods.
156-1	29392-29403	Variability	_	
156-2	29404-29406	in	_	
156-3	29407-29410	THC	_	
156-4	29411-29414	and	_	
156-5	29415-29426	cannabidiol	_	
156-6	29427-29428	(	_	
156-7	29428-29431	CBD	_	
156-8	29431-29432	)	_	
156-9	29433-29439	dosage	_	
156-10	29440-29442	in	_	
156-11	29443-29451	cannabis	_	
156-12	29452-29460	products	_	
156-13	29460-29461	,	_	
156-14	29462-29473	differences	_	
156-15	29474-29476	in	_	
156-16	29477-29481	mode	_	
156-17	29482-29484	of	_	
156-18	29485-29499	administration	_	
156-19	29500-29503	and	_	
156-20	29504-29514	individual	_	
156-21	29515-29526	differences	_	
156-22	29527-29529	in	_	
156-23	29530-29540	metabolism	_	
156-24	29541-29543	of	_	
156-25	29544-29556	cannabinoids	_	
156-26	29557-29560	are	_	
156-27	29561-29570	difficult	_	
156-28	29571-29573	or	_	
156-29	29574-29584	impossible	_	
156-30	29585-29587	to	_	
156-31	29588-29594	assess	_	
156-32	29595-29597	by	_	
156-33	29598-29609	self-report	_	
156-34	29610-29617	methods	_	
156-35	29617-29618	.	_	

#Text=The lack of significant correlations may thus reflect this uncertainty in measurement of actual level of exposure.
157-1	29619-29622	The	_	
157-2	29623-29627	lack	_	
157-3	29628-29630	of	_	
157-4	29631-29642	significant	_	
157-5	29643-29655	correlations	_	
157-6	29656-29659	may	_	
157-7	29660-29664	thus	_	
157-8	29665-29672	reflect	_	
157-9	29673-29677	this	_	
157-10	29678-29689	uncertainty	_	
157-11	29690-29692	in	_	
157-12	29693-29704	measurement	_	
157-13	29705-29707	of	_	
157-14	29708-29714	actual	_	
157-15	29715-29720	level	_	
157-16	29721-29723	of	_	
157-17	29724-29732	exposure	_	
157-18	29732-29733	.	_	

#Text=Our CB user samples was relatively young (21.1 ± 3.8 years old; cf.
158-1	29734-29737	Our	_	
158-2	29738-29740	CB	_	
158-3	29741-29745	user	_	
158-4	29746-29753	samples	_	
158-5	29754-29757	was	_	
158-6	29758-29768	relatively	_	
158-7	29769-29774	young	_	
158-8	29775-29776	(	_	
158-9	29776-29780	21.1	_	
158-10	29781-29782	±	_	
158-11	29783-29786	3.8	_	
158-12	29787-29792	years	_	
158-13	29793-29796	old	_	
158-14	29796-29797	;	_	
158-15	29798-29800	cf	_	
158-16	29800-29801	.	_	

#Text=Table 1), period of use was an average of 4.7 ± 3.4 years and only a minority met criteria for dependence.
159-1	29802-29807	Table	_	
159-2	29808-29809	1	_	
159-3	29809-29810	)	_	
159-4	29810-29811	,	_	
159-5	29812-29818	period	_	
159-6	29819-29821	of	_	
159-7	29822-29825	use	_	
159-8	29826-29829	was	_	
159-9	29830-29832	an	_	
159-10	29833-29840	average	_	
159-11	29841-29843	of	_	
159-12	29844-29847	4.7	_	
159-13	29848-29849	±	_	
159-14	29850-29853	3.4	_	
159-15	29854-29859	years	_	
159-16	29860-29863	and	_	
159-17	29864-29868	only	_	
159-18	29869-29870	a	_	
159-19	29871-29879	minority	_	
159-20	29880-29883	met	_	
159-21	29884-29892	criteria	_	
159-22	29893-29896	for	_	
159-23	29897-29907	dependence	_	
159-24	29907-29908	.	_	

#Text=A longer duration of heavy use may be required for correlations to reach sufficient magnitude for statistical detection.
160-1	29909-29910	A	_	
160-2	29911-29917	longer	_	
160-3	29918-29926	duration	_	
160-4	29927-29929	of	_	
160-5	29930-29935	heavy	_	
160-6	29936-29939	use	_	
160-7	29940-29943	may	_	
160-8	29944-29946	be	_	
160-9	29947-29955	required	_	
160-10	29956-29959	for	_	
160-11	29960-29972	correlations	_	
160-12	29973-29975	to	_	
160-13	29976-29981	reach	_	
160-14	29982-29992	sufficient	_	
160-15	29993-30002	magnitude	_	
160-16	30003-30006	for	_	
160-17	30007-30018	statistical	_	
160-18	30019-30028	detection	_	
160-19	30028-30029	.	_	

#Text=Finally, our sample only included CB users without current psychiatric problems or other types of substance use disorders.
161-1	30030-30037	Finally	_	
161-2	30037-30038	,	_	
161-3	30039-30042	our	_	
161-4	30043-30049	sample	_	
161-5	30050-30054	only	_	
161-6	30055-30063	included	_	
161-7	30064-30066	CB	_	
161-8	30067-30072	users	_	
161-9	30073-30080	without	_	
161-10	30081-30088	current	_	
161-11	30089-30100	psychiatric	_	
161-12	30101-30109	problems	_	
161-13	30110-30112	or	_	
161-14	30113-30118	other	_	
161-15	30119-30124	types	_	
161-16	30125-30127	of	_	
161-17	30128-30137	substance	_	
161-18	30138-30141	use	_	
161-19	30142-30151	disorders	_	
161-20	30151-30152	.	_	

#Text=Since about 90% of persons with CB dependence have comorbid psychiatric disorders, this sampling approach likely excluded the most severely affected members of the user population.
162-1	30153-30158	Since	_	
162-2	30159-30164	about	_	
162-3	30165-30168	90%	_	
162-4	30169-30171	of	_	
162-5	30172-30179	persons	_	
162-6	30180-30184	with	_	
162-7	30185-30187	CB	_	
162-8	30188-30198	dependence	_	
162-9	30199-30203	have	_	
162-10	30204-30212	comorbid	_	
162-11	30213-30224	psychiatric	_	
162-12	30225-30234	disorders	_	
162-13	30234-30235	,	_	
162-14	30236-30240	this	_	
162-15	30241-30249	sampling	_	
162-16	30250-30258	approach	_	
162-17	30259-30265	likely	_	
162-18	30266-30274	excluded	_	
162-19	30275-30278	the	_	
162-20	30279-30283	most	_	
162-21	30284-30292	severely	_	
162-22	30293-30301	affected	_	
162-23	30302-30309	members	_	
162-24	30310-30312	of	_	
162-25	30313-30316	the	_	
162-26	30317-30321	user	_	
162-27	30322-30332	population	_	
162-28	30332-30333	.	_	

#Text=This study has several limitations.
163-1	30334-30338	This	_	
163-2	30339-30344	study	_	
163-3	30345-30348	has	_	
163-4	30349-30356	several	_	
163-5	30357-30368	limitations	_	
163-6	30368-30369	.	_	

#Text=First, SC-FC coupling measures in the present data were not significantly correlated with self-reported measures of recent or lifetime exposures.
164-1	30370-30375	First	_	
164-2	30375-30376	,	_	
164-3	30377-30382	SC-FC	_	
164-4	30383-30391	coupling	_	
164-5	30392-30400	measures	_	
164-6	30401-30403	in	_	
164-7	30404-30407	the	_	
164-8	30408-30415	present	_	
164-9	30416-30420	data	_	
164-10	30421-30425	were	_	
164-11	30426-30429	not	_	
164-12	30430-30443	significantly	_	
164-13	30444-30454	correlated	_	
164-14	30455-30459	with	_	
164-15	30460-30473	self-reported	_	
164-16	30474-30482	measures	_	
164-17	30483-30485	of	_	
164-18	30486-30492	recent	_	
164-19	30493-30495	or	_	
164-20	30496-30504	lifetime	_	
164-21	30505-30514	exposures	_	
164-22	30514-30515	.	_	

#Text=Therefore, it should be noted that the between-group effects attributed to CB use may be due at least in part to other between-group effects.
165-1	30516-30525	Therefore	_	
165-2	30525-30526	,	_	
165-3	30527-30529	it	_	
165-4	30530-30536	should	_	
165-5	30537-30539	be	_	
165-6	30540-30545	noted	_	
165-7	30546-30550	that	_	
165-8	30551-30554	the	_	
165-9	30555-30568	between-group	_	
165-10	30569-30576	effects	_	
165-11	30577-30587	attributed	_	
165-12	30588-30590	to	_	
165-13	30591-30593	CB	_	
165-14	30594-30597	use	_	
165-15	30598-30601	may	_	
165-16	30602-30604	be	_	
165-17	30605-30608	due	_	
165-18	30609-30611	at	_	
165-19	30612-30617	least	_	
165-20	30618-30620	in	_	
165-21	30621-30625	part	_	
165-22	30626-30628	to	_	
165-23	30629-30634	other	_	
165-24	30635-30648	between-group	_	
165-25	30649-30656	effects	_	
165-26	30656-30657	.	_	

#Text=Second, only structural and functional node pairs, linked by direct anatomical connections, were used to compute SC-FC coupling.
166-1	30658-30664	Second	_	
166-2	30664-30665	,	_	
166-3	30666-30670	only	_	
166-4	30671-30681	structural	_	
166-5	30682-30685	and	_	
166-6	30686-30696	functional	_	
166-7	30697-30701	node	_	
166-8	30702-30707	pairs	_	
166-9	30707-30708	,	_	
166-10	30709-30715	linked	_	
166-11	30716-30718	by	_	
166-12	30719-30725	direct	_	
166-13	30726-30736	anatomical	_	
166-14	30737-30748	connections	_	
166-15	30748-30749	,	_	
166-16	30750-30754	were	_	
166-17	30755-30759	used	_	
166-18	30760-30762	to	_	
166-19	30763-30770	compute	_	
166-20	30771-30776	SC-FC	_	
166-21	30777-30785	coupling	_	
166-22	30785-30786	.	_	

#Text=Because FC can also result from fewer interactions along multi-step structural paths, additional effects due to these indirect effects should not be underrated.
167-1	30787-30794	Because	_	
167-2	30795-30797	FC	_	
167-3	30798-30801	can	_	
167-4	30802-30806	also	_	
167-5	30807-30813	result	_	
167-6	30814-30818	from	_	
167-7	30819-30824	fewer	_	
167-8	30825-30837	interactions	_	
167-9	30838-30843	along	_	
167-10	30844-30854	multi-step	_	
167-11	30855-30865	structural	_	
167-12	30866-30871	paths	_	
167-13	30871-30872	,	_	
167-14	30873-30883	additional	_	
167-15	30884-30891	effects	_	
167-16	30892-30895	due	_	
167-17	30896-30898	to	_	
167-18	30899-30904	these	_	
167-19	30905-30913	indirect	_	
167-20	30914-30921	effects	_	
167-21	30922-30928	should	_	
167-22	30929-30932	not	_	
167-23	30933-30935	be	_	
167-24	30936-30946	underrated	_	
167-25	30946-30947	.	_	

#Text=SC was defined by the streamline counts extracted from our tractography technique.
168-1	30948-30950	SC	_	
168-2	30951-30954	was	_	
168-3	30955-30962	defined	_	
168-4	30963-30965	by	_	
168-5	30966-30969	the	_	
168-6	30970-30980	streamline	_	
168-7	30981-30987	counts	_	
168-8	30988-30997	extracted	_	
168-9	30998-31002	from	_	
168-10	31003-31006	our	_	
168-11	31007-31019	tractography	_	
168-12	31020-31029	technique	_	
168-13	31029-31030	.	_	

#Text=This may not be sufficient to reflect the true biological estimate of anatomical connectivity among distributed brain regions, since estimates from reconstructed fiber tracts are not considered to be directly equivalent to the density of axonal bundles, but rather an abstraction derived from the tracking algorithm.
169-1	31031-31035	This	_	
169-2	31036-31039	may	_	
169-3	31040-31043	not	_	
169-4	31044-31046	be	_	
169-5	31047-31057	sufficient	_	
169-6	31058-31060	to	_	
169-7	31061-31068	reflect	_	
169-8	31069-31072	the	_	
169-9	31073-31077	true	_	
169-10	31078-31088	biological	_	
169-11	31089-31097	estimate	_	
169-12	31098-31100	of	_	
169-13	31101-31111	anatomical	_	
169-14	31112-31124	connectivity	_	
169-15	31125-31130	among	_	
169-16	31131-31142	distributed	_	
169-17	31143-31148	brain	_	
169-18	31149-31156	regions	_	
169-19	31156-31157	,	_	
169-20	31158-31163	since	_	
169-21	31164-31173	estimates	_	
169-22	31174-31178	from	_	
169-23	31179-31192	reconstructed	_	
169-24	31193-31198	fiber	_	
169-25	31199-31205	tracts	_	
169-26	31206-31209	are	_	
169-27	31210-31213	not	_	
169-28	31214-31224	considered	_	
169-29	31225-31227	to	_	
169-30	31228-31230	be	_	
169-31	31231-31239	directly	_	
169-32	31240-31250	equivalent	_	
169-33	31251-31253	to	_	
169-34	31254-31257	the	_	
169-35	31258-31265	density	_	
169-36	31266-31268	of	_	
169-37	31269-31275	axonal	_	
169-38	31276-31283	bundles	_	
169-39	31283-31284	,	_	
169-40	31285-31288	but	_	
169-41	31289-31295	rather	_	
169-42	31296-31298	an	_	
169-43	31299-31310	abstraction	_	
169-44	31311-31318	derived	_	
169-45	31319-31323	from	_	
169-46	31324-31327	the	_	
169-47	31328-31336	tracking	_	
169-48	31337-31346	algorithm	_	
169-49	31346-31347	.	_	

#Text=Furthermore, although we examined the brain network at a relatively high spatial resolution (= 1,014) and with a probabilistic tractography allowing multiple connections to achieve a minimal risk of type 2 error, some portion of extracted fibers might be still inaccurate due to complex fiber structure not resolved with the underlying tensor model, partial volume effects, and distance-dependent biases during fiber tracking.
170-1	31348-31359	Furthermore	_	
170-2	31359-31360	,	_	
170-3	31361-31369	although	_	
170-4	31370-31372	we	_	
170-5	31373-31381	examined	_	
170-6	31382-31385	the	_	
170-7	31386-31391	brain	_	
170-8	31392-31399	network	_	
170-9	31400-31402	at	_	
170-10	31403-31404	a	_	
170-11	31405-31415	relatively	_	
170-12	31416-31420	high	_	
170-13	31421-31428	spatial	_	
170-14	31429-31439	resolution	_	
170-15	31440-31441	(	_	
170-16	31441-31442	=	_	
170-17	31443-31448	1,014	_	
170-18	31448-31449	)	_	
170-19	31450-31453	and	_	
170-20	31454-31458	with	_	
170-21	31459-31460	a	_	
170-22	31461-31474	probabilistic	_	
170-23	31475-31487	tractography	_	
170-24	31488-31496	allowing	_	
170-25	31497-31505	multiple	_	
170-26	31506-31517	connections	_	
170-27	31518-31520	to	_	
170-28	31521-31528	achieve	_	
170-29	31529-31530	a	_	
170-30	31531-31538	minimal	_	
170-31	31539-31543	risk	_	
170-32	31544-31546	of	_	
170-33	31547-31551	type	_	
170-34	31552-31553	2	_	
170-35	31554-31559	error	_	
170-36	31559-31560	,	_	
170-37	31561-31565	some	_	
170-38	31566-31573	portion	_	
170-39	31574-31576	of	_	
170-40	31577-31586	extracted	_	
170-41	31587-31593	fibers	_	
170-42	31594-31599	might	_	
170-43	31600-31602	be	_	
170-44	31603-31608	still	_	
170-45	31609-31619	inaccurate	_	
170-46	31620-31623	due	_	
170-47	31624-31626	to	_	
170-48	31627-31634	complex	_	
170-49	31635-31640	fiber	_	
170-50	31641-31650	structure	_	
170-51	31651-31654	not	_	
170-52	31655-31663	resolved	_	
170-53	31664-31668	with	_	
170-54	31669-31672	the	_	
170-55	31673-31683	underlying	_	
170-56	31684-31690	tensor	_	
170-57	31691-31696	model	_	
170-58	31696-31697	,	_	
170-59	31698-31705	partial	_	
170-60	31706-31712	volume	_	
170-61	31713-31720	effects	_	
170-62	31720-31721	,	_	
170-63	31722-31725	and	_	
170-64	31726-31744	distance-dependent	_	
170-65	31745-31751	biases	_	
170-66	31752-31758	during	_	
170-67	31759-31764	fiber	_	
170-68	31765-31773	tracking	_	
170-69	31773-31774	.	_	

#Text=FC at rest is now widely considered to be dynamic over time, while the underlying SC profile is relatively static.
171-1	31775-31777	FC	_	
171-2	31778-31780	at	_	
171-3	31781-31785	rest	_	
171-4	31786-31788	is	_	
171-5	31789-31792	now	_	
171-6	31793-31799	widely	_	
171-7	31800-31810	considered	_	
171-8	31811-31813	to	_	
171-9	31814-31816	be	_	
171-10	31817-31824	dynamic	_	
171-11	31825-31829	over	_	
171-12	31830-31834	time	_	
171-13	31834-31835	,	_	
171-14	31836-31841	while	_	
171-15	31842-31845	the	_	
171-16	31846-31856	underlying	_	
171-17	31857-31859	SC	_	
171-18	31860-31867	profile	_	
171-19	31868-31870	is	_	
171-20	31871-31881	relatively	_	
171-21	31882-31888	static	_	
171-22	31888-31889	.	_	

#Text=Therefore, the SC-FC coupling might not have a simple one-to-one correspondence with each other.
172-1	31890-31899	Therefore	_	
172-2	31899-31900	,	_	
172-3	31901-31904	the	_	
172-4	31905-31910	SC-FC	_	
172-5	31911-31919	coupling	_	
172-6	31920-31925	might	_	
172-7	31926-31929	not	_	
172-8	31930-31934	have	_	
172-9	31935-31936	a	_	
172-10	31937-31943	simple	_	
172-11	31944-31954	one-to-one	_	
172-12	31955-31969	correspondence	_	
172-13	31970-31974	with	_	
172-14	31975-31979	each	_	
172-15	31980-31985	other	_	
172-16	31985-31986	.	_	

#Text=Indeed, some studies have shown that different network states exhibited at different times during resting state show different levels of correspondence with the anatomical connectivity.
173-1	31987-31993	Indeed	_	
173-2	31993-31994	,	_	
173-3	31995-31999	some	_	
173-4	32000-32007	studies	_	
173-5	32008-32012	have	_	
173-6	32013-32018	shown	_	
173-7	32019-32023	that	_	
173-8	32024-32033	different	_	
173-9	32034-32041	network	_	
173-10	32042-32048	states	_	
173-11	32049-32058	exhibited	_	
173-12	32059-32061	at	_	
173-13	32062-32071	different	_	
173-14	32072-32077	times	_	
173-15	32078-32084	during	_	
173-16	32085-32092	resting	_	
173-17	32093-32098	state	_	
173-18	32099-32103	show	_	
173-19	32104-32113	different	_	
173-20	32114-32120	levels	_	
173-21	32121-32123	of	_	
173-22	32124-32138	correspondence	_	
173-23	32139-32143	with	_	
173-24	32144-32147	the	_	
173-25	32148-32158	anatomical	_	
173-26	32159-32171	connectivity	_	
173-27	32171-32172	.	_	

#Text=Future studies examining SC-FC coupling over time in CB users would be highly informative.
174-1	32173-32179	Future	_	
174-2	32180-32187	studies	_	
174-3	32188-32197	examining	_	
174-4	32198-32203	SC-FC	_	
174-5	32204-32212	coupling	_	
174-6	32213-32217	over	_	
174-7	32218-32222	time	_	
174-8	32223-32225	in	_	
174-9	32226-32228	CB	_	
174-10	32229-32234	users	_	
174-11	32235-32240	would	_	
174-12	32241-32243	be	_	
174-13	32244-32250	highly	_	
174-14	32251-32262	informative	_	
174-15	32262-32263	.	_	

#Text=Overall, the present study suggested that while global SC-FC coupling was preserved in CB users, rich-club analysis revealed impaired structural-functional coupling in the hippocampus and caudate of users.
175-1	32264-32271	Overall	_	
175-2	32271-32272	,	_	
175-3	32273-32276	the	_	
175-4	32277-32284	present	_	
175-5	32285-32290	study	_	
175-6	32291-32300	suggested	_	
175-7	32301-32305	that	_	
175-8	32306-32311	while	_	
175-9	32312-32318	global	_	
175-10	32319-32324	SC-FC	_	
175-11	32325-32333	coupling	_	
175-12	32334-32337	was	_	
175-13	32338-32347	preserved	_	
175-14	32348-32350	in	_	
175-15	32351-32353	CB	_	
175-16	32354-32359	users	_	
175-17	32359-32360	,	_	
175-18	32361-32370	rich-club	_	
175-19	32371-32379	analysis	_	
175-20	32380-32388	revealed	_	
175-21	32389-32397	impaired	_	
175-22	32398-32419	structural-functional	_	
175-23	32420-32428	coupling	_	
175-24	32429-32431	in	_	
175-25	32432-32435	the	_	
175-26	32436-32447	hippocampus	_	
175-27	32448-32451	and	_	
175-28	32452-32459	caudate	_	
175-29	32460-32462	of	_	
175-30	32463-32468	users	_	
175-31	32468-32469	.	_	

#Text=Additionally, the association between SC-FC coupling and the brain’s network topological characteristics was disrupted in CB users.
176-1	32470-32482	Additionally	_	
176-2	32482-32483	,	_	
176-3	32484-32487	the	_	
176-4	32488-32499	association	_	
176-5	32500-32507	between	_	
176-6	32508-32513	SC-FC	_	
176-7	32514-32522	coupling	_	
176-8	32523-32526	and	_	
176-9	32527-32530	the	_	
176-10	32531-32536	brain	_	
176-11	32536-32537	’	_	
176-12	32537-32538	s	_	
176-13	32539-32546	network	_	
176-14	32547-32558	topological	_	
176-15	32559-32574	characteristics	_	
176-16	32575-32578	was	_	
176-17	32579-32588	disrupted	_	
176-18	32589-32591	in	_	
176-19	32592-32594	CB	_	
176-20	32595-32600	users	_	
176-21	32600-32601	.	_	

#Text=This effect was predominant in shorter connections of the brain network, suggesting that the impact of CB use or predispositional factors may be most apparent in local interconnections.
177-1	32602-32606	This	_	
177-2	32607-32613	effect	_	
177-3	32614-32617	was	_	
177-4	32618-32629	predominant	_	
177-5	32630-32632	in	_	
177-6	32633-32640	shorter	_	
177-7	32641-32652	connections	_	
177-8	32653-32655	of	_	
177-9	32656-32659	the	_	
177-10	32660-32665	brain	_	
177-11	32666-32673	network	_	
177-12	32673-32674	,	_	
177-13	32675-32685	suggesting	_	
177-14	32686-32690	that	_	
177-15	32691-32694	the	_	
177-16	32695-32701	impact	_	
177-17	32702-32704	of	_	
177-18	32705-32707	CB	_	
177-19	32708-32711	use	_	
177-20	32712-32714	or	_	
177-21	32715-32731	predispositional	_	
177-22	32732-32739	factors	_	
177-23	32740-32743	may	_	
177-24	32744-32746	be	_	
177-25	32747-32751	most	_	
177-26	32752-32760	apparent	_	
177-27	32761-32763	in	_	
177-28	32764-32769	local	_	
177-29	32770-32786	interconnections	_	
177-30	32786-32787	.	_	

#Text=In terms of future research issues, replication of findings in early adolescence and later adulthood would help clarify the relation of SC-FC coupling alterations to age and duration of use.
178-1	32788-32790	In	_	
178-2	32791-32796	terms	_	
178-3	32797-32799	of	_	
178-4	32800-32806	future	_	
178-5	32807-32815	research	_	
178-6	32816-32822	issues	_	
178-7	32822-32823	,	_	
178-8	32824-32835	replication	_	
178-9	32836-32838	of	_	
178-10	32839-32847	findings	_	
178-11	32848-32850	in	_	
178-12	32851-32856	early	_	
178-13	32857-32868	adolescence	_	
178-14	32869-32872	and	_	
178-15	32873-32878	later	_	
178-16	32879-32888	adulthood	_	
178-17	32889-32894	would	_	
178-18	32895-32899	help	_	
178-19	32900-32907	clarify	_	
178-20	32908-32911	the	_	
178-21	32912-32920	relation	_	
178-22	32921-32923	of	_	
178-23	32924-32929	SC-FC	_	
178-24	32930-32938	coupling	_	
178-25	32939-32950	alterations	_	
178-26	32951-32953	to	_	
178-27	32954-32957	age	_	
178-28	32958-32961	and	_	
178-29	32962-32970	duration	_	
178-30	32971-32973	of	_	
178-31	32974-32977	use	_	
178-32	32977-32978	.	_	

#Text=Research designs utilizing longitudinal tracking of at-risk persons, direct administration of cannabinoids while imaging and genetically informed designs could clarify whether these disturbances are consequences of CB use or neurodevelopmental factors which predate initiation of CB use.
179-1	32979-32987	Research	_	
179-2	32988-32995	designs	_	
179-3	32996-33005	utilizing	_	
179-4	33006-33018	longitudinal	_	
179-5	33019-33027	tracking	_	
179-6	33028-33030	of	_	
179-7	33031-33038	at-risk	_	
179-8	33039-33046	persons	_	
179-9	33046-33047	,	_	
179-10	33048-33054	direct	_	
179-11	33055-33069	administration	_	
179-12	33070-33072	of	_	
179-13	33073-33085	cannabinoids	_	
179-14	33086-33091	while	_	
179-15	33092-33099	imaging	_	
179-16	33100-33103	and	_	
179-17	33104-33115	genetically	_	
179-18	33116-33124	informed	_	
179-19	33125-33132	designs	_	
179-20	33133-33138	could	_	
179-21	33139-33146	clarify	_	
179-22	33147-33154	whether	_	
179-23	33155-33160	these	_	
179-24	33161-33173	disturbances	_	
179-25	33174-33177	are	_	
179-26	33178-33190	consequences	_	
179-27	33191-33193	of	_	
179-28	33194-33196	CB	_	
179-29	33197-33200	use	_	
179-30	33201-33203	or	_	
179-31	33204-33222	neurodevelopmental	_	
179-32	33223-33230	factors	_	
179-33	33231-33236	which	_	
179-34	33237-33244	predate	_	
179-35	33245-33255	initiation	_	
179-36	33256-33258	of	_	
179-37	33259-33261	CB	_	
179-38	33262-33265	use	_	
179-39	33265-33266	.	_	

#Text=Finally, animal models of CB exposure could help characterize the cellular basis of these alterations in SC-FC coupling.
180-1	33267-33274	Finally	_	
180-2	33274-33275	,	_	
180-3	33276-33282	animal	_	
180-4	33283-33289	models	_	
180-5	33290-33292	of	_	
180-6	33293-33295	CB	_	
180-7	33296-33304	exposure	_	
180-8	33305-33310	could	_	
180-9	33311-33315	help	_	
180-10	33316-33328	characterize	_	
180-11	33329-33332	the	_	
180-12	33333-33341	cellular	_	
180-13	33342-33347	basis	_	
180-14	33348-33350	of	_	
180-15	33351-33356	these	_	
180-16	33357-33368	alterations	_	
180-17	33369-33371	in	_	
180-18	33372-33377	SC-FC	_	
180-19	33378-33386	coupling	_	
180-20	33386-33387	.	_	

#Text=Supplementary Material
#Text=References
#Text=Rates of psychiatric comorbidity among U.S. residents with lifetime cannabis dependence.
181-1	33388-33401	Supplementary	_	
181-2	33402-33410	Material	_	
181-3	33411-33421	References	_	
181-4	33422-33427	Rates	_	
181-5	33428-33430	of	_	
181-6	33431-33442	psychiatric	_	
181-7	33443-33454	comorbidity	_	
181-8	33455-33460	among	_	
181-9	33461-33464	U.S	_	
181-10	33464-33465	.	_	
181-11	33466-33475	residents	_	
181-12	33476-33480	with	_	
181-13	33481-33489	lifetime	_	
181-14	33490-33498	cannabis	_	
181-15	33499-33509	dependence	_	
181-16	33509-33510	.	_	

#Text=The anatomical distance of functional connections predicts brain network topology in health and schizophrenia.
182-1	33511-33514	The	_	
182-2	33515-33525	anatomical	_	
182-3	33526-33534	distance	_	
182-4	33535-33537	of	_	
182-5	33538-33548	functional	_	
182-6	33549-33560	connections	_	
182-7	33561-33569	predicts	_	
182-8	33570-33575	brain	_	
182-9	33576-33583	network	_	
182-10	33584-33592	topology	_	
182-11	33593-33595	in	_	
182-12	33596-33602	health	_	
182-13	33603-33606	and	_	
182-14	33607-33620	schizophrenia	_	
182-15	33620-33621	.	_	

#Text=How to correct susceptibility distortions in spin-echo echo-planar images: application to diffusion tensor imaging.
183-1	33622-33625	How	_	
183-2	33626-33628	to	_	
183-3	33629-33636	correct	_	
183-4	33637-33651	susceptibility	_	
183-5	33652-33663	distortions	_	
183-6	33664-33666	in	_	
183-7	33667-33676	spin-echo	_	
183-8	33677-33688	echo-planar	_	
183-9	33689-33695	images	_	
183-10	33695-33696	:	_	
183-11	33697-33708	application	_	
183-12	33709-33711	to	_	
183-13	33712-33721	diffusion	_	
183-14	33722-33728	tensor	_	
183-15	33729-33736	imaging	_	
183-16	33736-33737	.	_	

#Text=An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging.
184-1	33738-33740	An	_	
184-2	33741-33751	integrated	_	
184-3	33752-33760	approach	_	
184-4	33761-33763	to	_	
184-5	33764-33774	correction	_	
184-6	33775-33778	for	_	
184-7	33779-33792	off-resonance	_	
184-8	33793-33800	effects	_	
184-9	33801-33804	and	_	
184-10	33805-33812	subject	_	
184-11	33813-33821	movement	_	
184-12	33822-33824	in	_	
184-13	33825-33834	diffusion	_	
184-14	33835-33837	MR	_	
184-15	33838-33845	imaging	_	
184-16	33845-33846	.	_	

#Text=Rich-club organization of the newborn human brain.
185-1	33847-33856	Rich-club	_	
185-2	33857-33869	organization	_	
185-3	33870-33872	of	_	
185-4	33873-33876	the	_	
185-5	33877-33884	newborn	_	
185-6	33885-33890	human	_	
185-7	33891-33896	brain	_	
185-8	33896-33897	.	_	

#Text=Signature of consciousness in the dynamics of resting-state brain activity.
186-1	33898-33907	Signature	_	
186-2	33908-33910	of	_	
186-3	33911-33924	consciousness	_	
186-4	33925-33927	in	_	
186-5	33928-33931	the	_	
186-6	33932-33940	dynamics	_	
186-7	33941-33943	of	_	
186-8	33944-33957	resting-state	_	
186-9	33958-33963	brain	_	
186-10	33964-33972	activity	_	
186-11	33972-33973	.	_	

#Text=Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings.
187-1	33974-33984	Structural	_	
187-2	33985-33988	and	_	
187-3	33989-33999	functional	_	
187-4	34000-34007	imaging	_	
187-5	34008-34015	studies	_	
187-6	34016-34018	in	_	
187-7	34019-34026	chronic	_	
187-8	34027-34035	cannabis	_	
187-9	34036-34041	users	_	
187-10	34041-34042	:	_	
187-11	34043-34044	a	_	
187-12	34045-34055	systematic	_	
187-13	34056-34062	review	_	
187-14	34063-34065	of	_	
187-15	34066-34076	adolescent	_	
187-16	34077-34080	and	_	
187-17	34081-34086	adult	_	
187-18	34087-34095	findings	_	
187-19	34095-34096	.	_	

#Text=Neuroimaging studies of acute effects of THC and CBD in humans and animals: a systematic review.
188-1	34097-34109	Neuroimaging	_	
188-2	34110-34117	studies	_	
188-3	34118-34120	of	_	
188-4	34121-34126	acute	_	
188-5	34127-34134	effects	_	
188-6	34135-34137	of	_	
188-7	34138-34141	THC	_	
188-8	34142-34145	and	_	
188-9	34146-34149	CBD	_	
188-10	34150-34152	in	_	
188-11	34153-34159	humans	_	
188-12	34160-34163	and	_	
188-13	34164-34171	animals	_	
188-14	34171-34172	:	_	
188-15	34173-34174	a	_	
188-16	34175-34185	systematic	_	
188-17	34186-34192	review	_	
188-18	34192-34193	.	_	

#Text=Attenuated frontal and sensory inputs to the basal ganglia in cannabis users.
189-1	34194-34204	Attenuated	_	
189-2	34205-34212	frontal	_	
189-3	34213-34216	and	_	
189-4	34217-34224	sensory	_	
189-5	34225-34231	inputs	_	
189-6	34232-34234	to	_	
189-7	34235-34238	the	_	
189-8	34239-34244	basal	_	
189-9	34245-34252	ganglia	_	
189-10	34253-34255	in	_	
189-11	34256-34264	cannabis	_	
189-12	34265-34270	users	_	
189-13	34270-34271	.	_	

#Text=The effects of Delta9-tetrahydrocannabinol on the dopamine system.
190-1	34272-34275	The	_	
190-2	34276-34283	effects	_	
190-3	34284-34286	of	_	
190-4	34287-34293	Delta9	_	
190-5	34293-34294	-	_	
190-6	34294-34314	tetrahydrocannabinol	_	
190-7	34315-34317	on	_	
190-8	34318-34321	the	_	
190-9	34322-34330	dopamine	_	
190-10	34331-34337	system	_	
190-11	34337-34338	.	_	

#Text=Genetic and Environmental Factors Associated with Cannabis Involvement.
191-1	34339-34346	Genetic	_	
191-2	34347-34350	and	_	
191-3	34351-34364	Environmental	_	
191-4	34365-34372	Factors	_	
191-5	34373-34383	Associated	_	
191-6	34384-34388	with	_	
191-7	34389-34397	Cannabis	_	
191-8	34398-34409	Involvement	_	
191-9	34409-34410	.	_	

#Text=Resting state functional magnetic resonance imaging reveals distinct brain activity in heavy cannabis users - a multi-voxel pattern analysis.
192-1	34412-34419	Resting	_	
192-2	34420-34425	state	_	
192-3	34426-34436	functional	_	
192-4	34437-34445	magnetic	_	
192-5	34446-34455	resonance	_	
192-6	34456-34463	imaging	_	
192-7	34464-34471	reveals	_	
192-8	34472-34480	distinct	_	
192-9	34481-34486	brain	_	
192-10	34487-34495	activity	_	
192-11	34496-34498	in	_	
192-12	34499-34504	heavy	_	
192-13	34505-34513	cannabis	_	
192-14	34514-34519	users	_	
192-15	34520-34521	-	_	
192-16	34522-34523	a	_	
192-17	34524-34535	multi-voxel	_	
192-18	34536-34543	pattern	_	
192-19	34544-34552	analysis	_	
192-20	34552-34553	.	_	

#Text=Impaired rich club connectivity in unaffected siblings of schizophrenia patients.
193-1	34554-34562	Impaired	_	
193-2	34563-34567	rich	_	
193-3	34568-34572	club	_	
193-4	34573-34585	connectivity	_	
193-5	34586-34588	in	_	
193-6	34589-34599	unaffected	_	
193-7	34600-34608	siblings	_	
193-8	34609-34611	of	_	
193-9	34612-34625	schizophrenia	_	
193-10	34626-34634	patients	_	
193-11	34634-34635	.	_	

#Text=Structural and functional aspects relating to cost and benefit of rich club organization in the human cerebral cortex.
194-1	34636-34646	Structural	_	
194-2	34647-34650	and	_	
194-3	34651-34661	functional	_	
194-4	34662-34669	aspects	_	
194-5	34670-34678	relating	_	
194-6	34679-34681	to	_	
194-7	34682-34686	cost	_	
194-8	34687-34690	and	_	
194-9	34691-34698	benefit	_	
194-10	34699-34701	of	_	
194-11	34702-34706	rich	_	
194-12	34707-34711	club	_	
194-13	34712-34724	organization	_	
194-14	34725-34727	in	_	
194-15	34728-34731	the	_	
194-16	34732-34737	human	_	
194-17	34738-34746	cerebral	_	
194-18	34747-34753	cortex	_	
194-19	34753-34754	.	_	

#Text=Polysubstance use in cannabis users referred for treatment: drug use profiles, psychiatric comorbidity and cannabis-related beliefs.
195-1	34755-34768	Polysubstance	_	
195-2	34769-34772	use	_	
195-3	34773-34775	in	_	
195-4	34776-34784	cannabis	_	
195-5	34785-34790	users	_	
195-6	34791-34799	referred	_	
195-7	34800-34803	for	_	
195-8	34804-34813	treatment	_	
195-9	34813-34814	:	_	
195-10	34815-34819	drug	_	
195-11	34820-34823	use	_	
195-12	34824-34832	profiles	_	
195-13	34832-34833	,	_	
195-14	34834-34845	psychiatric	_	
195-15	34846-34857	comorbidity	_	
195-16	34858-34861	and	_	
195-17	34862-34878	cannabis-related	_	
195-18	34879-34886	beliefs	_	
195-19	34886-34887	.	_	

#Text=Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders.
196-1	34888-34908	Cannabinoid-dopamine	_	
196-2	34909-34920	interaction	_	
196-3	34921-34923	in	_	
196-4	34924-34927	the	_	
196-5	34928-34943	pathophysiology	_	
196-6	34944-34947	and	_	
196-7	34948-34957	treatment	_	
196-8	34958-34960	of	_	
196-9	34961-34964	CNS	_	
196-10	34965-34974	disorders	_	
196-11	34974-34975	.	_	

#Text=Functional connectivity in inhibitory control networks and severity of cannabis use disorder.
197-1	34976-34986	Functional	_	
197-2	34987-34999	connectivity	_	
197-3	35000-35002	in	_	
197-4	35003-35013	inhibitory	_	
197-5	35014-35021	control	_	
197-6	35022-35030	networks	_	
197-7	35031-35034	and	_	
197-8	35035-35043	severity	_	
197-9	35044-35046	of	_	
197-10	35047-35055	cannabis	_	
197-11	35056-35059	use	_	
197-12	35060-35068	disorder	_	
197-13	35068-35069	.	_	

#Text=Differential reward network functional connectivity in cannabis dependent and non-dependent users.
198-1	35070-35082	Differential	_	
198-2	35083-35089	reward	_	
198-3	35090-35097	network	_	
198-4	35098-35108	functional	_	
198-5	35109-35121	connectivity	_	
198-6	35122-35124	in	_	
198-7	35125-35133	cannabis	_	
198-8	35134-35143	dependent	_	
198-9	35144-35147	and	_	
198-10	35148-35161	non-dependent	_	
198-11	35162-35167	users	_	
198-12	35167-35168	.	_	

#Text=Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain.
199-1	35171-35182	Cannabinoid	_	
199-2	35183-35192	receptors	_	
199-3	35193-35195	in	_	
199-4	35196-35199	the	_	
199-5	35200-35205	human	_	
199-6	35206-35211	brain	_	
199-7	35211-35212	:	_	
199-8	35213-35214	a	_	
199-9	35215-35223	detailed	_	
199-10	35224-35234	anatomical	_	
199-11	35235-35238	and	_	
199-12	35239-35251	quantitative	_	
199-13	35252-35268	autoradiographic	_	
199-14	35269-35274	study	_	
199-15	35275-35277	in	_	
199-16	35278-35281	the	_	
199-17	35282-35287	fetal	_	
199-18	35287-35288	,	_	
199-19	35289-35297	neonatal	_	
199-20	35298-35301	and	_	
199-21	35302-35307	adult	_	
199-22	35308-35313	human	_	
199-23	35314-35319	brain	_	
199-24	35319-35320	.	_	

#Text=Resting-state functional connectivity reflects structural connectivity in the default mode network.
200-1	35321-35334	Resting-state	_	
200-2	35335-35345	functional	_	
200-3	35346-35358	connectivity	_	
200-4	35359-35367	reflects	_	
200-5	35368-35378	structural	_	
200-6	35379-35391	connectivity	_	
200-7	35392-35394	in	_	
200-8	35395-35398	the	_	
200-9	35399-35406	default	_	
200-10	35407-35411	mode	_	
200-11	35412-35419	network	_	
200-12	35419-35420	.	_	

#Text=Mapping the structural core of human cerebral cortex.
201-1	35421-35428	Mapping	_	
201-2	35429-35432	the	_	
201-3	35433-35443	structural	_	
201-4	35444-35448	core	_	
201-5	35449-35451	of	_	
201-6	35452-35457	human	_	
201-7	35458-35466	cerebral	_	
201-8	35467-35473	cortex	_	
201-9	35473-35474	.	_	

#Text=White matter maturation reshapes structural connectivity in the late developing human brain.
202-1	35475-35480	White	_	
202-2	35481-35487	matter	_	
202-3	35488-35498	maturation	_	
202-4	35499-35507	reshapes	_	
202-5	35508-35518	structural	_	
202-6	35519-35531	connectivity	_	
202-7	35532-35534	in	_	
202-8	35535-35538	the	_	
202-9	35539-35543	late	_	
202-10	35544-35554	developing	_	
202-11	35555-35560	human	_	
202-12	35561-35566	brain	_	
202-13	35566-35567	.	_	

#Text=Prevalence of Marijuana Use Disorders in the United States Between 2001–2002 and 2012–2013.
203-1	35568-35578	Prevalence	_	
203-2	35579-35581	of	_	
203-3	35582-35591	Marijuana	_	
203-4	35592-35595	Use	_	
203-5	35596-35605	Disorders	_	
203-6	35606-35608	in	_	
203-7	35609-35612	the	_	
203-8	35613-35619	United	_	
203-9	35620-35626	States	_	
203-10	35627-35634	Between	_	
203-11	35635-35639	2001	_	
203-12	35639-35640	–	_	
203-13	35640-35644	2002	_	
203-14	35645-35648	and	_	
203-15	35649-35653	2012	_	
203-16	35653-35654	–	_	
203-17	35654-35658	2013	_	
203-18	35658-35659	.	_	

#Text=The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire.
204-1	35660-35663	The	_	
204-2	35664-35674	Fagerstrom	_	
204-3	35675-35679	Test	_	
204-4	35680-35683	for	_	
204-5	35684-35692	Nicotine	_	
204-6	35693-35703	Dependence	_	
204-7	35703-35704	:	_	
204-8	35705-35706	a	_	
204-9	35707-35715	revision	_	
204-10	35716-35718	of	_	
204-11	35719-35722	the	_	
204-12	35723-35733	Fagerstrom	_	
204-13	35734-35743	Tolerance	_	
204-14	35744-35757	Questionnaire	_	
204-15	35757-35758	.	_	

#Text=Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.
205-1	35759-35767	Neuronal	_	
205-2	35768-35780	localization	_	
205-3	35781-35783	of	_	
205-4	35784-35795	cannabinoid	_	
205-5	35796-35805	receptors	_	
205-6	35806-35808	in	_	
205-7	35809-35812	the	_	
205-8	35813-35818	basal	_	
205-9	35819-35826	ganglia	_	
205-10	35827-35829	of	_	
205-11	35830-35833	the	_	
205-12	35834-35837	rat	_	
205-13	35837-35838	.	_	

#Text=Predicting human resting-state functional connectivity from structural connectivity.
206-1	35839-35849	Predicting	_	
206-2	35850-35855	human	_	
206-3	35856-35869	resting-state	_	
206-4	35870-35880	functional	_	
206-5	35881-35893	connectivity	_	
206-6	35894-35898	from	_	
206-7	35899-35909	structural	_	
206-8	35910-35922	connectivity	_	
206-9	35922-35923	.	_	

#Text=Dynamic functional connectivity: promise, issues, and interpretations.
207-1	35924-35931	Dynamic	_	
207-2	35932-35942	functional	_	
207-3	35943-35955	connectivity	_	
207-4	35955-35956	:	_	
207-5	35957-35964	promise	_	
207-6	35964-35965	,	_	
207-7	35966-35972	issues	_	
207-8	35972-35973	,	_	
207-9	35974-35977	and	_	
207-10	35978-35993	interpretations	_	
207-11	35993-35994	.	_	

#Text=Impact of adolescent marijuana use on intelligence: Results from two longitudinal twin studies.
208-1	35995-36001	Impact	_	
208-2	36002-36004	of	_	
208-3	36005-36015	adolescent	_	
208-4	36016-36025	marijuana	_	
208-5	36026-36029	use	_	
208-6	36030-36032	on	_	
208-7	36033-36045	intelligence	_	
208-8	36045-36046	:	_	
208-9	36047-36054	Results	_	
208-10	36055-36059	from	_	
208-11	36060-36063	two	_	
208-12	36064-36076	longitudinal	_	
208-13	36077-36081	twin	_	
208-14	36082-36089	studies	_	
208-15	36089-36090	.	_	

#Text=Long-term consequences of adolescent cannabis exposure on the development of cognition, brain structure and function: an overview of animal and human research.
209-1	36091-36100	Long-term	_	
209-2	36101-36113	consequences	_	
209-3	36114-36116	of	_	
209-4	36117-36127	adolescent	_	
209-5	36128-36136	cannabis	_	
209-6	36137-36145	exposure	_	
209-7	36146-36148	on	_	
209-8	36149-36152	the	_	
209-9	36153-36164	development	_	
209-10	36165-36167	of	_	
209-11	36168-36177	cognition	_	
209-12	36177-36178	,	_	
209-13	36179-36184	brain	_	
209-14	36185-36194	structure	_	
209-15	36195-36198	and	_	
209-16	36199-36207	function	_	
209-17	36207-36208	:	_	
209-18	36209-36211	an	_	
209-19	36212-36220	overview	_	
209-20	36221-36223	of	_	
209-21	36224-36230	animal	_	
209-22	36231-36234	and	_	
209-23	36235-36240	human	_	
209-24	36241-36249	research	_	
209-25	36249-36250	.	_	

#Text=An MRI study of white matter tract integrity in regular cannabis users: effects of cannabis use and age.
210-1	36251-36253	An	_	
210-2	36254-36257	MRI	_	
210-3	36258-36263	study	_	
210-4	36264-36266	of	_	
210-5	36267-36272	white	_	
210-6	36273-36279	matter	_	
210-7	36280-36285	tract	_	
210-8	36286-36295	integrity	_	
210-9	36296-36298	in	_	
210-10	36299-36306	regular	_	
210-11	36307-36315	cannabis	_	
210-12	36316-36321	users	_	
210-13	36321-36322	:	_	
210-14	36323-36330	effects	_	
210-15	36331-36333	of	_	
210-16	36334-36342	cannabis	_	
210-17	36343-36346	use	_	
210-18	36347-36350	and	_	
210-19	36351-36354	age	_	
210-20	36354-36355	.	_	

#Text=Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture.
211-1	36356-36368	Cannabinoids	_	
211-2	36369-36376	inhibit	_	
211-3	36377-36380	the	_	
211-4	36381-36390	formation	_	
211-5	36391-36393	of	_	
211-6	36394-36397	new	_	
211-7	36398-36406	synapses	_	
211-8	36407-36414	between	_	
211-9	36415-36426	hippocampal	_	
211-10	36427-36434	neurons	_	
211-11	36435-36437	in	_	
211-12	36438-36445	culture	_	
211-13	36445-36446	.	_	

#Text=Prenatal Maternal Cortisol Has Sex-Specific Associations with Child Brain Network Properties.
212-1	36447-36455	Prenatal	_	
212-2	36456-36464	Maternal	_	
212-3	36465-36473	Cortisol	_	
212-4	36474-36477	Has	_	
212-5	36478-36490	Sex-Specific	_	
212-6	36491-36503	Associations	_	
212-7	36504-36508	with	_	
212-8	36509-36514	Child	_	
212-9	36515-36520	Brain	_	
212-10	36521-36528	Network	_	
212-11	36529-36539	Properties	_	
212-12	36539-36540	.	_	

#Text=An investigation of functional and anatomical connectivity using magnetic resonance imaging.
213-1	36541-36543	An	_	
213-2	36544-36557	investigation	_	
213-3	36558-36560	of	_	
213-4	36561-36571	functional	_	
213-5	36572-36575	and	_	
213-6	36576-36586	anatomical	_	
213-7	36587-36599	connectivity	_	
213-8	36600-36605	using	_	
213-9	36606-36614	magnetic	_	
213-10	36615-36624	resonance	_	
213-11	36625-36632	imaging	_	
213-12	36632-36633	.	_	

#Text=Neurobiology of addiction: a neurocircuitry analysis.
214-1	36634-36646	Neurobiology	_	
214-2	36647-36649	of	_	
214-3	36650-36659	addiction	_	
214-4	36659-36660	:	_	
214-5	36661-36662	a	_	
214-6	36663-36677	neurocircuitry	_	
214-7	36678-36686	analysis	_	
214-8	36686-36687	.	_	

#Text=Effects of drugs of abuse on hippocampal plasticity and hippocampus-dependent learning and memory: contributions to development and maintenance of addiction.
215-1	36688-36695	Effects	_	
215-2	36696-36698	of	_	
215-3	36699-36704	drugs	_	
215-4	36705-36707	of	_	
215-5	36708-36713	abuse	_	
215-6	36714-36716	on	_	
215-7	36717-36728	hippocampal	_	
215-8	36729-36739	plasticity	_	
215-9	36740-36743	and	_	
215-10	36744-36765	hippocampus-dependent	_	
215-11	36766-36774	learning	_	
215-12	36775-36778	and	_	
215-13	36779-36785	memory	_	
215-14	36785-36786	:	_	
215-15	36787-36800	contributions	_	
215-16	36801-36803	to	_	
215-17	36804-36815	development	_	
215-18	36816-36819	and	_	
215-19	36820-36831	maintenance	_	
215-20	36832-36834	of	_	
215-21	36835-36844	addiction	_	
215-22	36844-36845	.	_	

#Text=Economic small-world behavior in weighted networks.
216-1	36846-36854	Economic	_	
216-2	36855-36866	small-world	_	
216-3	36867-36875	behavior	_	
216-4	36876-36878	in	_	
216-5	36879-36887	weighted	_	
216-6	36888-36896	networks	_	
216-7	36896-36897	.	_	

#Text=Fronto-striatal effective connectivity of working memory in adults with cannabis use disorder.
217-1	36898-36913	Fronto-striatal	_	
217-2	36914-36923	effective	_	
217-3	36924-36936	connectivity	_	
217-4	36937-36939	of	_	
217-5	36940-36947	working	_	
217-6	36948-36954	memory	_	
217-7	36955-36957	in	_	
217-8	36958-36964	adults	_	
217-9	36965-36969	with	_	
217-10	36970-36978	cannabis	_	
217-11	36979-36982	use	_	
217-12	36983-36991	disorder	_	
217-13	36991-36992	.	_	

#Text=Signaling via CNS cannabinoid receptors.
218-1	36993-37002	Signaling	_	
218-2	37003-37006	via	_	
218-3	37007-37010	CNS	_	
218-4	37011-37022	cannabinoid	_	
218-5	37023-37032	receptors	_	
218-6	37032-37033	.	_	

#Text=Specificity and stability in topology of protein networks.
219-1	37034-37045	Specificity	_	
219-2	37046-37049	and	_	
219-3	37050-37059	stability	_	
219-4	37060-37062	in	_	
219-5	37063-37071	topology	_	
219-6	37072-37074	of	_	
219-7	37075-37082	protein	_	
219-8	37083-37091	networks	_	
219-9	37091-37092	.	_	

#Text=Prominence and control: the weighted rich-club effect.
220-1	37093-37103	Prominence	_	
220-2	37104-37107	and	_	
220-3	37108-37115	control	_	
220-4	37115-37116	:	_	
220-5	37117-37120	the	_	
220-6	37121-37129	weighted	_	
220-7	37130-37139	rich-club	_	
220-8	37140-37146	effect	_	
220-9	37146-37147	.	_	

#Text=Shared Predisposition in the Association Between Cannabis Use and Subcortical Brain Structure.
221-1	37148-37154	Shared	_	
221-2	37155-37169	Predisposition	_	
221-3	37170-37172	in	_	
221-4	37173-37176	the	_	
221-5	37177-37188	Association	_	
221-6	37189-37196	Between	_	
221-7	37197-37205	Cannabis	_	
221-8	37206-37209	Use	_	
221-9	37210-37213	and	_	
221-10	37214-37225	Subcortical	_	
221-11	37226-37231	Brain	_	
221-12	37232-37241	Structure	_	
221-13	37241-37242	.	_	

#Text=Challenges of marijuana research.
222-1	37243-37253	Challenges	_	
222-2	37254-37256	of	_	
222-3	37257-37266	marijuana	_	
222-4	37267-37275	research	_	
222-5	37275-37276	.	_	

#Text=Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion.
223-1	37277-37285	Spurious	_	
223-2	37286-37289	but	_	
223-3	37290-37300	systematic	_	
223-4	37301-37313	correlations	_	
223-5	37314-37316	in	_	
223-6	37317-37327	functional	_	
223-7	37328-37340	connectivity	_	
223-8	37341-37344	MRI	_	
223-9	37345-37353	networks	_	
223-10	37354-37359	arise	_	
223-11	37360-37364	from	_	
223-12	37365-37372	subject	_	
223-13	37373-37379	motion	_	
223-14	37379-37380	.	_	

#Text=Functional connectivity alterations in brain networks relevant to self-awareness in chronic cannabis users.
224-1	37381-37391	Functional	_	
224-2	37392-37404	connectivity	_	
224-3	37405-37416	alterations	_	
224-4	37417-37419	in	_	
224-5	37420-37425	brain	_	
224-6	37426-37434	networks	_	
224-7	37435-37443	relevant	_	
224-8	37444-37446	to	_	
224-9	37447-37461	self-awareness	_	
224-10	37462-37464	in	_	
224-11	37465-37472	chronic	_	
224-12	37473-37481	cannabis	_	
224-13	37482-37487	users	_	
224-14	37487-37488	.	_	

#Text=Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex.
225-1	37489-37499	Adolescent	_	
225-2	37500-37508	exposure	_	
225-3	37509-37511	to	_	
225-4	37512-37515	THC	_	
225-5	37516-37518	in	_	
225-6	37519-37525	female	_	
225-7	37526-37530	rats	_	
225-8	37531-37539	disrupts	_	
225-9	37540-37553	developmental	_	
225-10	37554-37561	changes	_	
225-11	37562-37564	in	_	
225-12	37565-37568	the	_	
225-13	37569-37579	prefrontal	_	
225-14	37580-37586	cortex	_	
225-15	37586-37587	.	_	

#Text=Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood.
226-1	37588-37595	Changes	_	
226-2	37596-37598	in	_	
226-3	37599-37610	hippocampal	_	
226-4	37611-37621	morphology	_	
226-5	37622-37625	and	_	
226-6	37626-37641	neuroplasticity	_	
226-7	37642-37649	induced	_	
226-8	37650-37652	by	_	
226-9	37653-37663	adolescent	_	
226-10	37664-37667	THC	_	
226-11	37668-37677	treatment	_	
226-12	37678-37681	are	_	
226-13	37682-37692	associated	_	
226-14	37693-37697	with	_	
226-15	37698-37707	cognitive	_	
226-16	37708-37718	impairment	_	
226-17	37719-37721	in	_	
226-18	37722-37731	adulthood	_	
226-19	37731-37732	.	_	

#Text=Complex network measures of brain connectivity: uses and interpretations.
227-1	37733-37740	Complex	_	
227-2	37741-37748	network	_	
227-3	37749-37757	measures	_	
227-4	37758-37760	of	_	
227-5	37761-37766	brain	_	
227-6	37767-37779	connectivity	_	
227-7	37779-37780	:	_	
227-8	37781-37785	uses	_	
227-9	37786-37789	and	_	
227-10	37790-37805	interpretations	_	
227-11	37805-37806	.	_	

#Text=Trouble at rest: how correlation patterns and group differences become distorted after global signal regression.
228-1	37807-37814	Trouble	_	
228-2	37815-37817	at	_	
228-3	37818-37822	rest	_	
228-4	37822-37823	:	_	
228-5	37824-37827	how	_	
228-6	37828-37839	correlation	_	
228-7	37840-37848	patterns	_	
228-8	37849-37852	and	_	
228-9	37853-37858	group	_	
228-10	37859-37870	differences	_	
228-11	37871-37877	become	_	
228-12	37878-37887	distorted	_	
228-13	37888-37893	after	_	
228-14	37894-37900	global	_	
228-15	37901-37907	signal	_	
228-16	37908-37918	regression	_	
228-17	37918-37919	.	_	

#Text=Neurophysiological architecture of functional magnetic resonance images of human brain.
229-1	37920-37938	Neurophysiological	_	
229-2	37939-37951	architecture	_	
229-3	37952-37954	of	_	
229-4	37955-37965	functional	_	
229-5	37966-37974	magnetic	_	
229-6	37975-37984	resonance	_	
229-7	37985-37991	images	_	
229-8	37992-37994	of	_	
229-9	37995-38000	human	_	
229-10	38001-38006	brain	_	
229-11	38006-38007	.	_	

#Text=Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks.
230-1	38008-38019	Genome-wide	_	
230-2	38020-38031	Association	_	
230-3	38032-38037	Study	_	
230-4	38038-38040	of	_	
230-5	38041-38049	Cannabis	_	
230-6	38050-38060	Dependence	_	
230-7	38061-38069	Severity	_	
230-8	38069-38070	,	_	
230-9	38071-38076	Novel	_	
230-10	38077-38081	Risk	_	
230-11	38082-38090	Variants	_	
230-12	38090-38091	,	_	
230-13	38092-38095	and	_	
230-14	38096-38102	Shared	_	
230-15	38103-38110	Genetic	_	
230-16	38111-38116	Risks	_	
230-17	38116-38117	.	_	

#Text=Brain connectivity is not only lower but different in schizophrenia: a combined anatomical and functional approach.
231-1	38118-38123	Brain	_	
231-2	38124-38136	connectivity	_	
231-3	38137-38139	is	_	
231-4	38140-38143	not	_	
231-5	38144-38148	only	_	
231-6	38149-38154	lower	_	
231-7	38155-38158	but	_	
231-8	38159-38168	different	_	
231-9	38169-38171	in	_	
231-10	38172-38185	schizophrenia	_	
231-11	38185-38186	:	_	
231-12	38187-38188	a	_	
231-13	38189-38197	combined	_	
231-14	38198-38208	anatomical	_	
231-15	38209-38212	and	_	
231-16	38213-38223	functional	_	
231-17	38224-38232	approach	_	
231-18	38232-38233	.	_	

#Text=Functional connectomics from resting-state fMRI.
232-1	38234-38244	Functional	_	
232-2	38245-38257	connectomics	_	
232-3	38258-38262	from	_	
232-4	38263-38276	resting-state	_	
232-5	38277-38281	fMRI	_	
232-6	38281-38282	.	_	

#Text=The human connectome: A structural description of the human brain.
233-1	38284-38287	The	_	
233-2	38288-38293	human	_	
233-3	38294-38304	connectome	_	
233-4	38304-38305	:	_	
233-5	38306-38307	A	_	
233-6	38308-38318	structural	_	
233-7	38319-38330	description	_	
233-8	38331-38333	of	_	
233-9	38334-38337	the	_	
233-10	38338-38343	human	_	
233-11	38344-38349	brain	_	
233-12	38349-38350	.	_	

#Text=Development of functional and structural connectivity within the default mode network in young children.
234-1	38351-38362	Development	_	
234-2	38363-38365	of	_	
234-3	38366-38376	functional	_	
234-4	38377-38380	and	_	
234-5	38381-38391	structural	_	
234-6	38392-38404	connectivity	_	
234-7	38405-38411	within	_	
234-8	38412-38415	the	_	
234-9	38416-38423	default	_	
234-10	38424-38428	mode	_	
234-11	38429-38436	network	_	
234-12	38437-38439	in	_	
234-13	38440-38445	young	_	
234-14	38446-38454	children	_	
234-15	38454-38455	.	_	

#Text=Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures--a short review.
235-1	38456-38467	Cannabinoid	_	
235-2	38468-38477	receptors	_	
235-3	38478-38479	1	_	
235-4	38480-38483	and	_	
235-5	38484-38485	2	_	
235-6	38486-38487	(	_	
235-7	38487-38490	CB1	_	
235-8	38491-38494	and	_	
235-9	38495-38498	CB2	_	
235-10	38498-38499	)	_	
235-11	38499-38500	,	_	
235-12	38501-38506	their	_	
235-13	38507-38519	distribution	_	
235-14	38519-38520	,	_	
235-15	38521-38528	ligands	_	
235-16	38529-38532	and	_	
235-17	38533-38543	functional	_	
235-18	38544-38555	involvement	_	
235-19	38556-38558	in	_	
235-20	38559-38566	nervous	_	
235-21	38567-38573	system	_	
235-22	38574-38584	structures	_	
235-23	38584-38585	-	_	
235-24	38585-38586	-	_	
235-25	38586-38587	a	_	
235-26	38588-38593	short	_	
235-27	38594-38600	review	_	
235-28	38600-38601	.	_	

#Text=Geometric analysis of the b-dependent effects of Rician signal noise on diffusion tensor imaging estimates and determining an optimal b value.
236-1	38602-38611	Geometric	_	
236-2	38612-38620	analysis	_	
236-3	38621-38623	of	_	
236-4	38624-38627	the	_	
236-5	38628-38639	b-dependent	_	
236-6	38640-38647	effects	_	
236-7	38648-38650	of	_	
236-8	38651-38657	Rician	_	
236-9	38658-38664	signal	_	
236-10	38665-38670	noise	_	
236-11	38671-38673	on	_	
236-12	38674-38683	diffusion	_	
236-13	38684-38690	tensor	_	
236-14	38691-38698	imaging	_	
236-15	38699-38708	estimates	_	
236-16	38709-38712	and	_	
236-17	38713-38724	determining	_	
236-18	38725-38727	an	_	
236-19	38728-38735	optimal	_	
236-20	38736-38737	b	_	
236-21	38738-38743	value	_	
236-22	38743-38744	.	_	

#Text=FATCAT: (an efficient) Functional and Tractographic Connectivity Analysis Toolbox.
237-1	38745-38751	FATCAT	_	
237-2	38751-38752	:	_	
237-3	38753-38754	(	_	
237-4	38754-38756	an	_	
237-5	38757-38766	efficient	_	
237-6	38766-38767	)	_	
237-7	38768-38778	Functional	_	
237-8	38779-38782	and	_	
237-9	38783-38796	Tractographic	_	
237-10	38797-38809	Connectivity	_	
237-11	38810-38818	Analysis	_	
237-12	38819-38826	Toolbox	_	
237-13	38826-38827	.	_	

#Text=Rich-club organization of the human connectome.
238-1	38828-38837	Rich-club	_	
238-2	38838-38850	organization	_	
238-3	38851-38853	of	_	
238-4	38854-38857	the	_	
238-5	38858-38863	human	_	
238-6	38864-38874	connectome	_	
238-7	38874-38875	.	_	

#Text=Abnormal rich club organization and functional brain dynamics in schizophrenia.
239-1	38876-38884	Abnormal	_	
239-2	38885-38889	rich	_	
239-3	38890-38894	club	_	
239-4	38895-38907	organization	_	
239-5	38908-38911	and	_	
239-6	38912-38922	functional	_	
239-7	38923-38928	brain	_	
239-8	38929-38937	dynamics	_	
239-9	38938-38940	in	_	
239-10	38941-38954	schizophrenia	_	
239-11	38954-38955	.	_	

#Text=The conception of the ABCD study: From substance use to a broad NIH collaboration.
240-1	38956-38959	The	_	
240-2	38960-38970	conception	_	
240-3	38971-38973	of	_	
240-4	38974-38977	the	_	
240-5	38978-38982	ABCD	_	
240-6	38983-38988	study	_	
240-7	38988-38989	:	_	
240-8	38990-38994	From	_	
240-9	38995-39004	substance	_	
240-10	39005-39008	use	_	
240-11	39009-39011	to	_	
240-12	39012-39013	a	_	
240-13	39014-39019	broad	_	
240-14	39020-39023	NIH	_	
240-15	39024-39037	collaboration	_	
240-16	39037-39038	.	_	

#Text=Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review.
241-1	39039-39046	Effects	_	
241-2	39047-39049	of	_	
241-3	39050-39058	Cannabis	_	
241-4	39059-39062	Use	_	
241-5	39063-39065	on	_	
241-6	39066-39071	Human	_	
241-7	39072-39080	Behavior	_	
241-8	39080-39081	,	_	
241-9	39082-39091	Including	_	
241-10	39092-39101	Cognition	_	
241-11	39101-39102	,	_	
241-12	39103-39113	Motivation	_	
241-13	39113-39114	,	_	
241-14	39115-39118	and	_	
241-15	39119-39128	Psychosis	_	
241-16	39128-39129	:	_	
241-17	39130-39131	A	_	
241-18	39132-39138	Review	_	
241-19	39138-39139	.	_	

#Text=Brain Imaging Studies on the Cognitive, Pharmacological and Neurobiological Effects of Cannabis in Humans: Evidence from Studies of Adult Users.
242-1	39140-39145	Brain	_	
242-2	39146-39153	Imaging	_	
242-3	39154-39161	Studies	_	
242-4	39162-39164	on	_	
242-5	39165-39168	the	_	
242-6	39169-39178	Cognitive	_	
242-7	39178-39179	,	_	
242-8	39180-39195	Pharmacological	_	
242-9	39196-39199	and	_	
242-10	39200-39215	Neurobiological	_	
242-11	39216-39223	Effects	_	
242-12	39224-39226	of	_	
242-13	39227-39235	Cannabis	_	
242-14	39236-39238	in	_	
242-15	39239-39245	Humans	_	
242-16	39245-39246	:	_	
242-17	39247-39255	Evidence	_	
242-18	39256-39260	from	_	
242-19	39261-39268	Studies	_	
242-20	39269-39271	of	_	
242-21	39272-39277	Adult	_	
242-22	39278-39283	Users	_	
242-23	39283-39284	.	_	

#Text=Effect of long-term cannabis use on axonal fibre connectivity.
243-1	39285-39291	Effect	_	
243-2	39292-39294	of	_	
243-3	39295-39304	long-term	_	
243-4	39305-39313	cannabis	_	
243-5	39314-39317	use	_	
243-6	39318-39320	on	_	
243-7	39321-39327	axonal	_	
243-8	39328-39333	fibre	_	
243-9	39334-39346	connectivity	_	
243-10	39346-39347	.	_	

#Text=Altered functional-structural coupling of large-scale brain networks in idiopathic generalized epilepsy.
244-1	39348-39355	Altered	_	
244-2	39356-39377	functional-structural	_	
244-3	39378-39386	coupling	_	
244-4	39387-39389	of	_	
244-5	39390-39401	large-scale	_	
244-6	39402-39407	brain	_	
244-7	39408-39416	networks	_	
244-8	39417-39419	in	_	
244-9	39420-39430	idiopathic	_	
244-10	39431-39442	generalized	_	
244-11	39443-39451	epilepsy	_	
244-12	39451-39452	.	_	

#Text=Altered orbitofrontal activity and dorsal striatal connectivity during emotion processing in dependent marijuana users after 28 days of abstinence.
245-1	39453-39460	Altered	_	
245-2	39461-39474	orbitofrontal	_	
245-3	39475-39483	activity	_	
245-4	39484-39487	and	_	
245-5	39488-39494	dorsal	_	
245-6	39495-39503	striatal	_	
245-7	39504-39516	connectivity	_	
245-8	39517-39523	during	_	
245-9	39524-39531	emotion	_	
245-10	39532-39542	processing	_	
245-11	39543-39545	in	_	
245-12	39546-39555	dependent	_	
245-13	39556-39565	marijuana	_	
245-14	39566-39571	users	_	
245-15	39572-39577	after	_	
245-16	39578-39580	28	_	
245-17	39581-39585	days	_	
245-18	39586-39588	of	_	
245-19	39589-39599	abstinence	_	
245-20	39599-39600	.	_	

#Text=Overall structural-functional (SC-FC) association.
246-1	39601-39608	Overall	_	
246-2	39609-39630	structural-functional	_	
246-3	39631-39632	(	_	
246-4	39632-39637	SC-FC	_	
246-5	39637-39638	)	_	
246-6	39639-39650	association	_	
246-7	39650-39651	.	_	

#Text=(A) Higher SC predicted higher FC (i.e., positive SC-FC coupling with r = 0.34).
247-1	39652-39653	(	_	
247-2	39653-39654	A	_	
247-3	39654-39655	)	_	
247-4	39656-39662	Higher	_	
247-5	39663-39665	SC	_	
247-6	39666-39675	predicted	_	
247-7	39676-39682	higher	_	
247-8	39683-39685	FC	_	
247-9	39686-39687	(	_	
247-10	39687-39690	i.e	_	
247-11	39690-39691	.	_	
247-12	39691-39692	,	_	
247-13	39693-39701	positive	_	
247-14	39702-39707	SC-FC	_	
247-15	39708-39716	coupling	_	
247-16	39717-39721	with	_	
247-17	39722-39723	r	_	
247-18	39724-39725	=	_	
247-19	39726-39730	0.34	_	
247-20	39730-39731	)	_	
247-21	39731-39732	.	_	

#Text=Histograms of SC and FC were additionally plotted in the top and right side of scatter plot.
248-1	39733-39743	Histograms	_	
248-2	39744-39746	of	_	
248-3	39747-39749	SC	_	
248-4	39750-39753	and	_	
248-5	39754-39756	FC	_	
248-6	39757-39761	were	_	
248-7	39762-39774	additionally	_	
248-8	39775-39782	plotted	_	
248-9	39783-39785	in	_	
248-10	39786-39789	the	_	
248-11	39790-39793	top	_	
248-12	39794-39797	and	_	
248-13	39798-39803	right	_	
248-14	39804-39808	side	_	
248-15	39809-39811	of	_	
248-16	39812-39819	scatter	_	
248-17	39820-39824	plot	_	
248-18	39824-39825	.	_	

#Text=(B) SC-FC coupling, C, did not differ between the cannabis (CB) users and healthy non-user controls (HC) (p = 0.34).
249-1	39826-39827	(	_	
249-2	39827-39828	B	_	
249-3	39828-39829	)	_	
249-4	39830-39835	SC-FC	_	
249-5	39836-39844	coupling	_	
249-6	39844-39845	,	_	
249-7	39846-39847	C	_	
249-8	39847-39848	,	_	
249-9	39849-39852	did	_	
249-10	39853-39856	not	_	
249-11	39857-39863	differ	_	
249-12	39864-39871	between	_	
249-13	39872-39875	the	_	
249-14	39876-39884	cannabis	_	
249-15	39885-39886	(	_	
249-16	39886-39888	CB	_	
249-17	39888-39889	)	_	
249-18	39890-39895	users	_	
249-19	39896-39899	and	_	
249-20	39900-39907	healthy	_	
249-21	39908-39916	non-user	_	
249-22	39917-39925	controls	_	
249-23	39926-39927	(	_	
249-24	39927-39929	HC	_	
249-25	39929-39930	)	_	
249-26	39931-39932	(	_	
249-27	39932-39933	p	_	
249-28	39934-39935	=	_	
249-29	39936-39940	0.34	_	
249-30	39940-39941	)	_	
249-31	39941-39942	.	_	

#Text=(C) SC-FC coupling was associated with the global network efficiency (GE: r = 0.44, p = 0.02) and network path length (λ: r = −0.38, p = 0.04) in non-users, but not in the CB users (p > 0.05).
250-1	39943-39944	(	_	
250-2	39944-39945	C	_	
250-3	39945-39946	)	_	
250-4	39947-39952	SC-FC	_	
250-5	39953-39961	coupling	_	
250-6	39962-39965	was	_	
250-7	39966-39976	associated	_	
250-8	39977-39981	with	_	
250-9	39982-39985	the	_	
250-10	39986-39992	global	_	
250-11	39993-40000	network	_	
250-12	40001-40011	efficiency	_	
250-13	40012-40013	(	_	
250-14	40013-40015	GE	_	
250-15	40015-40016	:	_	
250-16	40017-40018	r	_	
250-17	40019-40020	=	_	
250-18	40021-40025	0.44	_	
250-19	40025-40026	,	_	
250-20	40027-40028	p	_	
250-21	40029-40030	=	_	
250-22	40031-40035	0.02	_	
250-23	40035-40036	)	_	
250-24	40037-40040	and	_	
250-25	40041-40048	network	_	
250-26	40049-40053	path	_	
250-27	40054-40060	length	_	
250-28	40061-40062	(	_	
250-29	40062-40063	λ	_	
250-30	40063-40064	:	_	
250-31	40065-40066	r	_	
250-32	40067-40068	=	_	
250-33	40069-40070	−	_	
250-34	40070-40074	0.38	_	
250-35	40074-40075	,	_	
250-36	40076-40077	p	_	
250-37	40078-40079	=	_	
250-38	40080-40084	0.04	_	
250-39	40084-40085	)	_	
250-40	40086-40088	in	_	
250-41	40089-40098	non-users	_	
250-42	40098-40099	,	_	
250-43	40100-40103	but	_	
250-44	40104-40107	not	_	
250-45	40108-40110	in	_	
250-46	40111-40114	the	_	
250-47	40115-40117	CB	_	
250-48	40118-40123	users	_	
250-49	40124-40125	(	_	
250-50	40125-40126	p	_	
250-51	40127-40128	>	_	
250-52	40129-40133	0.05	_	
250-53	40133-40134	)	_	
250-54	40134-40135	.	_	

#Text=Distance dependence of SC-FC coupling.
251-1	40136-40144	Distance	_	
251-2	40145-40155	dependence	_	
251-3	40156-40158	of	_	
251-4	40159-40164	SC-FC	_	
251-5	40165-40173	coupling	_	
251-6	40173-40174	.	_	

#Text=Scatter plots of: (A) SC against log-transformed distance between brain regions (r = −0.49); and (B) FC against the inverse of distance (r = 0.59).
252-1	40175-40182	Scatter	_	
252-2	40183-40188	plots	_	
252-3	40189-40191	of	_	
252-4	40191-40192	:	_	
252-5	40193-40194	(	_	
252-6	40194-40195	A	_	
252-7	40195-40196	)	_	
252-8	40197-40199	SC	_	
252-9	40200-40207	against	_	
252-10	40208-40223	log-transformed	_	
252-11	40224-40232	distance	_	
252-12	40233-40240	between	_	
252-13	40241-40246	brain	_	
252-14	40247-40254	regions	_	
252-15	40255-40256	(	_	
252-16	40256-40257	r	_	
252-17	40258-40259	=	_	
252-18	40260-40261	−	_	
252-19	40261-40265	0.49	_	
252-20	40265-40266	)	_	
252-21	40266-40267	;	_	
252-22	40268-40271	and	_	
252-23	40272-40273	(	_	
252-24	40273-40274	B	_	
252-25	40274-40275	)	_	
252-26	40276-40278	FC	_	
252-27	40279-40286	against	_	
252-28	40287-40290	the	_	
252-29	40291-40298	inverse	_	
252-30	40299-40301	of	_	
252-31	40302-40310	distance	_	
252-32	40311-40312	(	_	
252-33	40312-40313	r	_	
252-34	40314-40315	=	_	
252-35	40316-40320	0.59	_	
252-36	40320-40321	)	_	
252-37	40321-40322	.	_	

#Text=(C) Histogram of connection distances.
253-1	40323-40324	(	_	
253-2	40324-40325	C	_	
253-3	40325-40326	)	_	
253-4	40327-40336	Histogram	_	
253-5	40337-40339	of	_	
253-6	40340-40350	connection	_	
253-7	40351-40360	distances	_	
253-8	40360-40361	.	_	

#Text=(D) Shorter connections (e.g., the 1st-quartile [=Q1], lower 25%) of healthy non-user controls (HC, blue colors) had dominant associations between SC-FC coupling and network measures.
254-1	40362-40363	(	_	
254-2	40363-40364	D	_	
254-3	40364-40365	)	_	
254-4	40366-40373	Shorter	_	
254-5	40374-40385	connections	_	
254-6	40386-40387	(	_	
254-7	40387-40390	e.g	_	
254-8	40390-40391	.	_	
254-9	40391-40392	,	_	
254-10	40393-40396	the	_	
254-11	40397-40409	1st-quartile	_	
254-12	40410-40411	[	_	
254-13	40411-40412	=	_	
254-14	40412-40414	Q1	_	
254-15	40414-40415	]	_	
254-16	40415-40416	,	_	
254-17	40417-40422	lower	_	
254-18	40423-40426	25%	_	
254-19	40426-40427	)	_	
254-20	40428-40430	of	_	
254-21	40431-40438	healthy	_	
254-22	40439-40447	non-user	_	
254-23	40448-40456	controls	_	
254-24	40457-40458	(	_	
254-25	40458-40460	HC	_	
254-26	40460-40461	,	_	
254-27	40462-40466	blue	_	
254-28	40467-40473	colors	_	
254-29	40473-40474	)	_	
254-30	40475-40478	had	_	
254-31	40479-40487	dominant	_	
254-32	40488-40500	associations	_	
254-33	40501-40508	between	_	
254-34	40509-40514	SC-FC	_	
254-35	40515-40523	coupling	_	
254-36	40524-40527	and	_	
254-37	40528-40535	network	_	
254-38	40536-40544	measures	_	
254-39	40544-40545	.	_	

#Text=(E-F) Scatter plot of SC-FC coupling and global network efficiency (GE) and network path length (λ) at Q1 of healthy non-users.
255-1	40546-40547	(	_	
255-2	40547-40550	E-F	_	
255-3	40550-40551	)	_	
255-4	40552-40559	Scatter	_	
255-5	40560-40564	plot	_	
255-6	40565-40567	of	_	
255-7	40568-40573	SC-FC	_	
255-8	40574-40582	coupling	_	
255-9	40583-40586	and	_	
255-10	40587-40593	global	_	
255-11	40594-40601	network	_	
255-12	40602-40612	efficiency	_	
255-13	40613-40614	(	_	
255-14	40614-40616	GE	_	
255-15	40616-40617	)	_	
255-16	40618-40621	and	_	
255-17	40622-40629	network	_	
255-18	40630-40634	path	_	
255-19	40635-40641	length	_	
255-20	40642-40643	(	_	
255-21	40643-40644	λ	_	
255-22	40644-40645	)	_	
255-23	40646-40648	at	_	
255-24	40649-40651	Q1	_	
255-25	40652-40654	of	_	
255-26	40655-40662	healthy	_	
255-27	40663-40672	non-users	_	
255-28	40672-40673	.	_	

#Text=Rich-club (RC) analysis.
256-1	40674-40683	Rich-club	_	
256-2	40684-40685	(	_	
256-3	40685-40687	RC	_	
256-4	40687-40688	)	_	
256-5	40689-40697	analysis	_	
256-6	40697-40698	.	_	

#Text=(A) Mean degree distribution normalized by the number of total nodes (=1,014) with shaded regions for the standard deviation.
257-1	40699-40700	(	_	
257-2	40700-40701	A	_	
257-3	40701-40702	)	_	
257-4	40703-40707	Mean	_	
257-5	40708-40714	degree	_	
257-6	40715-40727	distribution	_	
257-7	40728-40738	normalized	_	
257-8	40739-40741	by	_	
257-9	40742-40745	the	_	
257-10	40746-40752	number	_	
257-11	40753-40755	of	_	
257-12	40756-40761	total	_	
257-13	40762-40767	nodes	_	
257-14	40768-40769	(	_	
257-15	40769-40770	=	_	
257-16	40770-40775	1,014	_	
257-17	40775-40776	)	_	
257-18	40777-40781	with	_	
257-19	40782-40788	shaded	_	
257-20	40789-40796	regions	_	
257-21	40797-40800	for	_	
257-22	40801-40804	the	_	
257-23	40805-40813	standard	_	
257-24	40814-40823	deviation	_	
257-25	40823-40824	.	_	

#Text=Top 10% of high degree nodes were defined as RC members.
258-1	40825-40828	Top	_	
258-2	40829-40832	10%	_	
258-3	40833-40835	of	_	
258-4	40836-40840	high	_	
258-5	40841-40847	degree	_	
258-6	40848-40853	nodes	_	
258-7	40854-40858	were	_	
258-8	40859-40866	defined	_	
258-9	40867-40869	as	_	
258-10	40870-40872	RC	_	
258-11	40873-40880	members	_	
258-12	40880-40881	.	_	

#Text=(B) Mean RC curve for the cannabis users (CB) and healthy non-user controls (HC).
259-1	40882-40883	(	_	
259-2	40883-40884	B	_	
259-3	40884-40885	)	_	
259-4	40886-40890	Mean	_	
259-5	40891-40893	RC	_	
259-6	40894-40899	curve	_	
259-7	40900-40903	for	_	
259-8	40904-40907	the	_	
259-9	40908-40916	cannabis	_	
259-10	40917-40922	users	_	
259-11	40923-40924	(	_	
259-12	40924-40926	CB	_	
259-13	40926-40927	)	_	
259-14	40928-40931	and	_	
259-15	40932-40939	healthy	_	
259-16	40940-40948	non-user	_	
259-17	40949-40957	controls	_	
259-18	40958-40959	(	_	
259-19	40959-40961	HC	_	
259-20	40961-40962	)	_	
259-21	40962-40963	.	_	

#Text=Users had a significantly decreased RC organization for the range 70 to 82 of normalized node degree (p < 0.05 after 10,000-times permutation tests).
260-1	40964-40969	Users	_	
260-2	40970-40973	had	_	
260-3	40974-40975	a	_	
260-4	40976-40989	significantly	_	
260-5	40990-40999	decreased	_	
260-6	41000-41002	RC	_	
260-7	41003-41015	organization	_	
260-8	41016-41019	for	_	
260-9	41020-41023	the	_	
260-10	41024-41029	range	_	
260-11	41030-41032	70	_	
260-12	41033-41035	to	_	
260-13	41036-41038	82	_	
260-14	41039-41041	of	_	
260-15	41042-41052	normalized	_	
260-16	41053-41057	node	_	
260-17	41058-41064	degree	_	
260-18	41065-41066	(	_	
260-19	41066-41067	p	_	
260-20	41068-41069	<	_	
260-21	41070-41074	0.05	_	
260-22	41075-41080	after	_	
260-23	41081-41087	10,000	_	
260-24	41087-41088	-	_	
260-25	41088-41093	times	_	
260-26	41094-41105	permutation	_	
260-27	41106-41111	tests	_	
260-28	41111-41112	)	_	
260-29	41112-41113	.	_	

#Text=(C) RC probability at each node across the whole subjects.
261-1	41114-41115	(	_	
261-2	41115-41116	C	_	
261-3	41116-41117	)	_	
261-4	41118-41120	RC	_	
261-5	41121-41132	probability	_	
261-6	41133-41135	at	_	
261-7	41136-41140	each	_	
261-8	41141-41145	node	_	
261-9	41146-41152	across	_	
261-10	41153-41156	the	_	
261-11	41157-41162	whole	_	
261-12	41163-41171	subjects	_	
261-13	41171-41172	.	_	

#Text=Higher probability of RC members included the precuneus, posterior cingulate, superior frontal and superior parietal cortex, as well as the subcortical regions including hippocampus, putamen, caudate, thalamus, pallidum, and putamen.
262-1	41173-41179	Higher	_	
262-2	41180-41191	probability	_	
262-3	41192-41194	of	_	
262-4	41195-41197	RC	_	
262-5	41198-41205	members	_	
262-6	41206-41214	included	_	
262-7	41215-41218	the	_	
262-8	41219-41228	precuneus	_	
262-9	41228-41229	,	_	
262-10	41230-41239	posterior	_	
262-11	41240-41249	cingulate	_	
262-12	41249-41250	,	_	
262-13	41251-41259	superior	_	
262-14	41260-41267	frontal	_	
262-15	41268-41271	and	_	
262-16	41272-41280	superior	_	
262-17	41281-41289	parietal	_	
262-18	41290-41296	cortex	_	
262-19	41296-41297	,	_	
262-20	41298-41300	as	_	
262-21	41301-41305	well	_	
262-22	41306-41308	as	_	
262-23	41309-41312	the	_	
262-24	41313-41324	subcortical	_	
262-25	41325-41332	regions	_	
262-26	41333-41342	including	_	
262-27	41343-41354	hippocampus	_	
262-28	41354-41355	,	_	
262-29	41356-41363	putamen	_	
262-30	41363-41364	,	_	
262-31	41365-41372	caudate	_	
262-32	41372-41373	,	_	
262-33	41374-41382	thalamus	_	
262-34	41382-41383	,	_	
262-35	41384-41392	pallidum	_	
262-36	41392-41393	,	_	
262-37	41394-41397	and	_	
262-38	41398-41405	putamen	_	
262-39	41405-41406	.	_	

#Text=Represented colors followed the convention of Freesurfer parcellation (Right).
263-1	41407-41418	Represented	_	
263-2	41419-41425	colors	_	
263-3	41426-41434	followed	_	
263-4	41435-41438	the	_	
263-5	41439-41449	convention	_	
263-6	41450-41452	of	_	
263-7	41453-41463	Freesurfer	_	
263-8	41464-41476	parcellation	_	
263-9	41477-41478	(	_	
263-10	41478-41483	Right	_	
263-11	41483-41484	)	_	
263-12	41484-41485	.	_	

#Text=(D) RC probability over the normalized node degree at subcortical regions.
264-1	41486-41487	(	_	
264-2	41487-41488	D	_	
264-3	41488-41489	)	_	
264-4	41490-41492	RC	_	
264-5	41493-41504	probability	_	
264-6	41505-41509	over	_	
264-7	41510-41513	the	_	
264-8	41514-41524	normalized	_	
264-9	41525-41529	node	_	
264-10	41530-41536	degree	_	
264-11	41537-41539	at	_	
264-12	41540-41551	subcortical	_	
264-13	41552-41559	regions	_	
264-14	41559-41560	.	_	

#Text=Reduced RC coefficient in (B) was found only for histograms of the hippocampus, caudate, and pallidum.
265-1	41561-41568	Reduced	_	
265-2	41569-41571	RC	_	
265-3	41572-41583	coefficient	_	
265-4	41584-41586	in	_	
265-5	41587-41588	(	_	
265-6	41588-41589	B	_	
265-7	41589-41590	)	_	
265-8	41591-41594	was	_	
265-9	41595-41600	found	_	
265-10	41601-41605	only	_	
265-11	41606-41609	for	_	
265-12	41610-41620	histograms	_	
265-13	41621-41623	of	_	
265-14	41624-41627	the	_	
265-15	41628-41639	hippocampus	_	
265-16	41639-41640	,	_	
265-17	41641-41648	caudate	_	
265-18	41648-41649	,	_	
265-19	41650-41653	and	_	
265-20	41654-41662	pallidum	_	
265-21	41662-41663	.	_	

#Text=(E-F) CB users had an increased SC-FC coupling in the hippocampus and a reduced coupling in the caudate.
266-1	41664-41665	(	_	
266-2	41665-41668	E-F	_	
266-3	41668-41669	)	_	
266-4	41670-41672	CB	_	
266-5	41673-41678	users	_	
266-6	41679-41682	had	_	
266-7	41683-41685	an	_	
266-8	41686-41695	increased	_	
266-9	41696-41701	SC-FC	_	
266-10	41702-41710	coupling	_	
266-11	41711-41713	in	_	
266-12	41714-41717	the	_	
266-13	41718-41729	hippocampus	_	
266-14	41730-41733	and	_	
266-15	41734-41735	a	_	
266-16	41736-41743	reduced	_	
266-17	41744-41752	coupling	_	
266-18	41753-41755	in	_	
266-19	41756-41759	the	_	
266-20	41760-41767	caudate	_	
266-21	41767-41768	.	_	

#Text=RH = right hemisphere; LH = left hemisphere.
267-1	41769-41771	RH	_	
267-2	41772-41773	=	_	
267-3	41774-41779	right	_	
267-4	41780-41790	hemisphere	_	
267-5	41790-41791	;	_	
267-6	41792-41794	LH	_	
267-7	41795-41796	=	_	
267-8	41797-41801	left	_	
267-9	41802-41812	hemisphere	_	
267-10	41812-41813	.	_	

#Text=Demographic information of the study sample
#Text=\tCannabis users(n=37)\tNon-users(n=31)\tStatistics(t or χ2)\tp-value\t \tAge (years)\t21.1 ± 3.8\t22.1 ± 3.5\t1.14\t0.26\t \tSex (male/female)\t17/20\t13/18\t0.11\t0.74\t \tRace (CC/AA/A/M/U)\t24/7/5/1/0\t18/4/6/2/1\t2.59\t0.63\t \tIntelligence (WASI)\t110.0 ± 9.8\t113.7 ± 10.4\t1.50\t0.14\t \tEducation (years)\t14.0 ± 1.93\t15.4 ± 2.10\t2.95\t0.004\t \tAlcoholic drinks/week (past month)\t3.06 ± 2.86\t2.23 ± 2.82\t1.20\t0.23\t \tCB Use\t\t\t\t\t \t    Recent use (#/month)\t32.6 ± 25.1\t0 ± 0\t7.22\t< 0.001\t \t    Lifetime use\t1184.7 ± 1830.2\t0.8 ± 2.4\t3.60\t< 0.001\t \t    Age of onset\t16.4 ± 2.3\t19.5 ± 2.0†\t–\t–\t \t
#Text=Note: AA, African American/Black; A, Asian; CC, Caucasian; M, multiple races; U, Unknown; WASI, Wechsler Abbreviated Scale of Intelligence.
268-1	41814-41825	Demographic	_	
268-2	41826-41837	information	_	
268-3	41838-41840	of	_	
268-4	41841-41844	the	_	
268-5	41845-41850	study	_	
268-6	41851-41857	sample	_	
268-7	41859-41867	Cannabis	_	
268-8	41868-41873	users	_	
268-9	41873-41874	(	_	
268-10	41874-41875	n	_	
268-11	41875-41876	=	_	
268-12	41876-41878	37	_	
268-13	41878-41879	)	_	
268-14	41880-41889	Non-users	_	
268-15	41889-41890	(	_	
268-16	41890-41891	n	_	
268-17	41891-41892	=	_	
268-18	41892-41894	31	_	
268-19	41894-41895	)	_	
268-20	41896-41906	Statistics	_	
268-21	41906-41907	(	_	
268-22	41907-41908	t	_	
268-23	41909-41911	or	_	
268-24	41912-41914	χ2	_	
268-25	41914-41915	)	_	
268-26	41916-41923	p-value	_	
268-27	41926-41929	Age	_	
268-28	41930-41931	(	_	
268-29	41931-41936	years	_	
268-30	41936-41937	)	_	
268-31	41938-41942	21.1	_	
268-32	41943-41944	±	_	
268-33	41945-41948	3.8	_	
268-34	41949-41953	22.1	_	
268-35	41954-41955	±	_	
268-36	41956-41959	3.5	_	
268-37	41960-41964	1.14	_	
268-38	41965-41969	0.26	_	
268-39	41972-41975	Sex	_	
268-40	41976-41977	(	_	
268-41	41977-41981	male	_	
268-42	41981-41982	/	_	
268-43	41982-41988	female	_	
268-44	41988-41989	)	_	
268-45	41990-41992	17	_	
268-46	41992-41993	/	_	
268-47	41993-41995	20	_	
268-48	41996-41998	13	_	
268-49	41998-41999	/	_	
268-50	41999-42001	18	_	
268-51	42002-42006	0.11	_	
268-52	42007-42011	0.74	_	
268-53	42014-42018	Race	_	
268-54	42019-42020	(	_	
268-55	42020-42022	CC	_	
268-56	42022-42023	/	_	
268-57	42023-42025	AA	_	
268-58	42025-42026	/	_	
268-59	42026-42027	A	_	
268-60	42027-42028	/	_	
268-61	42028-42029	M	_	
268-62	42029-42030	/	_	
268-63	42030-42031	U	_	
268-64	42031-42032	)	_	
268-65	42033-42035	24	_	
268-66	42035-42036	/	_	
268-67	42036-42037	7	_	
268-68	42037-42038	/	_	
268-69	42038-42039	5	_	
268-70	42039-42040	/	_	
268-71	42040-42041	1	_	
268-72	42041-42042	/	_	
268-73	42042-42043	0	_	
268-74	42044-42046	18	_	
268-75	42046-42047	/	_	
268-76	42047-42048	4	_	
268-77	42048-42049	/	_	
268-78	42049-42050	6	_	
268-79	42050-42051	/	_	
268-80	42051-42052	2	_	
268-81	42052-42053	/	_	
268-82	42053-42054	1	_	
268-83	42055-42059	2.59	_	
268-84	42060-42064	0.63	_	
268-85	42067-42079	Intelligence	_	
268-86	42080-42081	(	_	
268-87	42081-42085	WASI	_	
268-88	42085-42086	)	_	
268-89	42087-42092	110.0	_	
268-90	42093-42094	±	_	
268-91	42095-42098	9.8	_	
268-92	42099-42104	113.7	_	
268-93	42105-42106	±	_	
268-94	42107-42111	10.4	_	
268-95	42112-42116	1.50	_	
268-96	42117-42121	0.14	_	
268-97	42124-42133	Education	_	
268-98	42134-42135	(	_	
268-99	42135-42140	years	_	
268-100	42140-42141	)	_	
268-101	42142-42146	14.0	_	
268-102	42147-42148	±	_	
268-103	42149-42153	1.93	_	
268-104	42154-42158	15.4	_	
268-105	42159-42160	±	_	
268-106	42161-42165	2.10	_	
268-107	42166-42170	2.95	_	
268-108	42171-42176	0.004	_	
268-109	42179-42188	Alcoholic	_	
268-110	42189-42195	drinks	_	
268-111	42195-42196	/	_	
268-112	42196-42200	week	_	
268-113	42201-42202	(	_	
268-114	42202-42206	past	_	
268-115	42207-42212	month	_	
268-116	42212-42213	)	_	
268-117	42214-42218	3.06	_	
268-118	42219-42220	±	_	
268-119	42221-42225	2.86	_	
268-120	42226-42230	2.23	_	
268-121	42231-42232	±	_	
268-122	42233-42237	2.82	_	
268-123	42238-42242	1.20	_	
268-124	42243-42247	0.23	_	
268-125	42250-42252	CB	_	
268-126	42253-42256	Use	_	
268-127	42266-42267	 	_	
268-128	42267-42273	Recent	_	
268-129	42274-42277	use	_	
268-130	42278-42279	(	_	
268-131	42279-42280	#	_	
268-132	42280-42281	/	_	
268-133	42281-42286	month	_	
268-134	42286-42287	)	_	
268-135	42288-42292	32.6	_	
268-136	42293-42294	±	_	
268-137	42295-42299	25.1	_	
268-138	42300-42301	0	_	
268-139	42302-42303	±	_	
268-140	42304-42305	0	_	
268-141	42306-42310	7.22	_	
268-142	42311-42312	<	_	
268-143	42313-42318	0.001	_	
268-144	42324-42325	 	_	
268-145	42325-42333	Lifetime	_	
268-146	42334-42337	use	_	
268-147	42338-42344	1184.7	_	
268-148	42345-42346	±	_	
268-149	42347-42353	1830.2	_	
268-150	42354-42357	0.8	_	
268-151	42358-42359	±	_	
268-152	42360-42363	2.4	_	
268-153	42364-42368	3.60	_	
268-154	42369-42370	<	_	
268-155	42371-42376	0.001	_	
268-156	42382-42383	 	_	
268-157	42383-42386	Age	_	
268-158	42387-42389	of	_	
268-159	42390-42395	onset	_	
268-160	42396-42400	16.4	_	
268-161	42401-42402	±	_	
268-162	42403-42406	2.3	_	
268-163	42407-42411	19.5	_	
268-164	42412-42413	±	_	
268-165	42414-42417	2.0	_	
268-166	42417-42418	†	_	
268-167	42419-42420	–	_	
268-168	42421-42422	–	_	
268-169	42426-42430	Note	_	
268-170	42430-42431	:	_	
268-171	42432-42434	AA	_	
268-172	42434-42435	,	_	
268-173	42436-42443	African	_	
268-174	42444-42452	American	_	
268-175	42452-42453	/	_	
268-176	42453-42458	Black	_	
268-177	42458-42459	;	_	
268-178	42460-42461	A	_	
268-179	42461-42462	,	_	
268-180	42463-42468	Asian	_	
268-181	42468-42469	;	_	
268-182	42470-42472	CC	_	
268-183	42472-42473	,	_	
268-184	42474-42483	Caucasian	_	
268-185	42483-42484	;	_	
268-186	42485-42486	M	_	
268-187	42486-42487	,	_	
268-188	42488-42496	multiple	_	
268-189	42497-42502	races	_	
268-190	42502-42503	;	_	
268-191	42504-42505	U	_	
268-192	42505-42506	,	_	
268-193	42507-42514	Unknown	_	
268-194	42514-42515	;	_	
268-195	42516-42520	WASI	_	
268-196	42520-42521	,	_	
268-197	42522-42530	Wechsler	_	
268-198	42531-42542	Abbreviated	_	
268-199	42543-42548	Scale	_	
268-200	42549-42551	of	_	
268-201	42552-42564	Intelligence	_	
268-202	42564-42565	.	_	

#Text=Based on 6 out of 31 non-using subjects who reported lifetime CB use – these 6 subjects had an average lifetime use of 4.16 ± 4.23.
269-1	42566-42571	Based	_	
269-2	42572-42574	on	_	
269-3	42575-42576	6	_	
269-4	42577-42580	out	_	
269-5	42581-42583	of	_	
269-6	42584-42586	31	_	
269-7	42587-42596	non-using	_	
269-8	42597-42605	subjects	_	
269-9	42606-42609	who	_	
269-10	42610-42618	reported	_	
269-11	42619-42627	lifetime	_	
269-12	42628-42630	CB	_	
269-13	42631-42634	use	_	
269-14	42635-42636	–	_	
269-15	42637-42642	these	_	
269-16	42643-42644	6	_	
269-17	42645-42653	subjects	_	
269-18	42654-42657	had	_	
269-19	42658-42660	an	_	
269-20	42661-42668	average	_	
269-21	42669-42677	lifetime	_	
269-22	42678-42681	use	_	
269-23	42682-42684	of	_	
269-24	42685-42689	4.16	_	
269-25	42690-42691	±	_	
269-26	42692-42696	4.23	_	
269-27	42696-42697	.	_	
